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Introduction 
The mammalian retina 
The retina is a light sensory organ lying in the back of the eyeball. This neural 
tissue consists of five major neuronal cell classes which are organized in three 
nuclear layers. There are two types of 
photoreceptors in the outer nuclear layer (ONL); 
rods for low light levels and cones for bright 
light, acuity and color vision. Photoreceptors lie 
at the back of the retina and their light-sensitive 
cell compartments, the outer segments (OS), 
are embedded in the retinal pigment epithelium 
(RPE). Light has to pass through the entire 
transparent tissue to stimulate the receptor cells. 
The second layer is named inner nuclear layer 
(INL) and consists of excitatory bipolar cells, 
inhibitory horizontal cells and amacrine cells. The ganglion cell layer (GCL) 
forms the third cell layer and is occupied by ganglion and amacrine cells. 
Ganglion cells have axons that reach to higher visual brain centers. The 
photoreceptors are connected to bipolar and horizontal cells in the outer 
plexiform layer (OPL). In the inner plexiform layer (IPL), bipolar cells are linked 
to amacrine and ganglion cells. Synaptic 
connections are made in these plexiform layers. 
The OPL and IPL are largely devoid of cell bodies 
(1) .  
The retina has to be considered as a delocalized 
brain area specialized to sense light signals and 
process this information before relaying it to 
further downstream brain centers. The vertical 
excitatory signal flow is shown in Figure 2. 
Many photoreceptors convert light signals into chemical signals that a few 
downstream bipolar cells read and transmit to a ganglion cell. At the bipolar cell 
ONL
INL
GCL
Figure 1 Retinal cross section, 
nuclear layers are shown in 
white (DAPI staining) 
OFF ON
OFF ON INL
IPL
OS
Figure 2 Scheme of excitatory 
retinal signal flow 
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level, light information also diverges into two major pathways, one being 
activated by increments of light (ON) and the other one by decrements of light 
(OFF). Morphologically, OFF bipolar cells meet OFF ganglion cells in the more 
upper part of the IPL whereas corresponding ON cells are connected in the 
lower IPL. At least ten types of bipolar cells lead to a formation of different 
parallel channels in the retina, each representing a different aspect of the visual 
input (2, 3) Higher grades of signal processing are mediated by inhibitory 
horizontal cells (in the OPL) and amacrine cells (in the IPL). In ganglion cells, 
these processed signals are coded into action potentials that are transmitted via 
axons to the higher visual centers.  
Phototransduction cascade 
The initial step of visual perception is the detection of photons by 
photoreceptive pigments, called opsins, in the outer segments of photoreceptor 
cells. The impact of 
a photon on an 
opsin changes its 
conformation and a 
G-protein signal 
cascade starts. 
Activated G-protein 
subunits activate a 
phosphodiesterase 
that reduces the 
cellular 
concentration of 
the second 
messenger cyclic 
GMP (cGMP). Low cellular cGMP levels induce the closure of cGMP-dependent 
Na+ channels. If positive ions stop diffusing through the channels into the 
photoreceptor cell, the membrane voltage becomes more and more negative 
relative to the outside. This hyperpolarization blocks the release of the 
neurotransmitter glutamate to the synaptic cleft at the photoreceptor terminal.  
cGMP
Phoshodiesterase
cGMP‐dependent
Na+ channels
Rhodopsin/
Opsin
Transducin
G‐protein
Na+ influx
intra
extra
cGMP level 
is high
cGMP level 
is low
Figure 3 Scheme of the phototransduction cascade 
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Differences in glutamate concentrations in the synaptic cleft are detected by 
downstream bipolar and horizontal cells and at this point, light signals are 
translated into neurochemical signals. Photoreceptors are depolarized in the 
dark and continuously release glutamate. The involvement of a signal cascade 
slows down the signal flow but more importantly, it amplifies the signal giving 
the detecting system a high sensitivity. A set of other proteins is involved in 
stopping, recharging and maintaining the phototransduction cascade (4). The 
phototransduction cascade is very similar between rod and cone photoreceptors 
but differs in the protein variants leading to spectral and sensitivity differences.  
Light adaptation and microRNAs as molecular regulators 
One important feature of the retina is its ability to adapt and maintain light 
sensitivity over an enormous range of light intensities. This adjustment 
increases sensitivity of the visual system at low light levels by improving the 
signal-to-noise ratio and prevents saturation at high light levels. Adaptation 
takes place at different levels in the retina, both in photoreceptors (5, 6) and in 
inner retinal neurons (7). The temporal features also range from millisecond 
timescales to hours. At longer timescales, light adaptation at the cellular level 
involves changes of gene expression that set the cell to the adapted state. Little 
is known about the cellular events that control the changes in gene expression. 
Recent research draws the attention to small non-coding RNA molecules, 
microRNA (8). These 21 nucleotide single-stranded RNA molecules interact 
with messenger RNA (mRNA) molecules and influence their translation to 
proteins by degrading mRNA or its removal from the translational machinery. 
According to target binding algorithms, microRNA molecules have the potential 
to bind and thereby affect various cellular mRNA targets. (8) The field of 
microRNA research is relatively young especially in the retina and many cellular 
functions of microRNAs have yet to be explored, exciting my exploratory 
interest. 
Retinitis Pigmentosa 
Retinitis pigmentosa (RP) refers to dysfunctions of retinal function leading to the 
loss of vision (9). Historically, RP was thought to be an inflammation of the 
retina but intensive research over the last 150 years tracked back the cause of 
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the disease to genetic lesion (10). These mutations primarily affect rod 
photoreceptors and affect genes involved in the phototransduction cascade, 
cellular structure (such as the outer segments), transcription factors, 
photoreceptor catabolism, mitochondrial metabolism and also many genes of 
unknown function. Today, more than 100 mutations in 44 genes have been 
mapped that affect rod photoreceptors, all leading to a similar pathology. 
Normally, the onset of the disease in humans is in their adulthood, leading to 
night blindness. Dysfunctional rod photoreceptors start to die from the retinal 
periphery. This retinal degeneration (RD) progresses to the central part of the 
retina also affecting cone photoreceptors leading to a loss of daytime vision and 
visual acuity. The lingering degeneration can cause overall blindness. Treating 
RP patients is a very difficult task not only due to RP’s genetic complexity but 
also the fact that the patients realize their condition too late after the onset of 
rod photoreceptor death. Most therapies aim to slow down retinal degeneration 
to preserve resting vision. It was postulated that cone photoreceptor cells follow 
rods in degeneration leading to a photoreceptor free retina. Recent research 
(11) indicated that cones change their morphology and lose their light-sensing 
outer segments but persist in a non-functional dormant state. However, the loss 
of OS makes cones light-insensitive and it is unknown if remaining cone 
photoreceptors are accessible for therapeutic intervention.  
“Optogenetic” tools 
In our visual system photoreceptors with their phototransduction machinery 
convert photons to chemical signals. In prokaryotic organisms, single proteins 
mediate light sensation. Intensive screening and characterization has provided 
us with a genetic toolbox of light-sensing proteins, called optogenetic 
modulators (12-14). If these genes are exogenously expressed in neurons, one 
can activate (depolarize) or silence (hyperpolarize) the cells simply by shining 
light. Because a single gene mediates light sensitivity and substitutes for an 
entire phototransduction cascade, optogenetic tools are ideal candidates to 
confer light sensitivity to disease-caused light-insensitive retinas. This approach 
was shown to restore light perception in animal models of RP by creating 
artificial photoreceptors out of inner retinal neurons (15-17).  
6
 
 
Retinal gene transfer 
The big challenge is to deliver genes to retinal cells in a cell-type-specific 
manner. The three main parameters are timing (regarding retinal development 
or disease onset, for example), efficiency and specificity of gene expression in 
targeted cells. One way is to simply inject naked DNA molecules close to retinal 
cells and induce the uptake by electric pulses. This technique is called in vivo 
electroporation (18). One advantage is the possibility of delivering genes 
without size limitations but on the other hand, there is only a short window 
during retinal development for intervention leading to stable gene expression. 
The use of cell-type-specific promoters can make this gene transfer specific but 
the overall efficiency would be very low (19). Viral delivery tools bear several 
advantages for efficiency and specificity and can be used to bring genes into 
the developing as well as into the adult retina. The most commonly used gene 
delivery tool resorts to non-pathogenic Adeno-Associated-Viruses (AAV) (20). 
These relatively small viral capsids (20 nm in diameter) contain 4.7kb single-
stranded DNA genomes. Recombinant AAVs are exploited for their viral genes 
and promoters except the genome flanking inverted tandem repeats (ITRs). The 
rest of the AAV genome can be replaced by engineered DNA fragments of 
choice. Cell type expression patterns can be obtained by using cell type specific 
promoters and by modifying the viral capsids. AAV capsid proteins interact with 
host cell surface receptors and pseudotyping (using capsid proteins from other 
AAV types) influences host cell tropism. AAVs are easy to produce (genome 
generation and assembling to infectious particles), they do not replicate in host 
cells and their genomes persist in the host cell genomes as stable episomal 
DNA aggregates. In combination with chosen promoters, the expression of 
genes from AAV genomes can be very efficient and stable for longer periods. 
AAVs are used for human gene transfer approaches (21). The retina is 
predestined for using AAVs because it lies at the back of the eyeball which as a 
closed compartment reduces diffusion of injected AAV particles. One can also 
control the injection site. A subretinal injection targets mostly RPE and the ONL 
whereas intra vitreal injections promote AAV uptake in ganglion and INL cells.  
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Chapter  1:  Genetic  reactivation  of  cone  photoreceptors  restores  visual 
responses in Retinitis pigmentosa 
My main project dealt with the functional repair of light-insensitive 
morphologically-altered cone photoreceptors in RP mouse models. The idea 
was to introduce a hyperpolarizing optogenetic tool into persisting cone 
photoreceptors after complete rod degeneration to retinas of mice suffering from 
slow and fast forms of retinal degeneration (s-RD and f-RD mice). 
 
Figure 4 Scheme of RD forms (ONL in dark gray, IPL in light gray). 
The functional reactivation of photoreceptors at the entry level of light 
perception was advantageous for preserving downstream retinal processing to 
restore vision and not only light perception. I will show reactivated sophisticated 
and complex vision in former blind mice, as well as the first steps for translating 
this biomedical approach from mice to humans.  
Chapter  2:  Characterization  of  microRNAs  induced  by  light  adaptation  in 
mouse  retina  reveals  rapid  turnover  as  a  common  property  of  neuronal 
microRNAs 
The field of microRNA research in the retina but also in general is relatively 
young and little is known about microRNA functions. My second more basic 
research project was to study the functional roles of microRNA in the retina. 
OFF ON
OFF ON
OFF ON
OFF ON
OFF ON
OFF ON
wild type S‐RD f‐RD
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Everything started with a screen of expressed microRNA in the mouse retina at 
two states of light adaptation conditions: dark or light adapted.  Differences in 
microRNA level in dependence of the light adaption state revealed a rapid 
turnover of these small molecules in the retina and more generally in neurons. I 
contributed to the understanding of how light adaptation occurs at the molecular 
level in photoreceptors and that microRNA levels can be highly dynamic in 
neurons. 
Chapter 3: Side projects 
During my PhD thesis, I made molecular tools, such as the generation of a 
transgenic mouse line that expresses a calcium sensor in a subset of retinal 
cells (22)In another project, I used in silico approaches to identify target 
molecules whose expression might be altered in the hippocampus due to the 
manipulation of epigenetic repression. I verified in silico results by combining 
robotics with high throughput quantitative real time PCR (23). Furthermore, I 
learned techniques for retinal gene transfer and contributed to the generation of 
artificial photoreceptors out of inner retinal cells to restore vision in a RP mouse 
model (16).  
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Chapter 1  ­ Genetic reactivation of cone photoreceptors restores 
visual responses in Retinitis pigmentosa  
 
 
Volker Busskamp, Jens Duebel, David Balya, Mathias Fradot, Tim James 
Viney, Sandra Siegert, Anna C. Groner, Erik Cabuy, Valérie Forster, Mathias 
Seeliger, Martin Biel, Peter Humphries, Michel Paques, Saddek Mohand-Said, 
Didier Trono, Karl Deisseroth, José A. Sahel, Serge Picaud & Botond Roska 
 
This work is published as a research article in Science  
(Volker Busskamp, et al. Science 329, 413 (2010)) 
 
 
(This image shows reactivated cones (green) that project on one retinal ganglion cell 
(magenta). This image served as the cover of the July 23rd 2010 Science issue)  
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Abstract 
Retinitis pigmentosa refers to a diverse group of hereditary diseases that lead to 
incurable blindness, affecting two million people worldwide. As a common 
pathology, rod photoreceptors die early, whereas light-insensitive, 
morphologically altered cone photoreceptors persist longer. It is unknown if 
these cones are accessible for therapeutic intervention. Here, we show that 
expression of archaebacterial halorhodopsin in light-insensitive cones can 
substitute for the native phototransduction cascade and restore light sensitivity 
in mouse models of retinitis pigmentosa. Resensitized photoreceptors activate 
all retinal cone pathways, drive sophisticated retinal circuit functions (including 
directional selectivity), activate cortical circuits, and mediate visually guided 
behaviors. Using human ex vivo retinas, we show that halorhodopsin can 
reactivate light-insensitive human photoreceptors. Finally, we identified blind 
patients with persisting, light-insensitive cones for potential halorhodopsin-
based therapy. 
Results and discussion 
Retinitis pigmentosa (10, 24) is the result of diverse mutations in more than 44 
genes expressed in rod photoreceptors (25); which then degenerate, causing 
loss of night vision. Subsequently, cone photoreceptors, which are responsible 
for color and high-acuity daytime vision, progressively lose their photoreceptive 
outer segments, leading to overall blindness. Despite this loss of sensitivity, 
cone cell bodies remain present longer than rods in both humans and animals 
(11, 26, 27) but it is not known whether these light-insensitive cells can be 
reactivated or if information from them can still flow to downstream visual 
circuits (Fig. 1A) for a substantial time window after the loss of photosensitivity 
(28). 
To restore light-evoked activity in light-insensitive cone photoreceptors we 
genetically targeted a light-activated chloride pump (12, 29, 30), enhanced 
Natronomonas pharaonis halorhodopsin (eNpHR) (14, 31), to photoreceptors by 
means of adeno-associated viruses (AAVs) (32, 33). Light-activated chloride 
pumps are rational candidates for reactivating vertebrate photoreceptors as 
both eNpHR-expressing cells (14) and healthy photoreceptors hyperpolarize in 
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response to increases in light intensity. We selected two animal models of 
Retinitis pigmentosa for gene therapy, both of which lead to retinal degeneration 
(RD). Cnga3-/-; Rho-/- double-knockout mice served as a model of slow forms of 
RD (s-RD mice) (34), and Pde6brd1 (also known as rd1) mice as a model of fast 
forms of RD (f-RD mice) (35). Targeted expression of eNpHR was 
accomplished with the use of three cell-specific promoters (Fig. 1B): (i) human 
rhodopsin (hRHO) (36); (ii) human red opsin (hRO) (37); and (iii) mouse cone 
arrestin-3 (mCAR)(38). 
 
Figure 1. Scheme of the excitatory pathways of cone retinal circuitry in WT and RD 
retinas. (A) Cone photoreceptors (cPR) in WT retinas (left) detect light with 
photopigments in their outer segments (OS). Cone cell bodies are located in the outer 
nuclear layer (ONL). Cones provide input to ON and OFF bipolar cells (BC) that have 
cell bodies in the inner nuclear layer (INL). Bipolar cells are connected to 
corresponding ON and OFF ganglion cells (GC). Ganglion cell bodies are in the 
ganglion cell layer (GCL), and their axons relay visual information to higher visual 
centers. The locations of inhibitory interactions mediated by horizontal cells in the outer 
plexiform layer (OPL) and by amacrine cells in the IPL are indicated by gray boxes. 
Light-insensitive RD cones (right) lack outer segments, but their cell bodies (green) 
persist longer than rods. (B) AAV-expression constructs. hRHO, hRO, or mCAR 
promoters drive eNpHR-EYFP. 
To assess the effectiveness and specificity of the promoters, we used eNpHR 
fused to enhanced yellow fluorescent protein (31) (EYFP) (Fig. 2, A to I). It is 
important to restrict the expression of eNpHR to photoreceptors only, because 
eNpHR in downstream retinal circuit elements, such as ON-bipolar and ON-
ganglion cells, may inhibit the flow of information across the retina. Enhanced 
green fluorescent protein (EGFP)-expressing AAVs were used as controls 
throughout this study (fig. S1). We selected the hRO and mCAR promoters for 
s-RD mice (Fig. 2, B and C) and the mCAR promoter for f-RD mice (Fig. 2F), on 
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the basis of their ability to selectively drive expression of eNpHR-EYFP in a high 
percentage of cone photoreceptors (figs. S2 and S3). 
 
Figure 2. Targeted expression of a light-sensitive chloride pump in persisting 
photoreceptors in RD retinas. (A to I) Cross sections of GFP-immunostained (35) 
retinas transduced by hRHO- (A, D, G), hRO- (B, E, H), and mCAR- (C, F, I) eNpHR-
EYFP AAVs in s-RD (A to C), f-RD (D to F), and WT (G to I) mice. Left panel of each 
pair, eNpHREYFP; right panel of each pair, co-stained with 4´,6´-diamidino-2-
phenylindole (DAPI). Scale bar, 20 mm. 
The life span of cones in RDmice defines the window of opportunity for 
reactivation. Therefore, we tested EYFP or EGFP expression driven by the 
mCAR promoter at different time points during retinal degeneration. 
Surprisingly, EYFP and EGFP expression lasted more than eight months (Fig. 
3A, fig. S4, last tested f-RD at postnatal day 264 (P264) and s-RD at P255), 
longer than opsin protein expression [~P95 (11) or between P21-P110 (39)] We 
isolated these long-lasting AAV- transduced cells from f-RD retinas at different 
time points and verified their identity by analyzing their ranscriptome (P110 to 
P220, fig. S5). Cone-specific genes were expressed in the isolated cells, 
whereas markers of other retinal cell types were absent, suggesting that AAV-
labeled cells are altered cones, even at later stages of degeneration. The fact 
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that opsin mRNA remained, whereas the opsin protein did not, suggests 
translational down-regulation of opsins, as also shown before (39). We estimate 
that ~27% of cones remain between P184 and P255 in s-RD and ~25% remain 
between P182 and P264 in f-RD mice (Fig. 3A). 
Figure 3. Light responses in surviving eNpHR-expressing RD cones. (A) (Left) 
Confocal top views of GFP-immunostained RD photoreceptors transduced by mCAR-
eNpHR-EYFP in P255 s-RD (top) and P264 f-RD (bottom) retinas. Left panel of each 
pair, eNpHR-EYFP; right panel of each pair, co-stained with DAPI. Scale bar 20 mm. 
(Right) Estimated fraction of surviving cones (see Material and Methods) in s-RD and f-
RD mice at different time points compared with WT cone numbers. n, number of retinas 
analyzed. (B) (Left) Photocurrent action spectrum of an eNpHR- (black) or EGFP- 
(gray) expressing s-RD cone. Top, color-ramp; bottom, light flashes. Gray bars indicate 
the timing of the full-field light stimuli. (Right) Magnitude of photocurrents in 
photoreceptors expressing eNpHR or EGFP. Dashed lines show the peak magnitude of 
photocurrents in WT cones (short dashes) and WT rods (long dashes). Stars indicate 
statistical significance (see Material and Methods). (C) Peak and steady-state 
photocurrents (0.5-s flash) in RD and WT animals. (D) Rise and decay time constants 
of eNpHR-mediated photocurrents compared with the rise time constant in WT 
photoreceptors. (E) eNpHR-mediated photocurrents in RD retinas at different holding 
voltages. Because the response properties in s-RD and f-RD mice were similar, the 
data from both mouse lineswere grouped in panels (C to E). All WT cone response 
data shown in Fig. 3 were taken from (40). Error bars indicate SEM. 
We tested whether eNpHR drives cone light responses in RD retinas at an age 
(P53 to P264, table S1) when many (s-RD) (34) or all (f-RD) (39) rods have 
already died. eNpHR-EYFP-expressing photoreceptors in s-RD and f-RD 
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retinas displayed larger (Fig. 3B and fig. S6), more sustained (Fig. 3C), and 
significantly faster (Fig. 3D) photocurrents than those of wild-type (WT) cones. 
The photocurrents peaked at 580 nm. Photoreceptors expressing only EGFP 
did not react to light. The magnitude of photocurrents in eNpHR-transduced s-
RD and f-RD mice were similar (Fig. 3B). The current size was independent of 
the holding voltage (Fig. 3E), a finding that is consistent with the view that the 
photocurrents are mediated by ion pumps (30). Photocurrents and voltages 
were modulated across three logarithmic units of intensities (fig. S6). In the 
absence of functional outer segments, which normally generate currents that 
depolarize photoreceptors in the dark, RD photoreceptors were expected to 
stay hyperpolarized. A hyperpolarized state would limit the ability of eNpHR 
currents to modulate synaptic transmission. However, the recorded eNpHR-
expressing RD photoreceptors were depolarized in the dark [–26 T 3 mV, n = 12 
cones; see supporting online material (SOM)]. 
The ability of eNpHR-reactivated RD photoreceptors to convey information to 
downstream retinal circuits depends on the presence of functional 
photoreceptor-to-bipolar cell synapses. As retinal degeneration progresses, 
these synapses morphologically reorganize (25). However, they still possess 
elements of both pre- and postsynaptic machinery (11). To test for potential 
signal flow from photoreceptors to ganglion cells, we recorded excitatory 
currents from ganglion cells, the output neurons of the retina. Ganglion cells in 
eNpHR-transduced s-RD and f-RD retinas displayed robust, light-evoked 
excitatory currents (Fig. 4A), indicating functional outer and inner retinal 
synaptic connections. The magnitudes of these excitatory currents were 
comparable to those in WTretinas (Fig. 4A). There were no measurable light-
evoked currents in the ganglion cells of retinas transfected with EGFP (Fig. 4A). 
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Figure 4. Light responses in eNpHR-expressing RD retinas. For each functional test, 
individual examples are shown on the left, followed by statistics on the right. (A) 
Ganglion cell excitatory currents. (Left) Light-evoked excitatory currents in ON (top), 
ON-OFF (middle), and OFF (bottom) ganglion cells in eNpHR-expressing s-RD retinas. 
Gray bars show the timing of the full-field light stimulus. (Right) Magnitude of light-
evoked peak excitatory currents in s-RD, f-RD, and WT mice; ON, OFF, and ON-OFF 
cells are pooled together. Full-field stimulus was used. (B) Ganglion cell spiking output. 
(Left) Top, spike recordings (four repetitions) from ON (left) and OFF (right) ganglion 
cells from an eNpHRexpressing f-RD retina; middle, spike frequency responses (gray 
bar shows the timing of a full-field light stimulus); bottom, corresponding cells filled with 
neurobiotin (green), choline acetyltransferase (magenta) as an IPL stratification 
marker, and DAPI staining (white) to visualize nuclear layers. (Right) Peak spike 
frequency distribution in response to full-field flash stimuli in s-RD, f-RD, and WT 
retinas. (C) Lateral inhibition. (Left) Top, spike trains from an OFF ganglion cell in 
response to light stimulation with a white spot of increasing size (three repetitions); 
bottom, corresponding spike frequency. (Right) Number of spikes evoked by 1-mm 
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diameter spot stimuli (center + surround stimulus) relative to the number of spikes 
evoked by a 0.1- to 0.2-mm spot (center stimulus). (D) Directional selective responses. 
(Left) Spike recordings during stimulation with a fast-moving bar (width, 200 mm; 
speed, 1.5 mm s–1; four repetitions) in the preferred direction (top) and in the opposite 
direction (“null” direction, bottom). Stimulus timing is shown by gray bars. (Right) 
Direction-selectivity index (see Materials and Methods (41)). (E) Light sensitivity. 
eNpHR-induced excitatory current responses in ganglion cells and photocurrents in 
photoreceptors as a function of light intensity. The gray lines at the bottom display the 
ranges of sensitivities for rods (only partially shown), cones, and intrinsically 
photosensitive ganglion cells (ipRGCs). The maximum light intensity at 580 nm allowed 
in the human eye, according to the 2006 European directives on artificial optical 
radiation (42), is shown by the vertical dashed line. In all panels, n, number of different 
cells from which we took our measurements; error bars, SEM; stars, statistical 
significance (see Materials and Methods). Light intensity was 1016 photons cm–2 s–1 for 
each experiment. 
The retina incorporates two major information channels that diverge at the level 
of bipolar cells and are physically separated by depth within the inner plexiform 
layer (IPL). ON cells are activated by light increments, whereas OFF cells are 
activated by light decrements (43). The activity of ganglion cells is coded by 
action potentials (“spikes”) that form the output signal of the retina (44) and the 
input signal to higher brain centers. Notably, light stimulation evoked excitatory 
currents and spiking activity in ganglion cells of eNpHR-transduced RD retinas, 
either at light increments, light decrements, or both (P53 to P264; Fig. 4, A and 
B). The dendritic processes of morphologically reconstructed ganglion cells 
were properly aligned in the corresponding ON or OFF strata (45) of the IPL 
(Fig. 4B). Ganglion cell spike frequencies spanned similar ranges in s-RD, f-RD, 
and WT retinas (Fig. 4B). Some ganglion cell types respond preferentially to 
changes in illumination and therefore spike transiently after a light step, 
whereas others represent the level of illumination and thus spike in a more 
sustained manner. The dynamics of spiking activity in eNpHR-transduced 
retinas varied from transient to sustained, as in WT retinas (fig. S7). Light-
stimulation of eNpHRreactivated photoreceptors in RD retinas even evoked 
ganglion cell spiking activity at later stages of degeneration (s-RD: <P255, f-RD: 
<P264; fig. S7). 
We next asked if basic forms of spatial processing were functional in the 
eNpHR-transduced RD retinas. Lateral inhibition is a conserved feature of 
vertebrate retinas that is important for spatial contrast (“edge”) enhancement. 
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When spots of increasing sizes were presented to eNpHRexpressing RD 
retinas, the responsemagnitude of ganglion cells reached a maximum and then 
gradually decreased, a sign of lateral inhibition (Fig. 4C and fig. S7) (43, 46). 
Lateral inhibition also results in ON-center, OFF-surround responses (43) that 
we were able to observe in eNpHR-expressing RD retinas (fig. S7). Another 
example of spatial processing is the directionalselective responses of types of 
ganglion cells to motion stimuli (47). The activity of directional selective ganglion 
cells is important for the optokinetic reflex (48). When eNpHR-transduced RD 
retinas were stimulated with bars moving in different directions, some ganglion 
cells responded preferentially to motion in a particular direction but produced 
little activity when the bar moved in the opposite direction (Fig. 4D) (49). This 
response asymmetry suggests that the retinal circuit for directional selectivity is, 
at least partially, maintained in RD retinas. 
The sensitivity of eNpHR to light is less than that of normal cones (Fig. 4E), and 
although normal cones can adapt to different light intensities, eNpHR-driven 
cones have a fixed sensitivity range (see SOM). However, the sensitivity of 
ganglion cells to light was 1.7 log units higher than that of the eNpHR-
expressing photoreceptors (Fig. 4E), and the light levels required for eNpHR 
stimulation at 580 nm are below the limit allowed for safe radiation of the human 
eye, according to the 2006 European directives on artificial optical radiation 
(Fig. 4E) (42). 
The slow and fast RD mouse models not only differ in the time course of 
photoreceptor degeneration, but also in the amount of light-driven activity 
present during development. s-RD mice have no light-sensitive rod-cone 
system during development (34), whereas f-RD mice lose the rod-cone function 
gradually and are blind by 4 weeks of age (35). In the retina, the responses in 
eNpHR-activated s-RD and f-RD mice were similar, suggesting that the 
development of the tested retinal functions, like direction selectivity, may not 
require light-driven input from rods and cones. Light stimulation of the eyes 
resulted in visually evoked potentials in eNpHR-expressing f-RD mice but not in 
EGFP-transduced controls (P42 to P118, fig. S8). In contrast to the retina, we 
could not measure light-driven cortical activity in eNpHR-transduced s-RD mice. 
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We next evaluated whether light could induce behavioral changes in eNpHR-
transduced mice. In dark-light box tests (50), eNpHR-expressing f-RD and s-
RDmice performed significantly better than the corresponding EGFP-expressing 
control groups (P44 to P143, Fig. 5A), and the increased performance 
depended on the illumination level (Fig. 5B). In the optomotor reflex test (51), 
only eNpHR-expressing f-RD mice performed better than EGFP-expressing 
control mice at a variety of drum speeds (P69 to P153, Fig. 5C).WT (fig. S8) 
and f-RD responses both peaked at the same speed. The optimum spatial 
frequency was higher for WT animals [0.26 cycles per degree (cpd)] compared 
to f-RD (0.13 cpd). These experiments demonstrated that resensitized 
photoreceptors are able to drive visually guided behavior in f-RD mice and, to 
some extent, in s-RD mice. 
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Figure 5. Visually guided behavior in eNpHR-expressing RD mice. (A) Dark-light box 
experiment. Percentage of time the AAV-injected RD animals and WT mice spent in 
the light compartment. (B) Darklight box test. Percentage of time mice spent in the light 
compartment as a function of light intensity. (C) Optomotor response score of eNpHR- 
or EGFP-expressing RD animals at different rotational speeds and spatial frequencies. 
rpm, revolutions per minute. In all panels, n, number of different animals; error bars, 
SEM; stars, statistical significance (see Materials and Methods). 
To test for potential toxicity of eNpHR or the unmodified NpHR, we first 
compared the retinas of eNpHR-transduced WT mice (6 weeks after AAV 
administration) with those of normal WT mice. The number of photoreceptors 
was similar in both conditions (fig. S9), and, in addition to the light-induced 
spiking activity, ganglion cells in eNpHR-transduced WTretinas had awider 
action spectrum (a gain of function at longer wavelengths) than ganglion cells in 
uninjected WT retinas (fig. S9). This suggests that both intrinsic opsins and 
eNpHR are at work. Next, we compared the retinas of transgenic mice 
expressing NpHR in photoreceptors under the control of a bovine rhodopsin 
promoter with WT retinas and found similar numbers of photoreceptors (at 
P140, fig. S9). These results suggest that, in the studied time window, neither 
the unmodified NpHR nor eNpHR induced additional photoreceptor 
degeneration.  
 
The translation of gene therapy achieved in mice to human participants requires 
the use of promoters andAAV serotypes that drive photoreceptor-specific 
eNpHR expression in human retinas. Therefore, we tested ourAAVs on human 
ex vivo retinal explants (Fig. 6A), which we could keep in culture for 2 to 3 
weeks. Because of this short time window and the relatively long period of time 
required to efficiently express eNpHR from AAVs, we had to use 
immunohistochemistry to visualize eNpHR-EYFP protein expression in the 
cultured human retinas. Of the three promoters, mCAR directed expression of 
eNpHR specifispecifically in human photoreceptors (fig. S10). To reduce the 
time required to obtain robust eNpHR-EYFP expression, which is necessary for 
two-photon laser–targeted electrophysiology, we inserted the mCAR-eNpHR 
construct into a lentiviral vector (fig. S10) (52). Using this new vector, we found 
high levels of eNpHR expression, specifically in human photoreceptors after 
only 1 to 2 days of incubation (Fig. 6B and fig. S10). Brightly labeled 
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photoreceptors in the parafoveal region displayed photocurrents and 
photovoltages with spectral tuning reflecting eNpHR activation (Fig. 6C and fig. 
S10). We could not measure any photocurrents from control human retinas, 
even at the time when the retina was isolated.  
To find potential patients with retinitis pigmentosa eligible for eNpHR-mediated 
restoration of visual functions, we screened a database (see SOM) that 
contained records of retinal images acquired by optical coherence tomography 
(OCT), Goldman visual field tests, multifocal electroretinograms (ERGs), full-
field ERGs, and visualacuity tests. We identified legally blind patients (data from 
one of whom are shown in Fig. 6 and fig. S11) with no visible outer segments 
on OCT pictures, but cone cell bodies in the central region. These criteria may 
be used in the future for selecting patients who could benefit from this therapy.  
 Figure 6. Translational aspects of eNpHR-EYFP–mediated reactivation of 
photoreceptors. (A) Retinal slice from a human retinal explant (24 hours 
postmortem). Scale bar, 30 mm. (B) Fluorescent live image of a lentivirus-
transfected area from a human retina after 7 days in culture and 2 days after 
lentiviral administration. Scale bar, 20 mm. (C) Action spectrum of an eNpHR-
expressing human photoreceptor stimulated with full-field light flashes ranging 
from 450 to 650 nm (top, current response; bottom, voltage response). Gray 
bars indicate the timing of the stimulus. (D) Representative OCT scan covering 
the foveal region of a healthy individual. (E) Magnified image. IS, inner 
segments; RPE, retinal pigment epithelium. Scale bar, 200 mm. (F) OCT from 
the left eye of a 40-year-old male patient with sporadic retinitis pigmentosa (loss 
of vision since the age of 15). Outer segments are undetectable.  
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We have shown that a microbial gene introduced to surviving cone cell bodies 
reactivated retinal ON and OFF pathways and the retinal circuitry for lateral 
inhibition and directional selective responses. Moreover, the reactivated cones 
enabled RD mice to perform visually guided behaviors. The tested time window 
of intervention was up to ~260 days in f-RD and s-RD mice, suggesting that 
persisting cone cell bodies (~25%) are enough to induce ganglion cell activity, 
even during later stages of degeneration. Our finding that AAVs with the mCAR 
promoter specifically transduced human photoreceptors and the identification of 
patients with little measurable visual function and no outer segments but 
surviving cone cell bodies suggest a potential for translating eNpHR-based 
rescue of visual function to humans (see SOM). In the future, eNpHR-based 
restoration may be combined with other approaches that increase the survival 
of altered photoreceptors (39, 53-55). 
 
Supplementary discussion 
Selecting patients for possible eNpHR­based gene therapy. 
Possible criteria to stratify patients for eNpHR-based therapy include the 
following: No central visual field in Goldmann perimetry; legal blindness; and no 
visible outer segments on OCT pictures; but a layer of cone cells in the foveal 
region at least. There may, however, be several other factors for consideration 
when selecting patients. First, after losing central vision it is most often difficult 
to obtain good quality OCT due to the lack of fixation. Improved OCT imaging 
techniques (56) or, alternatively, a reversible blockade of muscle activity could 
overcome this difficulty. Second, the disappearance of the photoreceptor 
nuclear layer on OCT images may not necessarily be indicative of a complete 
photoreceptor loss: We found in the f-RD mouse model that, at later stages, the 
AAV-labeled cone cells did not form a distinct layer above the outer plexiform 
layer, but merged into the upper row of the inner nuclear layer. In Retinitis 
pigmentosa patients, even at late stages, the macula has a monolayer of cone 
cell bodies (27), which may not be detectable with current OCTs. New, high 
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resolution and fast scanning techniques (56) may facilitate the detection of even 
a single layer of cone cell bodies for eNpHR treatment. Third, we note that a 
major advantage of targeting remaining cone cell bodies with eNpHR, as 
compared with targeting bipolar or ganglion cells with channelrhodopsin (15, 
16), is that, unlike cones, bipolar and ganglion cells are not arranged in a 
mosaic in the fovea (since these cells are moved away from the path of light in 
the fovea) and, therefore, light stimulation with patterns will cause spatially 
irregular activation of bipolar and ganglion cells. Fourth, we noted in both the 
transgenic mice expressing NpHR on a wild-type background, and also in 
eNpHR-EYFP-AAV-injected wild-type mice, that normal visual function was 
preserved in these mice, and eNpHR-induced additional light sensitivity at 
longer wavelengths. This finding implies that it may even be beneficial to 
consider targeting cones with eNpHR in patients that who have not completely 
lost central vision (57). Since eNpHR is less sensitive than normal cones, 
stimulation will require image intensifier goggles (see below) and we predict that 
in the absence of these goggles the remaining natural vision would not be 
affected. This later approach should only be considered if clinical results with 
patients without any central vision are established and safety is proved. 
Light intensity requirements for eNpHR­based treatment. 
Since eNpHR is not able to adapt to different intensities, stimulator goggles with 
an adaptive front sensor array and an LED array (42, 58) (or other patterned 
light source) facing the eye will be needed, independent of the exact sensitivity 
range of these halobacterial sensors. Without the goggles, if the mean light 
intensity is too low, halorhodopsins will not respond, or, if the mean light 
intensity is too high, halorhodopsins will be saturated. The key point is that the 
sensitivity of halorhodopsins is tuned to intensities that are safe to use in the 
human eye. In this respect, the red-shifted spectra (peak at 580nm) of 
halorhodopsins compared to that of channelrhodopsin (peak at 470 nm, blue 
light) is of importance since blue light has a higher potential for inducing 
photochemical damage than yellow light (42). We envision that adaptation to 
the different background intensities of the visual world will be achieved by 
artificial image sensors in the goggles, similar to those used in commercial 
video cameras. Nevertheless, new mutants and other types of light-activated 
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ion pumps (59) that produce more current per captured photon can make it 
even more sure that the light intensity required to stimulate the eye is safe (42). 
There are two factors that it may be worth balancing for potential clinical trials. 
On the one hand, increasing the sensitivity of eNpHR-transduced cones, by 
enhanced expression of eNpHR or by increased current per photon, is 
beneficial. On the other hand, if the regained visual sensation may, for some 
unforeseen reason, cause headache or tiredness after long light exposure, 
eNpHR stimulation could be simply turned off by removing the stimulation 
goggles. Finally, light-sensitive pumps activated at different wavelengths (59) 
may open the way for restoring color vision. 
The state of cone photoreceptors in RD mice. 
Cones of healthy retinas respond to light with hyperpolarization caused by the 
closure of cyclic-nucleotide gated (CNG) channels (60) located in the cone 
outer segment. CNG channels are open in the dark, and their closure is 
controlled through a molecular cascade induced by the capture of photons by 
opsins. In later stages of RD, the outer segment of cones degenerate and, 
therefore, one would expect no dark current and, consequently, a 
hyperpolarized cone. In contrast, we found that RD cone cell bodies were 
depolarized at −26 mV. Although the reason for the depolarized state is 
currently not understood, we speculate here about a mechanism. One 
possibility is that CNG channels in RD retinas are present in the remaining cone 
cell body but these channels are no longer modulated by opsins. However, this 
explanation is inadequate because the CNG channels are not functional 
(Cnga3-/-) in s-RD mice, and CNG channel expression is low in f-RD mice (see 
Fig. S5). There are at least three other potential mechanisms. First, a 
compensatory mechanism may exist at the level of gene regulation that induces 
the expression of genes that keep the cell body in a depolarized state, for 
example by up-regulation of constitutively open Na+, Ca2+, or nonselective ion 
channels, either alone or in combination with the downregulation of K+ or Cl− 
channels. Second, depolarization can be achieved by a ligand, present in RD 
but not wild type retinas, that opens Na+, Ca2+, or nonselective ion channels or 
closes K+ or Cl− channels. Third, it is possible that the ion concentrations in the 
cone change in RD in such a way that a channel, for example a Cl− channel, 
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may have a new driving force. This last possibility alone is unlikely, since we 
controlled the ion concentrations in the recorded cone in our experiments. 
Finally, it is possible that the combination of these above events led to the 
depolarized state. 
Supplementary figures 
 
 
Supplementary Figure 1. (A) EGFP-expressing control AAV vectors. (B-E) Cross-
sections of hRHO-EGFP- (B), hRO-EGFP- (C), mCAR-EGFP- (D) transduced s-RD 
and mCAR-EGFP- (E) transduced f-RD retinas. Scale bar 20 μm. 
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Supplementary Figure 2. Efficiency of eNpHR expression from different promoters. 
Confocal top views of eNpHR-EYFP expressing, GFP-immunostained photoreceptors 
in s-RD (A-C), f-RD (E-G) and wild-type (I-K) retinas, promoters are indicated above. 
Scale bar 20 μm. (D, H, L) Percentage of transduced photoreceptors with different 
promoter constructs. (M-O) Confocal tile scans of GFP-immunostained s-RD (M, N) 
and f-RD (O) retinas. Scale bar 250 μm. 
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Supplementary Figure 3. The efficiency of cone photoreceptor targeting. (A, B) 
Percentage of transduced rods (A) and cones (B) by different promoter constructs 
quantified in wild-type retinas. 
 
 Supplementary Figure 4. Persisting eNpHR-EYFP or EGFP expression in RD retinas 
(P100-P248). (A, B) Left, confocal top view of GFP-immunostained s-RD (A) and f-RD 
(B) photoreceptors transduced by mCAR-EGFP. Right, co-stained with DAPI. (C-F) 
Cross-sections of GFP-immunostained s-RD retinas transduced by hRHO- (C), hRO- 
(D), and mCAR- (E, F) eNpHR-EYFP AAVs at P100 (C-E) and P175 (F, only mCAR-
eNpHR is shown). Scale bar 20 μm.   
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Supplementary Figure 5. Analysis of the transcriptome of eNpHR-EYFP and EGFP 
expression cells in f-RD retinas. (A) Microarray analysis of EGFP-expressing and 
FACS-sorted f-RD photoreceptors (from P110 and P220 mice, in quadruples), heat 
map shows known cone markers (61) and additional retinal cell-type markers. (B) 
Microarray analysis of eNpHR-EYFP-expressing FACS-sorted f-RD photoreceptors 
(from P165 mice, in quadruples).  
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Supplementary Figure 6. Functional properties of the light responses of the eNpHR-
expressing RD photoreceptors. (A) Two-photon laser scanning live image of 
photoreceptor cells expressing eNpHR-EYFP driven by the hRO promoter in an AAV-
injected s-RD retina. Scale bar 10 µm. (B) Action spectrum of eNpHR-expressing P255 
s-RD (top) and P264 f-RD (bottom) photoreceptors stimulated by full-field light flashes; 
gray bars indicate the timing of the stimulus. (C) Left, eNpHR-mediated modulation of 
photoreceptor membrane voltage from 9 to 125 Hz; right, normalized voltage response 
as a function of stimulus frequency (580 nm light). (D, E) Light-evoked changes of 
current (D) and membrane voltage (E) as a function of light intensity. “n” refers to the 
number of different cells we measured from.  
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Supplementary Figure 7. The properties of light responses of ganglion cells in 
eNpHR-expressing RD retinas. (A) Both transient and more sustained ganglion cell 
responses can be recorded in eNpHR-transduced RD retinas. Distribution of the 
estimated decay time of the spike frequency response to full-field flashes in s-RD, f-
RD, and wild-type (wt) retinas (difference between groups is not significant, p=0.17). 
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(B, C) Spiking frequency distribution in ganglion cells of eNpHR-transduced P184-255 
s-RD (B) and P262-264 f-RD (C) retinas. Full-field light stimuli. (D, E) The effect of 
lateral inhibition. Examples from four ganglion cells. Number of spikes (normalized to 
the mean of the peak response) as a function of stimulus diameter in ON-type (D) and 
OFF-type (E) ganglion cells. (F) Left, an ‘ON centre OFF surround’ response in 
ganglion cells of an s-RD and a wild-type retina. Excitatory currents evoked by 
stimulation with increasing spots and an annulus. Gray bars indicate the timing of the 
light stimulus. Note that the receptive field center stimulation with a spot evokes an ON 
response and the receptive field surround stimulation evokes an OFF response. 
Middle, magnitude of excitatory currents for the ON-centre and OFF surround 
responses as a function of stimulus size in s-RD ganglion cells. Right, comparison to 
wild-type responses. “n” refers to the number of different cells we measured from. (G) 
Age of AAV-injected RD mice used for testing light responses. Each row represents 
recordings with a particular AAV type, indicated on the left. The timeline at the bottom 
labels the age of RD mice. Each rectangle (s-RD) or triangle (f-RD) refers to recordings 
on a particular postnatal day.  
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Supplementary Figure 8. Visually evoked potentials (VEPs) in eNpHR-expressing RD 
and wild-type mice (wt). (A) Examples of VEPs recorded in the visual cortex. (B) VEP 
response amplitudes. The intensity of light was 1016 photons cm–2 s–1 at the eye 
surface (C) Optomotor response score of female wild-type mice (51) at different 
rotational speeds and spatial frequencies. “n” refers to the number of different animals 
we measured from. 
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Supplementary Figure 9. eNpHR and NpHR expression is not cytotoxic to wild-type 
photoreceptors. (A) Photoreceptor density measured in confocal horizontal planes (see 
Materials and methods) of uninjected wild-type (wt), wild-type injected with three 
different eNpHR-EYFP-expressing AAVs, and bRHO-NpHR-EYFP transgenic mice. (B) 
Action spectra of AAV-transduced wild-type retinas with eNpHR (black, merged hRO 
and mCAR), NpHR (dashed black, hRHO), uninjected wild-type retinas (dark gray), and 
bRHO-NpHR-EYFP transgenic retinas (light gray) by multi-electrode array recordings. 
“n” refers to the number of different cells we measured from. (C) Cross-section of a 
bRHO-NpHR-EYFP transgenic mouse retina (P140). Left, EYFP signal; right, merged 
with DAPI. Scale bar 20 μm. 
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Supplementary Figure 10. Viral targeting of 
photoreceptors in ex vivo post-mortem human retinal 
cultures. (A) Left, confocal cross-section of GFP-
immunostained AAV-transduced eNpHR-EYFP-expressing 
human photoreceptors. Right, merged with DAPI staining 
(white). (B) Lentiviral eNpHR-EYFP expression construct: 
SIN-LTR, self-inactivating long tandem repeat; ψ, extended 
packaging signal; cPPT, central polypurine tract; WPRE, 
woodchuck hepatitis virus post-transcriptional regulatory 
element. (C-E) Confocal image of GFP-immunostained 
(green) photoreceptors. Top view (C), side view (D), and 
side view together with DAPI staining (white, E). (F) 
Confocal image (top view) of a lentivirus-transduced area 
of a human retina after 7 days in culture and 2 days after 
lentiviral administration. Scale bars 20 μm. (G) eNpHR-
mediated modulation of human photoreceptor membrane 
voltage with light pulses from 9 to 125 Hz.    
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Supplementary Figure 11. Enlarged view of the OCT image of the patient shown in 
Fig. 6F. Left eye of a 40 year-old man with sporadic RP. Loss of vision since the age of 
15. Visual acuity, hand motion. Flat ERG. No detectable visual field. While the ONL 
and inner segments (IS) are clearly delineated, there are no detectable outer 
segments. The retinal pigment epithelium (RPE) and the Bruch membrane are 
indicated. 
Supplementary tables 
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My contribution 
My contribution to the following research article “Genetic reactivation of cone 
photoreceptors restores visual responses in Retinitis pigmentosa” published as 
a research article in Science was the following: I developed the underlying idea 
to express a hyperpolarizing light-sensitive chloride pump specifically in RD 
photoreceptors. I designed and tested all plasmids and AAV vectors (shown in 
Fig. 1 and S1). I performed all in vivo AAV injections in mice that were used for 
this study, I also transfected human retinas in vitro with lentiviral vectors (see 
Fig. 6 and S10). All immunohistochemistry, confocal microscopy, image 
processing and transfection quantifications (shown in Fig. 2-4, S1- S4, S9 and 
S10) were performed by me (except S10A). One of my images was selected as 
the cover image for the Juli 23rd 2010 Science issue. I recorded spikes from 
reactivated RD retinas using a multi-electrode array setup and analyzed these 
data (shown in Fig. 3 and S9). I planned and designed the plasmids to generate 
a transgenic mouse that was used as a control for cell toxicity of the light sensor 
(see Fig. S9). I performed the dark-light box behavioral assays and the 
optomotor response test (see Fig. 5 and S8). I dissociated GFP-labeled RD 
photoreceptors that were used for fluorescent-activated cell sorting following 
gene chip experiments (Fig. S5). I designed most experiments except two-
photon targeted patch clamp recordings, cortical recordings, isolation of human 
post-mortem retinas, gene chip analysis and optical coherence tomography 
(OCT) of human eyes. I actively wrote the paper and contributed in the 
reviewing process.  
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Summary 
Adaptation to different levels of illumination is central to the function of the 
retina. Here we demonstrate that levels of the miR-183/96/182 cluster, miR-204, 
and miR-211 are regulated by different light levels in the mouse retina. 
Concentrations of these microRNAs were down-regulated during dark 
adaptation and up-regulated in light-adapted retinas, with rapid decay and 
increased transcription being responsible for the respective changes. We 
identified the voltage-dependent glutamate transporter Slc1a1 as one of the 
miR-183/96/182 targets in photoreceptor cells. We found that microRNAs in 
retinal neurons decay much faster than microRNAs in non-neuronal cells. The 
high turnover is also characteristic of microRNAs in hippocampal and cortical 
neurons, and neurons differentiated from ES cells in vitro. Blocking activity 
reduced turnover of microRNAs in neuronal cells while stimulation with 
glutamate accelerated it. Our results demonstrate that microRNA metabolism in 
neurons is higher than in most other cells types and linked to neuronal activity. 
 
Introduction 
The first steps of vertebrate visual processing occur in the retina (62, 63). Light 
is converted to neural signals by photoreceptors, the more sensitive rods and 
the less sensitive cones, which can adapt to several log unit changes in 
intensity, enabling the rest of the visual system to remain responsive over an 
intensity span of ~8 log units. Information flows from photoreceptors to bipolar 
cells and then to ganglion cells, which then communicate with higher brain 
centers. The transfer of information from photoreceptors to bipolar cells is 
modified by the inhibitory horizontal cells in the outer plexiform layer (OPL), and 
from bipolar to ganglion cells by the inhibitory amacrine cells in the inner 
plexiform layer (IPL). The cell bodies of these neurons are located in distinct 
retinal layers: photoreceptors in the outer nuclear layer (ONL); bipolar-
horizontal-amacrine cells in the inner nuclear layer (INL); and amacrine and 
ganglion cells in the ganglion cell layer (GCL).  
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Adaptation to different light levels in the retina occurs on a timescale ranging 
from milliseconds to hours depending on the mechanism involved. The most-
studied cellular site of light-dark adaptation are the photoreceptors, where both 
the light-sensing (63) and adaptation machinery have been described in detail 
(64). In addition, different light-dark adaptation phenomena have also been 
noted in other cellular components of the retinal network, proximal from 
photoreceptors, in the INL and GCL (7). The coordination and regulation of the 
molecular network in different states of light-dark adaptation is not well 
understood. In this work, we investigated whether the process of light-dark 
adaptation in the mouse retina involves microRNAs (miRNAs). The layered 
organization of the retina and the fact that retinal cells activity can be controlled 
in vivo by light, the physiological input, make the retina a good model to study 
miRNAs regulation in neural circuits. 
In mammals, miRNAs generally base-pair imperfectly to sequences in the 3’-
untranslated region (UTR) of target mRNAs and repress protein synthesis, 
either by inhibiting translation of mRNAs or causing their destabilization (65) 
(66). miRNAs are implicated in the control of many fundamental processes and 
most miRNAs are expressed in a development- or tissue-specific manner (66) 
(67). In particular, many miRNAs are specifically expressed or enriched in 
neuronal cells, including those of the retina(68-71), consistent with growing 
evidence of importance of miRNAs for brain development and function(72, 73).  
Hundreds of different miRNAs have been characterized in mammals. They are 
either encoded by independent genes or are excised from introns. During 
miRNA processing, primary transcripts (pri-miRNAs) are first cleaved in the 
nucleus to ~70-nt-long pre-miRNA hairpins, which are then matured in the 
cytoplasm to miRNAs (74). Although details of miRNA biogenesis and its 
regulation are quite well established, little is known about catabolism of 
miRNAs. They are generally assumed to have a very long half-life, 
corresponding to many hours or even days (75-77). However, such a slow 
turnover may not be a universal feature of miRNAs since they often play a role 
in rapid developmental transitions or act as on and off switches, conditions 
which call for a more active miRNA metabolism (66, 67).         
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We found that a subset of miRNAs is reversibly up- and down-regulated in vivo 
in the retina during light-dark adaptation, independent of the circadian rhythm. 
The sensory neuron-specific miR-183/96/182 cluster, and miR-204 and miR-
211, are down-regulated during dark adaptation and up-regulated in light, with 
rapid miRNA decay and increased transcription being responsible for the 
changes. One of the identified targets of the light-regulated miRNAs, Slc1a1, 
might fine-tune synaptic function in different light-adaptation states. Finally, we 
found that fast turnover of many miRNAs is not limited to the retina but is a 
general property of neurons, and that activity is an important regulator of miRNA 
turnover in neurons.  
 
Results 
miRNAs expressed in dark­ and light­adapted mouse retina 
We characterized populations of small RNAs isolated from retinas of mice 
adapted to either light or dark (see Supplementary Experimental Procedures). 
To obtain a global picture of small RNAs expressed in these two conditions, 
cDNA libraries of gel-purified small RNAs were subjected to deep sequencing 
using the 454 methodology. Analysis of ~75,000 reads identified 253 retinal 
miRNAs expressed in either dark-adapted (DA) or light-adapted (LA) states 
(Figure S1A; Table S1). miRNAs, whose levels increased in LA retina included 
those encoded by the intergenic miR-183/96/182 cluster and intronic miRNAs 
miR-204 and -211 (Figure 1A, B; Table S1), identified previously as being 
expressed in the retina(69-71, 78). Two other platforms were also used to 
globally assess the effect of light on miRNA levels in the retina: Exiqon arrays 
and Illumina deep sequencing. A light-induced increase in the level of miR-
183/96/182 cluster miRNAs was seen in two independent array experiments, 
while increases in miR-204/211 was only detected in one (Figure 1A; Table S1). 
The Illumina sequencing did not yield consistent results. In one experiment, 
miR-96, -204, and -211 (but not miR-182 and -183) were up-regulated 1.5- to 
2.5-fold in LA retina, but in another experiment no stimulatory effect was 
observed (data not shown); possibly, ~2-fold effects are too small to be 
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reproducibly quantified by this method. To quantify miRNA levels by other, more 
direct techniques, the light-dependent changes in selected miRNAs were 
determined by quantitative real-time PCR (qRT-PCR) and RNase protection 
assays (RPA). These analyses demonstrated that expression levels of miRNAs 
encoded by the miR-183/96/182 cluster, and miR-204 and -211, increased 1.5- 
to 2.5-fold in LA retina (Figure 1C, D). Since a light-induced increase in the level 
of these miRNAs was detected by at least three independent methods, they 
were selected for further analysis (for comparable changes in expression of 
these miRNA ascertained by still another independent method, see below). It 
should be noted that both 454 and Exiqon I analyses identified light-dependent 
changes in a number of miRNAs other than miR-183/96/182, and miR-204 and -
211. Since these changes were not confirmed by other analyses, these miRNAs 
were not further investigated. The levels of miRNAs let-7b and miR-29c (Figure 
1A, C and D) did not change significantly in any analyses, and these miRNAs 
were therefore used as controls.  
The miR-183/96/182 cluster miRNAs have related seed sequences, while the 
seeds of miR-204 and -211 are identical. The latter two miRNAs are excised 
from introns of two related protein-coding genes, Trpm3 and Trpm1, which are 
expressed in the retina (Figure 1B; see also Figure S2B). Since the levels of 
miR-183/96/182 miRNAs have been reported to vary ~2-fold during the day 
(71), we verified that the alterations observed by us were not due to changes in 
gene expression associated with the circadian rhythm. For the miR-183/96/182 
cluster and other miRNAs tested, increased accumulation upon light adaptation 
occurred independently of whether the measurements were performed at noon 
[Zeitgeber (ZT) 6] or at midnight (ZT18) (Figure S1B, C). 
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Figure 1. Differences in miRNA levels between LA and DA retinas.  (A) Number of 
reads determined by 454 sequencing and Exiqon array hybridization signals (from two 
independent experiments) for selected miRNAs expressed in DA and LA retinas. NA, 
signal intensity close to background. (B) Schemes of genomic organization of the 
intergenic miR-183/96/182 cluster, and intronic miRNAs miR-204 and -211. Genes or 
exons flanking miRNA sequences, and chromosomal positions are indicated. 
Sequences of mature miRNAs are shown below, with seeds highlighted. (C) 
Comparison of miRNA levels in DA (black bars) and LA (white bars) retinas by qRT-
PCR. The values, normalized for U6 RNA, are means ± SEM [six independent 
experiments (n=6)]; *p < 0.05, **p < 0.01. Values for LA retinas are set to one. (D) 
Quantification of selected miRNAs by RPA. The graphs show phosphorimaging 
quantification of miRNA levels (means ± SEM; n=5). (E and F) miRNA levels in LCM-
dissected layers of DA and LA retina (E) or a whole retina (F). Values, normalized for 
U6 RNA, are means +/- SEM (n=3). See also Figure S1 and Table S1. 
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Expression of miRNAs in different retina layers 
To establish expression patterns of the miRNAs investigated in different retinal 
cell layers we used laser capture microscopy (LCM) to dissect the LA and DA 
retinas. The quality of the LCM dissection was verified by demonstrating that 
captured samples were enriched in mRNAs known to be expressed in specific 
retinal cells (Figure S2C). RNA was isolated from three different layers: a layer 
containing photoreceptor cells (ONL+OS/IS); INL; and GCL. These were 
analyzed by qRT-PCR (Figure 1E), revealing that miRNAs of the miR-
183/96/182 cluster were most abundant in photoreceptors, while miR-204 and -
211 were enriched in the INL. The levels of miR-183/96/182 miRNAs in the 
ONL+OS/IS layer and miR-204 and -211 in the INL increased in response to 
light, consistent with the data obtained for a whole retina captured by LCM 
(Figure 1F). Levels of miR-183/96/182, miR-204, and -211 in the GCL were very 
low, although the level of a brain-specific miRNA, miR-124a, was comparable to 
that in other cell layers (Figure 1E).  
Enrichment of the investigated miRNAs in different retinal layers was confirmed 
by in situ hybridizations (ISH) performed on sections from LA retina. In 
photoreceptors, strong signals were detected with probes specific for miR-182, -
183, and -96, but not with the respective mutant probes (Figure S1D). Weaker 
signals for miR-182, -183, and -96 were also detected in the INL (71). In 
contrast, the INL stained strongly with probes for miR-211 and let-7b (Figure 
S1D). None of the used probes used detected substantial levels of miRNAs in 
ganglion cells, consistent with the LCM data. 
Identification of potential targets of miR­183/96/182 cluster miRNAs 
To gain an insight into the biological role of miRNAs undergoing light-induced 
changes in the retina, we compiled a list of potential targets of miRNAs from the 
highly expressed miR-183/96/182 cluster, using three computational target 
prediction algorithms: TargetScan 5.1 (www.targetscan.org); MicroCosm 
(www.microrna.sanger.ac.uk); and PicTar (www.pictar.mdc-berlin.de). Of the 
potential targets bearing miR-183/96/182 binding sites in the 3’-UTR, 337 were 
predicted by all three algorithms (Figure 2A). 214 of them are expressed in 
mouse retina (Table S2). We used RNA isolated from retina cell layers obtained 
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by LCM to profile mRNA expression using Affymetrix arrays. For 12 gene 
transcripts predicted as potential targets of miR-183/96/182 miRNAs, we 
observed enrichment of more than 2.0-fold (p<0.05) in the ONL+OS/IS 
photoreceptor layer of DA retina as compared to LA retina (Figures S2A; Table 
S2). Among the aforementioned twelve mRNAs are those encoding a 
sodium/potassium-transporting ATPase subunit ATP1B3, a voltage-dependent 
glutamate transporter SLC1A1, and a polyA-binding protein interacting protein 
2B (PAIP2B, a translational inhibitor). The expression of Trpm1 and Trpm3 
genes, hosting miR-211 and -204 in their introns, was generally increased in a 
whole retina or its layers upon exposure to light, although in most instances the 
changes were not statistically significant (Figure S2B). This regulation is of 
potential interest since TRPM1 was recently implicated in the signal 
transduction in retinal ON bipolar cells (79, 80). 
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Figure 2. Glutamate transporter Slc1a1 is targeted by miR-183/96/182 miRNAs.  (A) 
Venn diagram showing targets of miR-183/96/182 cluster predicted by PicTar, 
Targetscan 5.1, and MicroCosm algorithms. (B) Western analysis of protein lysates of 
LA retinas and retinas from mice adapted to dark (DA) for 1, 2, or 3 h, using three 
different (a through c) anti-SLC1A1 Abs, and Abs against Dicer, Drosha, and β-Tubulin. 
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Asterisk, non-specific band recognized by SLC1A1(c) Ab. Increase in the intensity of 
SLC1A1 bands in DA retinas at 2 and 3 h of dark adaptation (always calculated relative 
to levels in LA retinas) is indicated. Values are means ± SEM from three Westerns 
performed with each Ab. (C) The heat map comparing Slc1a1 mRNA levels, as 
assessed using Affymetrix arrays and related to median expression values, in different 
LCM-dissected layers of DA and LA retinas. (D) Western blot analysis of lysates of 
different layers (~100,000 cells/layer) of DA and LA retinas, using anti-SLC1A1(a) and 
anti-β-Tubulin Abs. (E) Two-photon ratiometric imaging of EGFP expression from 
pEGFP-Slc1a1_wt and _mut constructs electroporated, together with a reference 
pDsRed plasmid to photoreceptors in vivo. The graphs show relative ratios of EGFP to 
RFP signals (measured for 20 individual cells for each combination of plasmids), with 
the ratio for pEGFP-Slc1a1_mut set to 1.0. Values are means ± SEM. (F) Scheme of 
the AAV-Rho-EGFP-triple sponge, harboring four sites for each of the miR-183/96/182 
miRNAs. (G) (left panel) Confocal cross section of an immunostained LA retina infected 
with AAV2-Rho-EGFP/triple. Left and right pictures visualize EGFP plus DAPI and 
EGFP alone, respectively. (right panel) Western analysis of lysates from five combined 
ONL+OS/IS layers of retinas infected with either AAV2-Rho-EGFP/triple or control 
sponge.See also Figures S2 and S3 and Table S2.  
 
Validation of selected targets of miR­183/96/182 cluster miRNAs 
The gene encoding the voltage-dependent glutamate transporter, SLC1A1, was 
first selected for a more detailed analysis. Glutamate transporters are 
responsible for scavenging glutamate from the synaptic cleft after release (81, 
82). Western blot analysis performed with extracts of DA and LA retinas, and 
three different antibodies recognizing distinct sequences of SLC1A1, revealed 
that the level of the protein increased by up to 3.8-fold following 2- or 3-h 
adaptation to dark, an effect expected to accompany the decrease in 
miR183/96/182 levels in the dark. No light-dependent changes were observed 
in the levels of several control proteins, including Drosha and Dicer (Figure 2B). 
Importantly, analysis of different LCM-dissected layers revealed a marked 
increase in both Slc1a1 mRNA and protein levels in the photoreceptors of DA 
retina (Figure 2C, D).  
Different approaches were used to demonstrate that SLC1A1 is a direct target 
of miR-183/96/182 miRNAs. We constructed enhanced green fluorescent 
protein (EGFP) and firefly luciferase (FL) reporters containing either wild-type 
(wt) full-length Slc1a1 3’-UTR or the 3’-UTR bearing mutations in seed 
sequences of the two predicted sites recognized by miR-183/96/182 miRNAs 
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(Figure S3A). When transfected into mouse NIH3T3 cells, both types of wt, but 
not mutant, reporters were inhibited by miRNA mimics specific for individual 
miR-183/96/182 miRNAs, co-transfected either individually or as a mixture of all 
three (Figure S3B, G). 
To find out if the EGFP reporter is similarly regulated in a more physiological 
context and in response to endogenous miRNAs, the wt (pEGFP-Slc1a1_wt) 
and mutant (pEGFP-Slc1a1_mut) EGFP reporters were in vivo electroporated 
into retinas of newborn mice to mostly target photoreceptors (18). The co-
electroporated reporter expressing red fluorescent protein (RFP) was used as a 
normalization control. EGFP and RFP fluorescence in individual photoreceptor 
cells from electroporated retinas (>21 days post-electroporation) was measured 
by two-photon live microscopy. Activity of the EGFP reporter containing wt 
miRNA sites was found to be ~5-fold lower than that of the mutated form (Figure 
2E). No significant difference was found in the levels of EGFP between LA and 
DA retinas electroporated with pEGFP-Slc1a1_wt (data not shown); possibly, 
electroporation of newborn mouse retinas affects proper light regulation of 
miRNA expression in photoreceptors. 
To get further support for the role of the miR-183/96/182 cluster in regulating 
Slc1a1 mRNA, we generated EGFP constructs expressing miR-183/96/182-
specific “sponges” in their 3’-UTR (83). Three sponges, each containing eight 
sites complementary to one of the three miR-183/96/182 cluster miRNAs and a 
sponge containing four sites specific to each of the three miRNAs (triple 
sponge) were constructed (Figure S3C-F). When tested in mouse NIH3T3 cells, 
all sponges markedly relieved the repression of FL-Slc1a1_wt reporter induced 
by the co-transfection of either single miR-183/96/182 cluster miRNAs or a 
mixture of the three (Figure S3G).  
We chose adeno-associated virus (AAV)-mediated gene transfer to deliver the 
triple sponge into photoreceptors in vivo. The sponge sequence was cloned into 
the 3’ UTR of an EGFP cDNA, whose expression is driven by the human 
rhodopsin (Rho) promoter, yielding AAV2-Rho-EGFP/triple (Figure 2F). The 
untagged EGFP AAV construct, AAV2-Rho-EGFP/control, served as a control. 
AAV particles were administrated subretinally, the sponged AAV into one eye 
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and the control AAV into the contra-lateral eye of the same adult mice (P>42). 
Infected retinas were isolated three weeks post-AAV injection and their EGFP-
expressing ONL+OS/IS layers were dissected by LCM (Figure 2G). Western 
blot analysis revealed that infection with AAV-Rho-EGFP-triple resulted in a 
marked increase in the SLC1A1 protein level when compared to retinas infected 
with AAV-Rho-EGFP-control (Figure 2G), indicating that Slc1a1 is a direct 
target of the miR-183/96/182 cluster. Of note, expression of the triple sponge 
had no effect on the level of targeted miRNAs (Figure S2G). 
Western analysis of extracts from DA and LA retinas, and from “sponged” 
ONL+OS/IS layers with antibodies specific for PAIP2 and ATP1B3, two other 
predicted miR-183/96/182 targets (Figure S2A and D), revealed that levels of 
these proteins are ~2-fold higher in DA retinas and in photoreceptors cells 
expressing the AAV-Rho-EGFP-triple sponge (Figure S2E, F). Hence, similarly 
to Slc1a1, also Paip2b and Atp1b3, likely represent direct targets of the miR-
183/96/182 cluster in photoreceptors.  
 
Kinetics of light­dependent changes in miRNA and pri­miRNA levels 
miRNAs are known to generally have a slow turnover(75-77). Our finding that 
the abundance of many retinal miRNAs markedly decreased following 3h in the 
dark (Figure 1) was therefore unexpected, and prompted us to measure the 
kinetics of changes in miRNA levels in response to dark and light adaptation. 
Following transfer of mice to the dark, levels of miR-183/96/182, and miR-204 
and -211, reached their minimum after approximately 90 min. However, upon 
return to light following dark adaptation for 3h, the miRNAs reached maximal 
levels after only 30 min. No significant changes were seen in the levels of let-7b 
and miR-29c (Figures 3A and S4A).  
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Figure 3. Kinetics of changes in mature miRNA (A) and pri-miRNA (B) levels in retina 
during adaptation to dark and light. Schemes at the top describe light/dark adaptation 
regime. Values, normalized to U6 RNA, represent means ± SEM; n=2. Values for LA 
retinas at 0 h were set to one. See also Figure S4. 
 
The kinetic data indicated that the more prolonged decrease in miRNA levels 
might be due to miRNA decay, while the rapid increase could result from 
augmented transcription and RNA processing. Generally (for exceptions, see 
(74)), processing of pri- and pre-miRNAs is quite rapid, and assessment of their 
levels provides an approximate measure of miRNA gene transcription. Analysis 
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of pri-miRNAs using qRT-PCR revealed that changes in their levels indeed 
occur relatively fast (≤ 30 min), irrespective of the animals being transferred 
from light to dark (decreased levels) or dark to light (increased levels) (Figures 
3B and S4B). Similar results were obtained when combined levels of both pri- 
and pre-miRNAs were analyzed using RT-PCR (Figure S4C, D). Quantification 
of pri- and pre-miRNA suggests that changes in the level of light-induced 
miRNAs are a consequence of transcriptional up-regulation of their genes in 
response to light. These measurements, performed by procedures different 
from those presented in Figure 1, also provide independent evidence that the 
expression of the investigated miRNA genes differs between LA and DA retinas. 
 
Inhibitor assays reveal rapid turnover of miRNAs in retina 
We used specific inhibitors to directly test whether transcription is responsible 
for the up-regulation of precursor and mature forms of miR-183/96/182, miR-
204, and miR-211. Transcription inhibitors, actinomycin D (ActD) or α-amanitin 
(α-Am), were injected intraocularly into the right eye, while retinas isolated from 
the left eye were used for control measurements (Figure 4A). The levels of pri-
miRNAs and mature miRNAs were measured at time points corresponding to 
the established minimal (dark adaptation, 90 min) and maximal (light 
adaptation, 30 min) levels of miRNAs (Figure 4B). Injection of α-Am (Figures 
4C-F and S5C-E, left panels) or ActD (middle panels) completely blocked the 
increase of pri-miRNA and miRNA levels upon exposure to light, while the 
expected changes occurred in the control eye. In the presence of inhibitors, the 
pri-miRNAs and mature miRNAs remained at the low levels characteristic of a 
DA retina. Notably, upon repression of transcription the levels of mature 
miRNAs which do not undergo light-mediated regulation (let-7b and miR-29c) 
and their precursors also decreased dramatically (Figure 4E, F), indicating that 
many, if not all, miRNAs expressed in the retina may turnover rather rapidly.  
Several control experiments were performed to demonstrate that the observed 
effects were indeed due to the action of injected inhibitors. As expected, the 
inhibitors blocked expression of the pol II-transcribed Gαt1 mRNA but had no 
effect on expression of U6 snRNA, a stable pol III transcript (Figure S5F, G). 
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Moreover, injection of only a buffer to the test eye had no effect on the level of 
any investigated RNA (Figures 4C-F and S5C-G, right panels). 
 
Figure 4. Effect of transcription inhibitors on miRNA and pri-miRNA levels in DA and 
LA retinas. (A) Injections were performed into right eye, and the non-injected left eye 
was used for isolation of control retina. (B) A scheme indicating time points used for 
collecting retinas. (C-F) Effect of α-Am (left panels) and Act D (middle panels) on levels 
of indicated miRNAs and pri-miRNAs. Control determinations, for the non-injected left 
eye, are in the left sub-panels. Levels of RNAs in retina from mice kept in continuous 
light, adapted to the dark for 90 min (a), or moved from dark to light for 30 min (b) are 
shown as white, black, and grey squares, respectively. Values, normalized to either U6 
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RNA (for α-Am and buffer injections) or 18S rRNA (for ActD injections) are means ± 
SEM; n=3. Values for retinas from the control eye of mice kept in continuous light (time-
point a) were set to one. See also Figure S5. 
 
We further investigated the turnover of selected miRNAs in LCM-dissected 
retinal layers of wild type mouse or in specific cell types obtained by 
fluorescence activated cell sorting (FACS) from retinas of transgenic mice 
expressing EGFP or RFP under control of cell-specific promoters. As for the 
whole retina, inhibition of transcription resulted in a marked decrease in all 
tested miRNAs (including those which are not light-regulated: let-7b, miR-29c, 
miR-15a, and miR-16) in each dissected retina layer (Figure 5A, B). 
Interestingly, all miRNAs were found to turn over fast in FACS-sorted amacrine 
cells but not in rod bipolar cells (Figure 5C-E; see Discussion). No rapid 
turnover of miRNAs was observed in the FACS-sorted population of Müller glia 
cells (Figure 5F).  
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Figure 5. Determination of miRNA turnover in LCM-dissected retinal layers and FACS-
sorted populations of specific retinal cells. (A and C) Schemes indicating experimental 
approaches. Mice expressing either EGFP or RFP under control of cell-specific 
promoters are indicated in (C). Retinas were always isolated 3h after in vivo injection of 
either α-Am or a buffer.  (B) Effect of α-Am on the level of selected miRNAs in 
dissected ONL+OS/IS, INL or GCL layers of LA retinas. Values represent means ± 
SEM (n=2; each RNA sample assayed in triplicate). (D-F) miRNAs decay rapidly in 
amacrine cells (D) but not in rod bipolar (E) or Müller glia (F) cells of LA retinas. RNA 
was extracted from pools of FACS-sorted amacrine cells (~10,000 cells/pool; n=2), a 
single pool of rod bipolar cells (~10,000 cells), or pools of Müller cells (~30,000 
cells/pool; n=2). Five animals were used for preparation of each pool. RNA from each 
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pool was tested in triplicate. Values, normalized to U6 RNA, represent means ± SEM. 
Values for eyes injected with a buffer were set to one. ND, not detectable. 
 
Taken together, these data indicate that miRNAs turnover rapidly in many types 
of retinal neurons, but not in rod bipolar cells or Müller glia, and that fast 
turnover applies to both light-responsive miRNAs and miRNAs which do not 
undergo light-mediated regulation. 
Fast  turnover of miRNAs also occurs  in non­retinal neurons and  is activity­
dependent  
The observed differences in the turnover of miRNAs between different retinal 
cell types and the fact that direct determination of miRNA decay was previously 
performed in only few studies, prompted us to measure miRNA catabolism in 
different cells and tissues. In all cases, the decay was determined using qRT-
PCR, following treatment with either α-Am or ActD. Measurements performed 
with cultured NIH3T3 and RPE-1 (human retinal pigmented epithelium) cells 
(Figure S7A-D, left panels) and also non-differentiated mouse embryonic stem 
(ES) cells (see Figure 7B) revealed no appreciable turnover of investigated 
miRNAs for 3 or 6h following the addition of transcription inhibitors; pri-miRNAs 
and urokinase (uPA) mRNA decayed rapidly, as expected (Figures S7A-D, right 
panels; Figure S7E).  
To find out whether the fast turnover of miRNAs may be a general property of 
neuronal cells, we first measured the decay of miRNAs in rat brain cultured 
hippocampal slices (84) and dissociated hippocampal neurons (85). In both 
systems, the addition of α-Am (Figure 6A, B; top panels) or ActD (not shown) 
resulted in a marked decrease in the level of neuron-specific miRNAs miR-124, 
-128, -134, and -138. However, levels of another neuron-enriched miRNA, miR-
132, and miRNAs known to be either ubiquitously expressed or enriched in glial 
cells (miR-16, 23a/b, -25, -29c, -193a; (86)) were not markedly affected. Similar 
rapid decay of many miRNAs was also observed in mouse cultured cortical 
neurons (Figure 6C). We note that, in most instances, the levels of mature 
neuronal miRNAs decreased only ~2-fold, indicating that either only part of the 
cellular miRNA pool is accessible to the degradation, or that miRNAs turn over 
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rapidly only in a fraction of neurons (see Discussion). As expected, pri-miRNAs 
underwent fast degradation no matter whether they were precursors to neuronal 
or non-neuronal miRNAs (Figure 6A-C).        
Interestingly, in all three investigated cultures the inclusion of tetrodotoxin 
(TTX), a toxin which blocks sodium channels and neuronal action potentials, 
prevented rapid turnover of miRNAs (Figure 6, panels +TTX +α-Am). Incubation 
with TTX in the absence of transcription inhibitors had no effect on miRNA 
levels (Figure 6, panels +TTX). We have verified that TTX is unlikely to affect 
the transcription of miRNA genes since its inclusion had no effect on pri-miRNA 
levels in any system (Figure S6A-C). Likewise, TTX had no apparent effect on 
the processing or turnover of pri-miRNAs (Figure S6A-C). These results also 
argue against TTX having any effect on the action of α-Am as transcription 
inhibitor. Analysis of hippocampal slices and dissociated neurons treated with α-
Am or α-Am+TTX, by either staining with calcein AM (CalAM; staining live cells) 
and ethidium homodimer-1 (EthD-1; staining dead cells) or counting apoptotic 
nuclei, indicated that toxic effects of the inhibitors were very limited (Figure 
S6D, E). This argues against a possibility that the observed reductions in 
miRNA levels are results of selective neuronal loss upon inhibitor treatment. In 
summary, our data indicate that accelerated turnover of miRNAs in neurons is 
dependent on their activity.  
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Figure 6. Activity-dependent decay of miRNAs in organotypic hippocampal slices 
(DIV25) (A), dissociated hippocampal neurons (DIV12) (B), and dissociated neocortical 
neurons (DIV25) (C). Levels of mature miRNAs (upper and two bottom rows) or pri-
miRNAs (second row) were determined using RNA from cultures treated for the 
indicated times with α-Am or TTX alone, or a mixture of both. TTX was added to 
hippocampal slices and cultured neuron, 1.5 and 0.5 h prior to the addition of α-Am, 
respectively. Values, normalized for U6 RNA, are means ± SEM (n≥3), with controls at 
0 h set to one. Note that in cortical neuron preparations, the non-neuron specific 
miRNAs (miR-16 and -25) also show accelerated turnover. ND, not detectable. See 
also Figure S6. 
 
Activity­dependent turnover of miRNAs in neurons derived from ES cells     
To obtain additional evidence that miRNAs turn over faster in neurons than in 
non-neuronal cells, we used an in vitro system in which mouse ES cells are 
differentiated into a population of glutamatergic neurons. In this system, ES 
cells are first differentiated into neural progenitors (NPs) characterized as radial 
glial cells, which then give rise to differentiated pyramidal neurons (DNs; Figure 
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7A), know to form functional synaptic connections (87). We found that in non-
differentiated ES cells (Figure 7B), NPs (not shown), and DNs maintained in 
culture for 15 days (Figure 7C), miRNAs did not show any appreciable turnover 
during the 6h following the α-Am addition (Figure 7B, C) or ActD (not shown); as 
expected, pri-miRNAs and uPA mRNA turned over rapidly in these cells (Figure 
S7E, F). In marked contrast to the 15-day culture, in neurons cultured for 25 
days neuronal miRNAs miR-124, -128, -134, and -138 turned over rapidly, and 
their turnover was blocked by TTX; in contrast, no significant changes in the 
level of miR-132, and constitutive miRNAs miR-16, -23b, and -25b were seen 
(Figure 7D). In control experiments, we have verified that the pri-miRNA levels 
decreased in 25-day cultures in the presence of α-Am with similar kinetics 
irrespective of TTX being added to the assays (Figure S7G). Moreover, addition 
of α-Am and/or TTX (or glutamate and/or NBQX/CPP; see below) did not result 
in a substantial cell death, particularly when cells were treated with inhibitors for 
2h (Figure S7H), sufficient time to reach maximal changes in miRNA levels 
(Figure 7D). We also ascertained that the observed changes in miRNA levels 
were not due to changes in levels of Dicer or Argonaute-2 (AGO2), proteins 
required for miRNP assembly; treatment with α-Am or α-Am + TTX had no 
effect on levels or electrophoretic mobility of these proteins in 25-day ES-cell-
derived or hippocampal neurons (data not shown).         
The ES-cell-derived neurons express glutamate receptors and respond to 
glutamate stimulation (87). Thus, we tested whether glutamate has an effect on 
miRNA turnover in neurons cultured for 25 days. Blocking glutamate receptors 
with NBQX/CPP (6-nitro-2,3-dioxo-1,4-dihydrobenzo[f]quinoxaline-7-
sulfonamide, blocking AMPA and kainate receptors, plus ( )-3-(2-
carboxypiperazin-4-yl)propyl-1-phosphonic acid, blocking NMDA receptors) 
prevented turnover of miR-124, -128, -134, and -138 but, surprisingly, activated 
decay of miR-132, which did not show any turnover in control neurons (Figure 
7E). In contrast, the addition of glutamate markedly accelerated decay of miR-
124, -128, -134, and -138, and also made constitutive miRNAs decay at an 
appreciable rate; inclusion of NBQX/CPP blocked the effect of exogenous 
glutamate (Figure 7E). Notably, miR-132 again showed an opposite trend. Its 
degradation was accelerated on the blocking of glutamate receptors and not by 
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treatment with glutamate. Identical results were obtained with dissociated 
hippocampal neurons (Figure 7F).  
We have also tested whether glutamate can induce the decay of miRNAs in ES-
cell-derived neurons cultured for 15 days. The addition of glutamate, or 
NBQX/CPP plus glutamate, had no effect on the turnover of any miRNA (Figure 
7G). To follow the electrophysiological properties of the ES-cell-derived neurons 
as a function of time in culture, we cultured them on microelectrode arrays 
(MEAs) and recorded their spontaneous spiking activity. Although some spiking 
was already visible after 10 to 15 days, maximal activity was reached after 25-
30 days of culturing (Figure S7I). 
 
Figure 7. Analysis of turnover of miRNAs in mouse ES cells and neurons derived from 
them. (A) Scheme of the in vitro differentiation of mouse ES cells into neuronal 
progenitors (NP) and neurons (DN). (B-D) Effect of α-Am or TTX + α-Am on the level of 
indicated miRNAs in ES cells or neurons maintained in culture for 15 or 25 days. (E-G) 
Effect of α-Am, glutamate + α-Am, or NBQX/CPP + glutamate + α-Am on the level of 
miRNAs in ES-cell-derived neurons (E, G) and hippocampal neurons (F). For cultures 
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treated with NBQX/CPP and α-Am (black triangles), only miR-132 level measurements 
are shown in panels E and F. Levels of other miRNAs were not affected by this 
treatment (not shown). Glutamate and/or NBQX/CPP were added to cultures 15 min 
prior to the addition of α-Am. Following α-Am addition, cultures were collected at 
indicated times (0-6h for panels B-D; 0-2h for panels E-G). Values, normalized for U6 
RNA, are means ± SEM (n=4).See also Figure S7. 
 
In summary, these experiments indicate that in both ES-cell-derived and 
hippocampal neurons neuronal activity may have both stimulatory and inhibitory 
effects on miRNA turnover. Experiments with differentiated ES cells also 
suggest that neurons have to reach a certain level of maturity or connectivity to 
manifest activity-dependent changes in miRNA decay. 
  
Discussion 
In this work, we identified miRNAs which respond to different light conditions in 
mouse retinal neurons, independent of the circadian clock. Levels of the 
sensory neuron-specific miR-183/96/182 cluster, and miR-204 and -211, were 
down-regulated during dark adaptation and up-regulated during light adaptation, 
with rapid miRNA decay and increased transcription being responsible for the 
respective changes. We identified the voltage-dependent glutamate transporter, 
Slc1a1, as one of the targets of the light-regulated miR-183/96/182 cluster; 
other likely targets of these miRNAs in photoreceptor cells include Paip2b and 
Atp1b3. We found that many miRNAs in retinal, and also non-retinal, neurons 
turn over much faster than miRNAs in other cell types. Blocking action 
potentials with TTX, or glutamate receptors with NBQX/CPP, strongly affected 
miRNA turnover rates, indicating that active miRNA metabolism may be 
important for the function of neurons. 
Different algorithms were previously used to predict targets of miRNAs 
expressed in the retina, and, in a few instances, the validity of the predictions 
was tested using 3’-UTR reporter fusions in HEK293 or NIH3T3 cells 
overexpressing retinal miRNA mimics (68, 71). Using three different algorithms, 
we compiled a list of potential miR183/96/182 targets, including 214 mRNAs 
expressed in the mouse retina. Levels of 12 of them were up by more than 2-
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fold (p<0.05) in the photoreceptor layer of the DA retina as compared to the LA 
retina, consistent with the decrease in miR-183/96/182 miRNAs in the dark.  
For mRNA encoding SLC1A1, we obtained compelling evidence that it is a bona 
fide target of miR-183/96/182 miRNAs. In addition to the support obtained from 
reporter assays, performed in vitro and in vivo, we found that: (1) the AAV-
mediated expression of “sponges”, which titrate miR-183/96/182 miRNAs in 
photoreceptors in vivo, resulted in a marked increase in the SLC1A1 level in the 
LCM-dissected photoreceptor layer; and, (2) in the western blot analyses, the 
level of SLC1A1 increased 2- to 3-fold during dark adaptation, an effect 
expected to accompany the decrease in miR183/96/182 in the dark. 
Experiments listed in (1) and (2), indicated that also Paip2b and Atp1b3 are 
likely to represent miR183/96/182 targets. To our knowledge, Slc1a1, Paip2b, 
and Atp1b3 represent the first examples of miRNA-regulated mRNAs 
documented in the physiological context of the retina.  
The finding that Slc1a1, which encodes a neuronal glutamate transporter, is a 
target of the miR-183/96/182 cluster, and that its level increases in the dark, is 
intriguing. Glutamate is the neurotransmitter used by vertebrate photoreceptors 
(88). In the dark, photoreceptors are depolarized and release glutamate. Light 
hyperpolarizes the membrane and the release of glutamate is reduced. It has 
been shown that glutamate transporters help to clear glutamate from the 
synaptic cleft in rods and cones(89, 90). In the DA state, the load on rod 
glutamate transporters is higher than in the LA state, when rods are saturated 
by light, and therefore the up-regulation of glutamate transporters in the dark 
may help to scavenge glutamate from the synaptic cleft. In LA retinas, when 
SLC1A1 expression of is low (Figure 2B, D), it has been suggested (90) that the 
glutamate transporter in rods is SLCA1A7. However, immunohistochemical 
evidence shows that SLC1A1 is also present in rods (91). We propose that 
SLCA1A1 in the dark helps SLC1A7 to remove glutamate from the first visual 
synapse.  
Kinetic experiments and the use of transcription inhibitors have revealed that all 
tested miRNAs, both light-regulated and constitutively expressed, decay in 
retinal neurons very rapidly (T1/2 of 1h or less). This contrasts with the situation 
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in purified Müller glia and rod bipolar cells, in which no decrease in the level of 
miRNAs was observed during 3h of α-Am treatment. Inhibitor experiments also 
indicated that fast up-regulation of miR-183/96/182, miR-204 and -211 levels 
upon exposure to light is due to increased transcription of the respective genes. 
It is important to emphasize that, while turnover experiments with non-retinal 
neurons involved the use of α-Am or ActD, the rapid decay of miRNAs in the 
retina in vivo was observed upon transfer of animals from light to dark, thus 
under physiological conditions, in the absence of the inhibitors. 
Rapid decay of many miRNAs was also observed in cultured rodent neurons or 
hippocampal slices, and in neurons differentiated from mouse ES cells in vitro. 
In all these systems, the addition of α-Am or ActD resulted in a rapid decrease 
in the level of neuron-specific miRNAs such as miR-124, -128, -134, and -138, 
In contrast, we observed no appreciable decay of miRNAs over 6h in cultured 
NIH3T3, RPE-1 or ES cells. Experiments with neurons indicated that miRNA 
turnover may be subject to complex activity-dependent regulation. In all four 
neuronal cultures investigated, blocking action potentials with TTX prevented 
rapid turnover of miRNAs. Blocking glutamate receptors with NBQX/CPP 
likewise prevented turnover of miR-124, -128, -134, and -138 in hippocampal 
and ES-cell-derived neurons, while the addition of glutamate accelerated it. 
Notably, the behaviour of miR-132 was opposite to the other miRNAs. Its 
degradation was induced by the blocking of glutamate receptors and not by the 
addition of glutamate. miR-132 represents one of the most studied neuronal 
miRNAs. Its transcription is up-regulated by light and it modulates the 
expression of clock genes in the superchiasmatic nucleus in mice (92). 
Importantly, the expression of miR-132 is activated in response to neuronal 
stimulation in rodent brain or culture neurons (93), and miR-132 is required for 
activity-dependent dendritic growth and spine formation (93, 94). These 
findings, clearly distinguishing the activity of miR-132 from that of miRNAs such 
as miR-134 or -138, which generally reduce dendritic spine growth (reviewed by 
(73), provide a possible rationale explaining why miR-132, in contrast to miR-
134 or -138, is not a subject of the accelerated decay in active neurons. 
The dependence of miRNA decay on neuronal activity may also explain why 
miRNAs were found to turn over fast in FACS-sorted amacrine cells but not rod 
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bipolar cells. Rod bipolar cells are thought to be inactive during daylight 
conditions, while amacrine cells are activated during both dark and light states 
(62). Since both types of cells were collected during daylight, it is likely that rod 
bipolar cells were less, or not at all, active. The observation that miRNAs decay 
fast in ES-cell-derived neurons cultured for 25 but not 15 days is also consistent 
with the idea that a defined level of neuronal maturation or connectivity is 
essential for increased catabolism of miRNAs. The MEA recordings showed 
that spontaneous spiking activity of 25-day neurons is substantially higher than 
that of 15-day neurons. In addition, we found that neither NBQX/CPP nor 
glutamate had any effect on miRNA decay in 15-day cultures.  
It was reported recently (95) that levels of two miRNAs, miR-124 and -184, are 
down-regulated 2 to 3-fold in Aplysia neurons upon stimulation with serotonine, 
although no inhibitor studies were performed to determine the mechanism 
involved. In another recent report, they (96) found that brain-enriched miRNAs 
in human primary neural cultured cells and post-mortem brain tissues have a 
T1/2 of 1-3.5h. Hence, rapid and/or activity-regulated miRNA decay may be a 
general feature of neurons. This contrasts with the situation in non-neuronal 
cells in which miRNAs generally turn over very slowly (75, 77) (this work), with 
estimated half-lives extending even beyond 24h (76). 
What could be a role of accelerated turnover of miRNAs in neurons, and why 
would turnover be dependent on neuronal activity? Several hundred protein-
coding genes have been identified in cortical and hippocampal neurons whose 
transcription is regulated by neuronal activity. Many of them encode 
transcription factors while others specify proteins with important functions in 
dendrites and synapses (reviewed by (97)). Possibly, the rapid turnover of 
miRNAs and, consequently, a continuous supply of de novo-transcribed 
miRNAs, are prerequisites for the assembly of new miRNPs, which would be 
available for regulating the newly-synthesized activity-dependent mRNA targets. 
Such regulation might involve not only translation or stability of the targeted 
mRNAs, but also their localization and expression in neuronal processes (73). 
Blocking neuronal activity would make the need for rapid miRNA metabolism 
obsolete because of the diminished supply of potential mRNA targets. In 
another scenario, the fast decay of miRNAs might by important for stimulating 
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translation of neuronal mRNAs, e.g. those located at dendritic spines, in 
response to synaptic activity (reviewed by (72, 73)).  
In the future, it will be important to establish what factors are responsible for the 
rapid decay of miRNAs and its regulation in neurons. Enzymes responsible for 
miRNA turnover are beginning to be identified (98, 99). In addition, the first 
examples of regulated miRNA turnover, such as differences in the miR-29b half-
life between cycling and mitotic HeLa cells (77), or the stabilizing effect of the A 
residue addition to the 3’end of miR-122 in liver (100), have already been 
reported. 
Supplemental data 
Supplemental Data include Supplemental Experimental Procedures, 
Supplemental References, seven figures, and three tables. 
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Supplemental figures 
 
Figure S1, related to Figure 1. Analysis of light dependent changes and localization of 
miRNAs expression in retina. (A) Summary of 454 deep sequencing data of small 
RNAs isolated from LA and DA retinas. (B) Schemes describing the light/dark 
adaptation regime at different times of the day. (C) Light dependent changes in the 
level of retinal miRNAs are not due to circadian regulation. Comparison of miRNA 
levels in DA and LA retinas collected at different times of the day. Values, normalized 
to U6 RNA, are means ± SEM from qRT-PCR reactions performed in triplicate with 
RNA isolated from pooled retinas of four animals. Values for LA retinas collected at 
ZT6 are set to one. (D) Localization of miRNAs in LA retina determined by in situ 
hybridization. Cryosections were hybridized with perfectly complementary or mutated 
digoxigenin-labeled LNA probes. Blue staining indicates a positive hybridization signal. 
65
 
 
ONL, outer nuclear layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, 
ganglion cell layer.  
 
 
Figure S2, relative to Figure 2. Analysis of miR-183/96/182 targets in LA and DA 
retinas. (A) List of putative miR-183/96/182 targets up-regulated ≥ 2-fold (p < 0.05) in 
retinal photoreceptors of DA relative to LA retina. (B) Comparison of expression of 
Trmp1 and Trpm3 genes, which host intronic miR-211 and miR-204 (both up-regulated 
by light), respectively. Values for different cell layers dissected from LA or DA retinas 
represent means ± SEM of transcript levels, relative to the median (data collected from 
two independent array experiments). ONL+OS/IS, photoreceptors; INL, inner nuclear 
layer; IPN, inner plexiform layer; GCL, ganglion cell layer.(C) Quality of LCM dissection 
verified by demonstration that mRNAs known to be expressed in specific retinal cells 
are enriched in LCM-captured samples of DA or LA retinas. The heat map displays 
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expression of rhodopsin (Rho), C. elegans ceh-10 homeodomain-containing homolog 
(Chx10), and Thy-1 membrane glycoprotein precursor (Thy1) genes, which represent 
markers for photoreceptors, bipolar cells and ganglion cells, respectively(19, 101-104). 
The Opn1sw gene represents a light/dark adaptation marker (105). Numerical values 
represented by different colors are indicated by the bar scale on the left. (D) 
Sequences and base-pairing of predicted sites in 3’UTRs of Atp1b3 and Paip2b 
mRNAs, potentially recognized by individual miR-183/96/182 cluster miRNAs. (E) 
Western blot analysis of protein lysates of LA retinas and retinas from mice adapted to 
dark (DA) for the indicated times, using Abs against PAIP2, ATP1B3, and β-Tubulin. 
Increase in the intensity of specific bands in DA retinas (always calculated relative to 
levels in LA retinas) is indicated. Values are means ± SEM (n=3). (F) Western blot 
analysis of lysates from five combined LCM-dissected ONL+OS/IS layers of retinas 
infected with either AAV2-Rho-EGFP/triple or control sponge. (G) Levels of 
endogenous or transfected miR-183/96/182 cluster miRNAs are not affected by 
expression of the triple sponge construct. RT-qPCR analysis of endogenous miRNA 
levels in the LCM-dissected ONL+OS/IS layer of retinas infected with either AAV2-
RHO-EGFP/triple or AAV2-RHO-EGFP/control. Values, normalized to U6 RNA, 
represent means ± SEM. Values for samples infected with AAV2-RHO-EGFP/control 
were set to one. 
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Figure S3, related to Figure 2. The EGFP-Slc1a1_wt reporter is specifically repressed 
by miR-183/96/182 cluster miRNAs in transfected mouse NIH3T3 cells. (A) Schematic 
representation of EGFP and FL reporter constructs harboring either wt or mut forms of 
the Slc1a1 3’UTR. Sequences of predicted sites (wt and mutant forms, with mutated 
residues in the seed regions shown in red) recognized by individual miR-183/96/182 
cluster miRNAs are shown below. Base-pairing to miR-182, miR-183 and miR-96, and 
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stability of miRNA/mRNA pairings calculated as ΔG using mfold v. 3.2 are also 
indicated. (B) Activity of EGFP-Slc1a1_wt and EGFP-Slc1a1_mut reporters in NIH3T3 
cells cotransfected with control pDsRed plasmid and indicated miRNA mimics. 
Expression of EGFP and RFP was analyzed by FACS, 48 h post-transfection. Values, 
normalized for expression of RFP, are means ± SEM (n=3); *p < 0.05, **p < 0.01. 
Expression value for EGFP-SLc1a1_mut co-trasfected with a mixture of three miRNA 
mimics was set to one. (C-G) Anti-miR-183/96/182 sponges rescue repression of FL-
Slc1a1_wt reporter by miR-183/96/182 cluster miRNAs in transfected NIH3T3 cells. 
Schematic representation of sponge constructs harboring either a mixture of sites for 
all three miR-183/96/182 cluster miRNAs (C) or sites specific for individual miRNAs: 
miR-96 (D), miR-182 (E), and miR-183 (F). Sequences of different variants of the 
designed miRNA target sites and their pairing to individual miRNAs are shown below 
each scheme. (G) Activity of FL-Slc1a1_wt and FL-Slc1a1_mut reporters in NIH3T3 
cells cotransfected with control pRL reporter and indicated sponges and miRNA 
mimics. Expression of luciferases was measured 48 h post-transfection. Values, 
normalized for expression of RL, are means ± SEM (n=3). Expression value for FL-
Slc1a1_mut co-trasfected with a mixture of three miRNA mimics and no sponge was 
set to one.  Black bars, transfections containing no sponge plasmids; grey bars, 
transfections containing sponge plasmids. 
 
 
Figure S4, related to Figure 3. Kinetics of changes in mature miRNA and pri/pre-
miRNA levels in retina during adaptation to dark and light.  Changes in mature (A) and 
pri-miRNA (B) levels during adaptation to dark and light. Schemes at the top describe 
light/dark adaptation regime. Values, normalized to U6 RNA, represent means ± SEM 
(n = 2). Values for LA retinas at 0 h (ZT3) were set to one. (C) A scheme explaining 
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amplification of pri- and pre-miRNAs. Hybridization positions of the pre-miRNA forward 
(F; green) and reverse (R; red) primers are indicated. To amplify specifically pri-
miRNAs, a forward primer (F; blue) was used along with the reverse (red) pre-miRNA 
primer. (D) Changes in pri- and pre-miRNA levels during adaptation to dark and light. 
Following PCR, a portion of each reaction was run on a 2.5% agarose gel. Positions of 
amplification products specific for either pri-miRNA or a sum of pri- and pre-miRNA, are 
indicated.  
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Figure S5, related to Figure 4. Effect of transcription inhibitors on the levels of 
miRNAs, Gat1 mRNA, and U6 RNA in DA and LA retinas. (A) A scheme indicating an 
experimental approach. Injections were performed into right eye and non-injected left 
eye was always used for isolation of control retina. (B) A scheme indicating the 
dark/light adaptation regime and time-points used for collecting retinas. Selected time-
points correspond to times when miRNA levels are at their minimum (a; dark 
adaptation for 90 min) and maximum (b; light adaptation for 30 min) in DA and LA 
retinas, respectively (see Figures 3 and S4). (C-E) Effect of injection of α-Am (left 
panels), ActD (middle panels), or buffer alone (right panels) on the level of indicated 
miRNAs. Control determinations, for non-injected left eye, are always in left sub-
panels. Levels of RNAs in retina from mice kept in continuous light, adapted to dark for 
90 min, or mice moved from dark to light for 30 min, are shown as white, black, and 
grey squares, respectively. Values, normalized either to U6 RNA (for α-Am and buffer 
injections) or 18S rRNA (for ActD injections) are means ± SEM (n = 3). Values for 
retinas from a control eye of mice kept in continuous light (time-point a) were set to 
one. (F) Control experiment demonstrating that injection of α-Am (left panel) or ActD 
(middle panel), but not buffer alone (right panel), strongly reduces the level of rod 
transducin (Gat1) mRNA, which is known to be expressed in mouse retina 
independently of the light/dark adaptation and shows fast turnover in vivo (106). (G) 
Control experiment demonstrating that injection of α-Am (left panel), ActD (middle 
panel), and buffer alone (right panel) has no marked effect on the level of U6 RNA. 
Levels of U6 RNA were normalized to the levels of RNA used for cDNA preparation. 
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Figure S6, related to Figure 6. Control experiments assessing the effect of TTX on 
pri-miRNA and uPA mRNA turnover, and determining extend of cell death following 
treatment with either α-Am alone or α-Am + TTX. (A-C) Control experiments 
demonstrating that TTX treatment has no effect on expression levels of pri-miRNAs 
(upper panels) and does not influence the inhibitory effect of α-Am on pri-miRNA levels 
(lower panels) in organotypic hippocampal slices (A), dissociated hippocampal neurons 
(B), and dissociated neocortical neurons (C). Levels of pri-miRNAs and uPA mRNA 
were determined using RNA from cultures treated with indicated inhibitors for 0, 3, or 6 
h. Note that TTX is added to hippocampal slices and cultured neurons 1.5 and 0.5 h 
prior to the addition of α-Am, respectively. Values, normalized for U6 RNA, are means 
± SEM (n=3), with controls at 0h set to one. ND, not detectable. (D and E) Effect of α-
Am or α-Am + TTX on cellular death in hippocampal slice cultures (D) and cultures of 
dissociated hypocampal neurons (E). In (D), cultures were stained with calcein AM 
(CalAM; staining living cells; green fluorescent signal) and ethidium homodimer-1 
(EthD-1; staining dead cells; red fluorescent signal). Representative pictures of 
hippocampal slices, treated with inhibitors for 6h and showing EthD-1 staining, are 
presented. The graph shows average percentages of intensity of green and red 
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fluorescent signals measured, using 2-photon microscopy, for three regions per slice, 
with slices originating from two independent cultures. Values from untreated slices are 
set to 100%. Time of treatment with inhibitors is indicated. In (E), primary hippocampal 
cultures were stained with antibodies recognizing neuronal (NeuN) or astrocyte (GFAP) 
markers, and with Hoechst, following treatment with inhibitors. Shown are 
representative pictures of cultures treated with α-Am, α-Am + TTX, or buffer alone for 3 
and 6h. Percentages of neurons (NeuN+) and dead neurons (NeuN+ containing 
apoptotic nuclei) represent means from 10 pictures obtained from two independent 
culture experiments. The total number of cells was determined by Hoechst staining.  
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Figure S7, related to Figure 7. Control experiments assessing: (A-G) the effect of 
inhibitors on miRNA and pri-miRNA levels and turnover in RPE-1, NIH3T3, ES cells 
and ES-cell-derived neurons; (H) spiking activity of the ES-cell-derived neurons; and (I) 
the effect of inhibitors on cell death in ES-cell-derived neurons. (A-D) Analysis of 
mature miRNA (left panels) and pri-miRNA (right panels) levels in RPE-1 (A and B) or 
NIH3T3 (C and D) cells treated with either α-Am  (A and C) or ActD (B and D) for 0, 3, 
or 6 h. Effectiveness of transcriptional inhibition was verified by analysis of urokinase 
(uPA) mRNA levels (right panels) (107). Values, normalized for U6 RNA (α-Am 
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treatment) or 18S rRNA (ActD treatment), are means ± SEM (n=3). ND, not detectable. 
(E and F) Effect of α-Am on the level of pri-miRNAs in ES cells (E) and neurons 
maintained in culture for 15 days (F). Expression of pri-miR-16, pri-miR-124 and pri-
miR-128 was analyzed for different genomic loci encoding the same mature miRNA. 
(G) Control experiments demonstrating that TTX treatment has no effect on expression 
levels of pri-miRNAs (middle panel) and does not influence the inhibitory effect of α-Am 
on pri-miRNA levels (lower panel) in ES-cell-derived neurons maintained in culture for 
25 days. Upper panel (treatment with α-Am alone) represents an experiment similar to 
that shown in panels A and B. Levels of pri-miRNAs and uPA mRNA were determined 
using RNA from cultures treated with indicated inhibitors for 0, 2, 4, or 6 h. Note that 
TTX is added to cultured neurons 0.5 h prior to the addition of α-Am. Values, 
normalized for U6 RNA, are means (± SEM; n=3) with controls at 0 h set to one.  (H) 
Effect of α-Am, α-Am + TTX, glutamate + α-Am, and NBQX/CPP + glutamate + α-Am 
on cellular death in ES cells-derived neurons maintained in culture for 15 or 25 days, 
measured by staining with CalAM and EthD-1. Values represent average percentages 
of living and dead cells, based on 10 pictures obtained from three independent 
cultures. (I) Spontaneous spiking activity profile, recorded with MEAs, in the ES-cell-
derived neurons at 5, 10, 15, 20, 25, and 30 days in culture. Normalized values of the 
array-wide spiking activity, measured for 30 different active electrodes (in two 
independent array experiments), are represented as grey lines. Red line represents a 
mean value. Only recordings from electrodes remaining active at day 30 are included in 
the graph. Spike range was 0-240 per min. 
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Supplemental tables 
Table S1 and S2. Supplied as a separate Excel files (only as online supporting 
material) 
Table S3. PCR primers used to amplify mouse, rat and human miRNA 
precursors and mRNAs. 
Name Forward primer (5’-3’) Reverse primer (5’-3’)  Species 
pri-miR-182 CCCTCCTAAAACCACCCTAA AGTTGGCAAGTCTAGAACCAC M 
pre-miR-182 TTTGGCAATGGTAGAACTCAC AGTTGGCAAGTCTAGAACCAC M 
pri-miR-183 
TGTAGGACCTCCAGGAGAAGG TATGGCCCTTCGGTAATTCA M 
pre-miR-183 
GGCACTGGTAGAATTCACTGTG TATGGCCCTTCGGTAATTCA M 
pri-miR-96 
GTGCCAGGGTACAAAGACCT GGCACTACACATGATTGCTCA M 
pre-miR-96 
TTTGGCACTAGCACATTTTTG GGCACTACACATGATTGCTCA M 
pri-miR-204 
GCTAAGATGCCGGAGAATCA GCCTTCCCAGCCTCCTTC M 
pre-miR-204 
TTCCTTTTGTCATCCTATGC GCCTTCCCAGCCTCCTTC M 
pri-let7b 
CTATGGCTCTAGTGGCCTGTG GTATAGTTATCTTCGGAGGGGCA M 
pre-let7b 
GAGGTAGTAGGTTGTGTGGTTTCAG GTATAGTTATCTTCGGAGGGGCA M 
pri-miR-29c 
TCATTCAGTCCTGGTTGCAG CCGATTTCAAATGGTGCTAGA M 
pre-miR-29c 
TGACCGATTTCTCCTGGTGT CCGATTTCAAATGGTGCTAGA M 
pri-miR-292 
TTTACAGGAGCGGACAACCT AACCGGTGACACTCAAAACC 
M 
pri-miR-16-1 
AAAAGGTGCAGGCCATACTG TTGCCAACCTTACTTCAGCA 
M 
pri-miR-16-2 
TGCTGAGTCCTGTCTTTTGG ACGCCAATATTTACGTGCTG 
M 
pri-miR-25 
AGGCTCCATTTGTTTGATGG GCACTGTCAGACCGAGACAA 
M 
pri-miR-124-1 
CCATCCCCTCCCTTTCTTT ACCGCGTGCCTTAATTGTAT 
M 
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pri-miR-124-2 
GGAGTAGGGACTCCAAGCCTA CTCCGCTCTTGGCATTCAC 
M 
pri-miR-124-3 
GGCGAAGAAGCTGGAGCA ACCGCGTGCCTTAATTGTAT 
M 
pri-miR-128-1 
TGACAGGTTTATAGGCCCTGA GAAGTCAGGAAGCAGCTGAAA 
M 
pri-miR-128-2 
TCCATGTTTTACTGCCACGA CGGATTGACAGGGAATTCTG 
M 
pri-miR-124-1 
CCCTCCCATCCTTCCTTCT TTGTGCTGAGTCGATCCTTC 
R 
pri-miR-124-2 
TACAAGCCTCGAACTGCAAG GCACAGGATGGGTTCATTCTA 
R 
pri-miR-124-3 
CCCTCTGCGTGTTCACAG ATTGTTCGCCGGATTTGTC 
R 
pri-miR-128-1 
AGCCCTGGCTCTTTGATACA TGAAGCCAAATGATGCAAAA 
R 
pri-miR-128-2 
CAGCAGGATTGACAGGGAAT ATGCAGCATACGTGATGGAA 
R 
pri-miR-16 
CATCACACTTGTATTATTATGTTTGGA TGGTTTTTATGTTAGAAAAGTGACAA 
R 
pri-miR-25 
AGGGGTGAAACCAAGGATCT ATGGGGAGCCTAGTGGAGTT 
R 
uPA 
GGGTCAGTCGAAGGAGAGC GTCTGAACCAAACGGAGCAT 
M 
β-actin TGTTACCAACTGGGACGACA GGAGAGCATAGCCCTCGTAG M/R 
β-tubulin ACCGTAGCCATGAGGGAAAT CCCAGGTTCTAGATCCACCA M/R 
Gαt1 GACGACGAAGTGAACCGAAT GGTGACAGCGTCAAAGACAA M 
18S rRNA CGGCTACCACATCCAAGGAA GCTGGAATTACCGCGGCT M/R/H 
uPA 
CGCTCAAGGCTTAACTCCAACAC AACGGATCTTCAGCAAGGCAATG 
H 
pri-let7b 
CTCCTGCTCTGGTGACTGAG CCCTGCAGGTCACTGAGGT 
H 
pri-miR-16-1 
AAAGGTGCAGGCCATATTGT TGAAAAGACTATCAATAAAACTGA AAA 
H 
pri-miR-16-2 
GCGAATCATTATTTGCTGCTC AAGAACAAAAACAAAGGAAAAGGA 
H 
pri-miR-25 
CAAGCTCCATCTGTCAT CT GACACCCTTGTTCTGGCTTT 
H 
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Supplemental table legends 
Table S1, related to Figure 1. 454 sequencing (worksheet I) and Exiqon array 
(worksheet II) data of miRNAs expressed in DA and LA retinas. The Exiqon data 
represent results of two independent array experiments (I and II). Single arrays were 
used in Experiment I, while the data from Experiment II represent average hybridization 
signals from two independent array analyses performed for each DA and LA RNA 
samples originating from two independent experiments. Only miRNAs for which 
hybridization signal was significantly above the background are listed. For other details, 
see Supplementary Experimental Procedures. Note, that in Experiment I, in which a 
pool of RNA from ten different mouse organs (not including retinas) was used as a 
reference RNA, there is a dramatic difference between test and reference samples in 
the intensity at hybridization signals for miR-183/96/182 cluster and mir-211. This 
argues for the specificity of hybridization for these particular miRNAs. 
 
Table S2, related to Figure 2. List of predicted miR-183/96/182 targets. (Worksheet I) 
List of genes expressed in mouse retina and predicted to be targets of the miR-
183/96/182 cluster miRNAs by each of the three algorithms: PicTar, Targetscan 5.1 
and MicroCosm (see also Figure 2A). Retinal expression of genes is based on data 
from (61, 108, 109) and our own array analysis. (Worksheet II) List of predicted targets 
of the miR-183/96/182 cluster miRNAs, which were found to be up-regulated ≥ 1.5-fold 
(p < 0.05) in retinal photoreceptors of DA relative to LA retina. Up-regulation and p 
values for individual mRNAs are indicated.   
 
Table S3. PCR primers used to amplify mouse, rat or human miRNA precursors, 
mRNAs, and U6 RNA. 
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My contribution 
My contribution to the research article “Characterization of microRNAs induced 
by light adaptation in mouse retina reveals rapid turnover as a common property 
of neuronal microRNAs” published in Cell was following: I performed retinal 
tissue isolation for all experiments, except for the initial 454 sequencing screen 
(see Fig. 1). I evolved the idea to generate sponge sequences under 
consideration of thermodynamic parameters and helped to write an algorithm 
for sponge design and selection (together with Michael Stadler, unpublished). I 
selected all in silico generated sponge sequences used for this study. I 
generated adeno-associated-virus (AAV) sponge expression vectors for 
photoreceptor-specific expression for in vivo knockdown of particular 
microRNAs. I transfected mouse retinas with sponge AAVs in vivo, performed 
immunohistochemistry, confocal microscopy of transfected retinas and image 
processing. I also performed in vivo electroporations to deliver fluorescent 
reporter constructs to retinas of newborn mice that were used for ratiometric 
measurements to isolate microRNA targets in vivo (see Fig.2 and S3). I 
contributed to the design and accomplishment of the kinetic experiments, as 
well as in data presentation (see Fig. 3, 4, 5, S4, S5). Furthermore, I did all in 
vivo injection of transcription inhibitors (see Fig. 4). I dissociated retinas for 
fluorescent activated cell sorting (FACS) experiments (see Fig. 5). I performed 
extracellular spike recordings from embryonic stem cells derived neurons using 
a multi-electrode array system and corresponding analysis (see Fig. S7). I 
helped in writing of the manuscript. 
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Chapter 3: Side projects 
3.1 ­ Genetically timed, activity­sensor and rainbow transsynaptic viral 
tools 
Nat Methods. 2009 Feb;6(2):127-30. Epub 2009 Jan 4. 
Genetically timed, activity-sensor and rainbow transsynaptic viral tools. 
Boldogkoi Z, Balint K, Awatramani GB, Balya D, Busskamp V, Viney TJ, Lagali 
PS, Duebel J, Pásti E, Tombácz D, Tóth JS, Takács IF, Scherf BG, Roska B. 
 
Abstract 
We developed retrograde, transsynaptic pseudorabies viruses (PRVs) with 
genetically encoded activity sensors that optically report the activity of 
connected neurons among spatially intermingled neurons in the brain. Next we 
engineered PRVs to express two differentially colored fluorescent proteins in a 
time-shifted manner to define a time period early after infection to investigate 
neural activity. Finally we used multiple-colored PRVs to differentiate and 
dissect the complex architecture of brain regions. 
PMID: 19122667 
 
My contribution 
I generated the DNA construct that was used to generate the transgenic mouse 
line expressing TN-L15 from the Thy1 promoter (see Methods.) 
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3.2 ­ KAP1­mediated epigenetic repression in the forebrain modulates 
behavioral vulnerability to stress 
 
Neuron. 2008 Dec 10;60(5):818-31. 
KAP1-mediated epigenetic repression in the forebrain modulates behavioral 
vulnerability to stress. 
Jakobsson J, Cordero MI, Bisaz R, Groner AC, Busskamp V, Bensadoun JC, 
Cammas F, Losson R, Mansuy IM, Sandi C, Trono D. 
Abstract 
KAP1 is an essential cofactor of KRAB-zinc finger proteins, a family of 
vertebrate-specific epigenetic repressors of largely unknown functions encoded 
in the hundreds by the mouse and human genomes. Here, we report that KAP1 
is expressed at high levels and necessary for KRAB-mediated repression in 
mature neurons of the mouse brain. Mice deleted for KAP1 in the adult 
forebrain exhibit heightened levels of anxiety-like and exploratory activity and 
stress-induced alterations in spatial learning and memory. In the hippocampus, 
a small number of genes are dysregulated, including some imprinted genes. 
Chromatin analyses of the promoters of two genes markedly upregulated in 
knockout mice reveal decreased histone 3 K9-trimethylation and increased 
histone 3 and histone 4 acetylation. We propose a model in which the tethering 
of KAP1-associated chromatin remodeling factors via KRAB-ZFPs 
epigenetically controls gene expression in the hippocampus, thereby 
conditioning responses to behavioral stress. 
PMID: 19081377 [PubMed - indexed for MEDLINE] 
My contribution 
I used in silico approaches to identify target molecules (Krueppel-associated 
box (KRAB) zinc finger proteins (KRAB-ZFPs)) whose expression might be 
altered in the hippocampus due to the manipulation of epigenetic repression 
(knock out of corepressor KAP1). I verified in silico results by combining 
robotics with high throughput quantitative real time PCR (see methods). 
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3.3  –  Light­activated  channels  targeted  to  ON  bipolar  cells  restore 
visual function in  retinal degeneration. 
 
Nat Neurosci. 2008 Jun;11(6):667-75. Epub 2008 Apr 27. 
Light-activated channels targeted to ON bipolar cells restore visual function in 
retinal degeneration. 
Lagali PS, Balya D, Awatramani GB, Münch TA, Kim DS, Busskamp V, Cepko 
CL, Roska B. 
Abstract 
Genetically encoded optical neuromodulators create an opportunity for circuit-
specific intervention in neurological diseases. One of the diseases most 
amenable to this approach is retinal degeneration, where the loss of 
photoreceptors leads to complete blindness. To restore photosensitivity, we 
genetically targeted a light-activated cation channel, channelrhodopsin-2, to 
second-order neurons, ON bipolar cells, of degenerated retinas in vivo in the 
Pde6b(rd1) (also known as rd1) mouse model. In the absence of 'classical' 
photoreceptors, we found that ON bipolar cells that were engineered to be 
photosensitive induced light-evoked spiking activity in ganglion cells. The 
rescue of light sensitivity was selective to the ON circuits that would naturally 
respond to increases in brightness. Despite degeneration of the outer retina, our 
intervention restored transient responses and center-surround organization of 
ganglion cells. The resulting signals were relayed to the visual cortex and were 
sufficient for the animals to successfully perform optomotor behavioral tasks. 
PMID: 18432197 
My contribution 
I helped performing in vivo electroporations to deliver channelrhodopsin-2 to 
bipolar cells of rd1 mice (see methods). 
  
82
 
 
Summarizing Discussion 
The reactivation of non-functional cone photoreceptors in mouse models of RP 
(Chapter 1) demonstrated that the intervention at the photoreceptor level had 
several advantages compared with inner retinal approaches. All complex cone 
pathways tested were restored in a sophisticated manner. This was important 
because it implied the restoration of vision as opposed to just reactivating light 
sensitivity. One single archaebacterial light sensor substituted for the entire 
intrinsic phototransduction cascade. This was of utmost significance for the 
feasibility of gene therapy concerning practical issues and legal issues if this 
approach will be translated to patients. The light requirements to stimulate 
eNpHR were considered safe regarding photochemical or photothermal 
damage due to the red-shifted action spectra (lower energy of photons) of the 
light sensor.  The therapeutic window for reactivated cones spanned about one 
third of a mouse lifetime (last point tested). This cannot be compared directly 
with the human disease but it is quite promising since the human RP 
progression is much slower. The ability of eNpHR to drive human 
photoreceptors in vitro demonstrates its translational potential. Apart from all 
biomedical aspects, my finding that morphologically altered cones in RP retinas 
are still connected to downstream bipolar cells has not been shown yet. At late 
stages of mouse RP, all cones were considered dead but my data suggested a 
preservation of ~25% at P260 in mice. This fraction of cones was enough to 
reactivate the retinas. The persisting cones also changed their protein 
expression pattern and merged with the inner nuclear layer. The use of s-RD 
mice indicated that the development of inner retinal pathways is genetically 
“hard-wired” and no light input is needed. My behavioral data showed 
differences between the two mouse models in the processing of light signals at 
higher visual centers suggesting visual-activity-dependent development of the 
brain circuitries. The reactivation of human photoreceptors in healthy but light-
insensitive post-mortem retinas in vitro also enables the use of this system to 
study human retinal circuitries functionally, like color vision or foveal pathways. 
The microRNA project (Chapter 2) addressed more basic questions of retinal 
functions. My contribution helped to understand how small non-coding RNA 
molecules regulate gene expression in retinal cells in a light level-dependent 
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manner. The finding that microRNA levels are regulated by their transcription 
but also by the turnover of mature microRNA in active neurons demonstrate 
their highly dynamic nature. MicroRNAs might act as master regulators or 
switches of gene expression. Current detection technologies are just starting to 
reach the resolution to study reliably the levels of these small molecules. Our 
findings shed light on the dynamics of the concentrations of a set of microRNAs 
in active neurons. Our results have to be taken under consideration by 
performing microRNA-mediated gene knock-downs in neurons for basic but 
also biomedical questions. The half-life of microRNAs in active neurons might 
be shorter than in other cell types tested so far. 
Chapter 3.1 demonstrated the necessity of molecular biological and imaging 
tools to study retinal functions. The use of transgenic animals is advantageous 
concerning reliability and reproduction of experiments but expression levels are 
often lower and the generation of transgenic animals is very time consuming (~1 
year). 
The field of epigenetics deals with the non-genetic factors of gene expression 
such as DNA methylations and histone modification. The hippocampus-specific 
ablation of an epigenetically repressing modulator (KAP1) had an impact on 
animal behaviors such as anxiety, learning and memory (Chapter 3.2). Lacking 
the ability to form heterochromatin and thereby silence certain genes induced 
an impact on memory. Normally, the repressor complex is directed to specific 
DNA regions via DNA-binding zinc finger proteins, in a controlled manner. This 
indicates that active heterochromatin formation is linked to memory by 
repressing the expression of certain genes.  
Chapter 3.3 was the first vision restoration project I contributed to. The 
combination of targeted gene expression and the knowledge of retinal circuitry 
led to the restoration of light perception in blind mice. The preservation of 
retinotopy - the spatial organization of neuronal responses - is essential to relay 
useful light information towards higher visual centers. In this project, the 
targeted expression of ChR2 to ON bipolar cells transformed these inner retinal 
cells to photoreceptors. This approach might be useful at late stages of RP 
when all functional photoreceptor-to-bipolar cell synapses are degenerated.
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Material and Methods 
Chapter 1: Material and Methods 
Plasmids.  
The sources and names of the plasmids that were used as starting materials 
are listed in Supplementary Table S2. Restriction enzymes were purchased 
from New England Biolabs. Polymerase chain reaction (PCR)-based cloning 
was performed using Herculase polymerase (Stratagene) followed by 
sequencing to verify that the constructs were free of mutations. The In-Fusion 
2.0 PCR Cloning Kit (Clontech) was used to insert PCR products into linearized 
plasmids via homologous recombination. Primers for In-Fusion cloning were 
designed to comprise 21 bp homology to the PCR product and 15 bp homology 
to the target vector backbone. In some cloning steps, linearization was 
performed using two restriction enzymes to remove unwanted DNA segments.  
First, to obtain pAAV2-hRHO-eNpHR-EYFP we linearized pAAV2.1-Rho-EGFP 
using NotI/HindIII, and inserted the PCR-amplified eNpHR-EYFP from Lenti-
CaMKIIa-eNpHR-EYFP-WPRE (31). Forward primer: 
atcacactggcggccctagcgccaccatgaggggta. Reverse primer: 
gattggatccaagcttcattacacctcgttctcgta. Note that Rho in pAAV2.1-Rho-EGFP and 
hRHO refer to the same promoter (hRHO, 0.9 kb).  
Second, to obtain pAAV2-hRO-EGFP we linearized pAAV2.1-Rho-EGFP using 
NheI/NotI and inserted the PCR-amplified human red opsin promoter (hRO, 2.1 
kb) from pRed2.1lacZ (37). Forward primer: 
tcgcccttaagctagcctacagcagccagggtgaga. Reverse primer: 
cgcccttgctcaccatggcggccgctatggaaagcc.  
Third, to obtain pAAV2-hRO-eNpHR-EYFP we linearized pAAV2-hRO-EGFP 
using NotI/HindIII and inserted the PCR-amplified eNpHR-EYFP from Lenti-
CaMKIIa-eNpHR-EYFP-WPRE. Forward primer: 
ctttccatagcggcctgccaccatgaggggtacgcc. Reverse primer: 
attggatccaagctattacacctcgttctcgtagca.  
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Fourth, to generate the intermediate plasmid pCR-Blunt II-TOPO-mCAR, the 
mouse cone arrestin promoter fragment (38) (mCAR, 0.5 kb) upstream of the 
Arr3 gene was PCR-amplified from mouse genomic DNA. Forward primer: 
ggttcttcccattttggcta. Reverse primer: cctccagctctggttgctaag. mCAR was then 
subcloned into the pCR-Blunt II-TOPO (Invitrogen) vector backbone. To obtain 
pAAV2-mCAR-EGFP, we linearized pAAV2.1-Rho-EGFP using NheI/EcoRV 
and inserted the PCR-amplified mCAR from pCR-Blunt II-TOPO-mCAR. 
Forward primer: tcgcccttaagctagggttcttcccattttggctac. Reverse primer: 
gccagtgtgatggatcctccagctctggttgctaag.  
Fifth, to obtain pAAV2-mCAR-eNpHR-EYFP we linearized pAAV2-mCAR-EGFP 
using NotI/HindIII and inserted the PCR-amplified eNpHR-EYFP from Lenti-
CaMKIIa-eNpHR-EYFP-WPRE. Forward primer: 
atcacactggcggcctgccaccatgaggggtacgcc. Reverse primer: 
attggatccaagctattacacctcgttctcgtagca.  
Sixth, to obtain pLV-mCAR-eNpHR-EYFP we linearized pRRLsincPPT-hPGK 
using EcoRV/BamHI and inserted the PCR-amplified mCAR-eNpHR-EYFP from 
pAAV2-mCAR-eNpHR-EYFP. Forward primer: 
ctcgagaagcttgatggttcttcccattttggctac. Reverse primer: 
ctgtttaaacggatcctattacacctcgttctcgta.  
Seventh, to obtain pbRHO-NpHR-EYFP (here bRho refers to the bovine 
rhodopsin promoter, 2.2 kb) the pRho-DsRed (18) was linearized using 
KpnI/NotI. The NotI site was blunted using T4 polymerase (New England 
Biolabs). NpHR-EYFP was cut out of pcDNA3.1/NpHR-EYFP (14) using 
KpnI/XbaI. The XbaI site was blunted using T4 polymerase. The two DNA 
fragments were ligated (2x Mighty Ligation Mix, Takara Bio) and called pbRHO-
NpHR-EYFP. pbRHO-NpHR-EYFP was used for pronuclear injections to obtain 
transgenic mice in FVB background.  
Eighth, to obtain pAAV2-hRHO-NpHR-EYFP we cut out NpHR-EYFP from 
pcDNA3.1/NpHR-EYFP (14) using NheI/BsrGI. The NheI site was blunted and 
NpHR-EYFP was ligated to EcoRV/BsrGI linearized pAAV2.1-Rho-EGFP (2x 
Mighty Ligation Mix, Takara Bio). 
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Animals.  
Wild-type C57BL/6 mice were purchased from RCC Ltd. (Füllinsdorf, 
Switzerland). C3H/HeNCrl (Pde6brd1) mice were purchased from Charles River 
Laboratories (L’Arbresle Cedex, France). Cnga3-/-; Rho-/- double knockout mice 
were provided by Mathias Seeliger, Peter Humphries, and Martin Biel. The Fvb-
Rho-NpHR-EYFP mouse line was generated in the transgenic mouse 
production facility at the Friedrich Miescher Institute. For this study, it was 
backcrossed to C57BL/6 mice. All animal experiments and procedures were 
approved by the Swiss Veterinary Office. The animals were maintained under a 
12-hour light-dark cycle. The ranges of mice age used for particular 
experiments are listed in Supplementary Table S1. The ages of mice 
transfected with AAVs and used for retinal electrophysiology are shown in Fig. 
S6. 
AAV production.  
All recombinant adeno-associated viruses were made by Penn Vector Core and 
serotyped as listed in Supplementary Table S3. Penn Vector Core performed 
the genome copy (GC) number titration (see Supplementary Table S3) by using 
real-time PCR (TaqMan reagents, Applied Biosystems).  
Lentivirus production.  
Lentivirus was produced as previously described (52).The titer of LV-mCAR-
eNpHR-EYFP was 2×109 VG/ml (viral genomes per ml). 
Subretinal AAV administration.  
The animals were anaesthetized using 3% isoflurane. A small incision was 
made with a sharp 30-gauge needle in the sclera near the lens. Through this 
hole, 2µl AAV were injected slowly (in 20-30 s) into the subretinal space using a 
blunt 5 μl Hamilton syringe held in a micromanipulator. Mice older than P21 
were used for injections. There was a minimum incubation time of 21 days 
before performing experiments on AAV-injected animals. For behavioral 
studies, we injected both eyes with either eNpHR- or EGFP-expressing AAVs. 
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Immunohistochemistry.  
Retinas were isolated and fixed in 4% paraformaldehyde in phosphate-buffered 
saline (PBS) for maximal 30 min at room temperature (RT), and washed in PBS 
overnight at 4°C. Retinal whole mounts were incubated in 30% sucrose 
overnight at RT. The retinas were treated with three freeze-thaw cycles. After 
the freeze-thaw treatment, all the steps were performed at RT. Retinas were 
incubated in a blocking solution (10% normal donkey serum (NDS, Chemicon), 
1% bovine serum albumin (BSA), and 0.5% Triton X-100 in PBS, pH 7.4) for 1h. 
Primary and secondary antibody applications were done in 3% NDS, 1% BSA, 
0.02% sodium azide, and 0.5% Triton X-100 in PBS. All antibodies, dilutions 
and sources are listed in Supplementary Table S4. Primary antibodies were 
applied for 3-7 days. After washing the retina three times for 10 minutes in PBS, 
the retina was incubated with Alexa Fluor-conjugated secondary antibodies 
(1:200 dilution) and 10 µg/ml 4’, 6-diamidino-2-phenylindole (DAPI, Roche 
Diagnostics), which stains cell nuclei, for 2h. After another three washes in 
PBS, the retina was mounted on a glass slide with ProLong Gold antifade 
reagent (Invitrogen). Retinal vibratome sections: Fixed retinas were embedded 
in 3% agarose (SeaKem Le Agarose, Lonza) in PBS, and 150μm vertical 
sections were cut using a Leica VT1000S vibratome. Antibody staining 
procedure was the same as in whole mounts. Note that we used primary anti 
green fluorescent protein (GFP) antibodies to label EYFP because of epitope 
homology. Neurobiotin-filled ganglion cells from patch clamping experiments 
were stained with Alexa Fluor 555-conjugated streptavidin (Invitrogen) as 
described before (110). We used choline acetyl transferase antibody to mark 
two IPL strata (110).  
Confocal microscopy.  
Confocal images of antibody-stained retinas were taken using a Zeiss LSM 510 
Meta Axioplan 2 laser scanning confocal microscope (Carl Zeiss) equipped with 
argon and helium-neon lasers. Plan-Apochromat 63X/1.4 or 40X/1.4 oil 
immersion objective lenses were used. Image analysis and quantification were 
done using Imaris software (Bitplane).  
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Quantification of AAV transduction.  
At least three retinal whole mounts per mouse line and AAV type were 
immunostained for GFP (to label eNpHR-EYFP- or EGFP-expressing cells) and 
cone arrestin (to label cones), as well as stained with DAPI (to label cell nuclei 
in order to count the total number of photoreceptors). In each wild-type retina 
the entire depth of the ONL was scanned by confocal microscopy at three 
randomly-chosen areas in AAV-transduced regions. Three horizontal sections 
of each ONL scan (top layer, central layer, and bottom layer close to OPL) were 
analyzed. Automatic cell count in Imaris (Bitplane) was used to determine the 
number of GFP-labeled, cone-arrestin-labeled, and DAPI positive 
photoreceptors. Due to the fact that eNpHR-EYFP is membrane-bound, the 
GFP channel in eNpHR-EYFP-transduced retinas was inverted. This inversion 
enabled automatic cell counting. After this automatic cell count procedure, 
which marked every counted cell, each confocal section was manually 
inspected to remove false automatic counts. In RD retinas the procedure was 
the same, but due to decreased ONL thickness only one horizontal section was 
analyzed per confocal scan. In total, 81 horizontal sections were analyzed from 
AAV-transduced wild-type retinas (n=7403 cells (hRHO), n=7974 (hRO), 
n=7996 (mCAR)), 26 for s-RD (n=1634 (hRHO), n=1865 (hRO), n=1871 
(mCAR)), and 18 for f-RD (n=1183 (hRO), n=1105 (mCAR)). The cone-arrestin 
antibody failed to label cone cell bodies in the RD retinas in a reproducible 
manner. Therefore, subtype-specific quantifications were performed in wild-type 
animals. Cones are only present in the top row of the ONL. In total, 27 
horizontal sections for cones (n=343 cells (hRHO), n=446 (hRO), n=463 
(mCAR)) and 81 sections for rods (n=7060 cells (hRHO), n=7528 (hRO), 
n=7533 (mCAR)) were analyzed. Total photoreceptor cell number in a 
horizontal confocal optical section was obtained by counting DAPI-labeled 
nuclei. We determined total photoreceptor number in uninjected wild-type 
retinas from 24 sections (n=7169 cells) and in NpHR transgenic mouse line 
from 9 sections (n=2793 cells). Estimation of persisting cone cell bodies (Fig. 
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S7) based on the quantification on GFP-labeled cells in P99-108 (n=5 retinas), 
P184-255 (n=5 retinas) s-RD, P50-77 (n=3), and P182-264 (n=3) f-RD retinas. 
These numbers were related to the retinal area, divided by the maximal 
transfection efficiency (Mean + SEM) for each mouse model (s-RD 88.6%, f-RD 
50.8%) and normalized to wild-type cone numbers (12,800 cells mm-2, (111)). 
Fluorescence­activated cell sorting (FACS).  
Retinas from 4 mice per group (f-RD injected with mCAR-EGFP from P110 or 
P220 mice, and f-RD injected with mCAR-eNpHR-EYFP from P165 animals) 
were isolated and dissociated to single cells by papain digestion as previously 
described (112). EGFP- or eNpHR-EYFP-positive cells were sorted using FACS 
(MoFlo from DakoCytomation) and used for microarray profiling. 
RNA isolation and amplification, and microarray profiling.  
All samples were obtained in four biological replicates per genotype for 
microarray gene expression profiling. Following cell dissociation, cells were 
immediately sorted by FACS and immersed in 50 µl extraction buffer (Arcturus, 
USA), left to lyse at RT for 10 minutes and stored at -80°C. Total RNA from 
samples containing 500 or 300 cells was isolated using the PicoPure RNA 
isolation kit (Arcturus) with the following modifications. The tubes were 
incubated at 42°C for 10 minutes and vortexed at low speed. Total RNA was 
treated with 10 units of DNase I (Qiagen) for 15 minutes to remove any 
remaining genomic DNA and eluted in 8 µl elution buffer. The RNA quality was 
assessed using RNA 6000 PicoChips with the Agilent 2100 Bioanalyzer 
(Agilent). No traces of DNA were detected; degradation of the ribosomal RNA 
was absent. The rRNA represented 90–95% of total RNA and a ratio of 
28S/18S equal to 1.9-2.2 was recorded, indicating that the extractions met the 
criteria for downstream genetic analysis. Total RNA from each sample was 
reverse-transcribed using 4 μM T7-(dT)24/T7-(dN)6 primer mix (Affymetrix) and 
150 units Superscript II reverse transcriptase (Invitrogen) in a volume of 10 µl. 
Synthesis of second-strand cDNA was performed by adding 4 mM dNTPs, 6 
units DNA Polymerase I, and 0.4 units RNase H in a 20 µl reaction volume. 
cRNA was produced by in vitro transcription (IVT) with a T7 RNA polymerase at 
37°C for 14 hours using the MEGAscript T7 kit (Ambion) as per manufacturer’s 
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instructions. For the second cycle, the first-strand cDNA was synthesized using 
0.2 μg random primers from 9μl purified cRNA. The second-strand cDNA was 
produced using 10 µM T7-(dN)6 primer and 40 units DNA polymerase at 16°C 
for two hours, after which 10 units of T4 DNA polymerase (Invitrogen) were 
added and incubation continued for another 10 minutes. The cDNA was in vitro-
transcribed with a T7 RNA polymerase at 37°C for 16 hours. The single-strand 
cDNA was synthesized using 10 µg purified cRNA in the presence of 4 µg 
random primers, 0.2 M DTT, 12 mM dNTP + dUTP, and 750 units Superscript II 
(Roche Diagnostics) in a total volume of 20 µl. The cRNA was hydrolyzed with 2 
units RNase H at 37°C for 40 minutes. The sense cDNA was purified and eluted 
in 28 µl elution buffer. Amplified products were purified using the GeneChip 
cDNA Sample Cleanup Module (Affymetrix) applying a 6,000 g centrifugation 
speed during the first two steps. To improve the recovery from the columns, 
water or elution buffer were spun into the matrix at 50 g and then left to stand 
for 4 minutes prior to 16,000 g centrifugation. The quantity and purity of the 
cRNA and cDNA produced during the first and second rounds were evaluated 
using the NanoDrop ND-1000 spectrophotometer (Nanodrop Technologies). 
The cDNA was then fragmented using UDG (uracil DNA glycosylase) and APE 
1 (apurinic/apyrimidic endonuclease 1), and biotin-labeled with TdT (terminal 
deoxynucleotidyl transferase) using the GeneChip WT Terminal labeling kit 
(Affymetrix). Hybridization was performed using 5 μg biotinylated target, which 
was incubated with the GeneChip Gene 1.0 ST array (Affymetrix) at 45°C for 16 
hours. Following hybridization, nonspecifically bound nucleotides were removed 
by washing, and detection of specifically bound target was performed using the 
GeneChip Hybridization, Wash and Stain kit, and the GeneChip Fluidics Station 
450 (Affymetrix). The arrays were scanned using the GeneChip Scanner 3000 
7G (Affymetrix), and CEL files acquired using the GeneChip Command Console 
Software (Affymetrix). Quality control and gene expression value estimates 
were obtained after RMA and quantile normalization performed in R (version 
2.10). To identify transcripts that are differentially expressed between the 
controls and the mutant mice, we defined a criterion of a 2-fold or greater 
difference, plus a P-value of < 0.01.  
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Human ocular tissue.  
Human ocular tissue was obtained from the Cornea Bank of Amsterdam and 
was handled in accordance with the guidelines of the Declaration of Helsinki. 
Eyes were collected from five donors (ranging in age from 58 to 65 years) after 
death through natural causes. After removal of the cornea, eyes were put into 
storage within 6 to 12 hours in cold phosphate-buffered saline solution (PBS) 
and shipped to Basel where the experiments took place. Retinas were always 
put into culture less than 36 hours post-mortem.  
Human retinal explant culture and vector administration.  
Immediately after the arrival of the eyes, the anterior parts were removed and 
the vitreous humor with attached neural retina was transferred to a CO2-
independent medium (Invitrogen). The retina was separated from the vitreous 
humor and from the retinal pigment epithelium, and cut into ~1 cm² pieces. With 
the photoreceptor face up, these retinal pieces were placed on the 
polycarbonate membrane of a Transwell 0.4 µm cell culture insert (Corning) 
with one drop of CO2-independent medium, and flattened with a polished 
Pasteur pipette. Next, the CO2-independent medium was removed and 2 ml 
neurobasal-A medium with 2mM L-glutamine plus B27 supplement (NBA+; 
Invitrogen) were added to each well. 10-50 µl AAV (3×1012 to 5×1012 GC ml-1, 
see Supplementary Table S3) or 10 µl lentivirus (2×107 VG ml-1) were added on 
top of the retinal explants. Virus-infected retinas were incubated for up to 18 
days for AAVs, and 24-72 h for lentivirus. The culture medium was renewed by 
a daily addition of fresh NBA+ medium to each well. Human retinas were 
already light insensitive at the time of isolation. 
Optical coherence tomography (OCT).  
OCT and functional tests (see below) were performed at the Center for Clinical 
Investigation (CIC) of the Centre Hospitalier National d’Ophtalmologie des 
Quinze-Vingts in Paris. OCT imaging was carried out using spectral domain 
OCT (Spectralis® OCT, Heidelberg Engineering, Dossenheim, Germany).  
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Goldmann perimetry. 
 Photopic visual field measurements were performed with a Goldmann 
perimeter (Haag-Streit AG, Bern, Switzerland). The kinetic perimetry was 
performed by moving the tests IV1, V1, and V4 from non-seeing to seeing 
areas. The visual field areas were then determined after plotting the fields with a 
desktop planimeter.  
Light stimulation of isolated retinas.  
Light generated by a 120W epifluorescent mercury lamp-based illuminator (X-
Cite 120PC, EXFO Photonics Solutions) was filtered with a band-pass filter 
(600-660 nm, Chroma Technology) and projected onto the retina. The light path 
was interrupted with a computer-controlled shutter (SC10, Thorlabs). Light 
intensity was modulated by neutral density filters over a range of 5 log units (ND 
0-ND 40). For patterned light stimuli, the retina was stimulated using a digital 
light projector (V-332, PLUS Vision) filtered with the same band-pass filter used 
for the epifluorescent light path. A monochromatic light source (15nm 
bandwidth, TILL Photonics Polychrome V, Agilent Technologies) was used to 
provide a color-ramp, light flashes, or periodic light pulses at defined 
wavelengths. The color-ramp started at 400 nm and continuously increased to 
650 nm within 5 s. Light intensities from all three light sources were measured 
using a fluorescent spectrometer (USB 4000, Ocean Optics) calibrated with a 
radiometric reference source (LS1-Cal, Ocean Optics). The stimulus was 
generated via custom-made software written by D.B. (Matlab, Mathworks and 
Labview, National Instruments).  
Two­photon targeted patch clamp recordings.  
AAV-transduced retinas from s-RD and f-RD mice were isolated in Ringer’s 
medium (110mM NaCl, 2.5mM KCl, 1mM CaCl2, 1.6mM MgCl2, 10mM D-
glucose, and 22mM NaHCO3, bubbled with 5% CO2/95% O2). For 
photoreceptor patch clamp recordings, retinal slices (200 μm) were cut with a 
razor blade tissue chopper (Stoelting) and placed in the recording chamber of 
the microscope. The tissue was superfused in Ringer’s medium at 36°C for the 
duration of the experiment. AAV-transduced fluorescent photoreceptors were 
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targeted with a patch electrode using a custom-made 2-photon microscope. A 
CCD camera was used to visualize the retina (illuminated with infrared light, 
725-775 nm) during two-photon scanning. Whole-cell recordings were made 
using an Axon Multiclamp 700B amplifier. Patch electrodes were made from 
borosilicate glass (BF100-50-10, Sutter Instruments) pulled to 8-10 MΩ, and 
filled with 115mM K Gluconate, 10mM KCl, 1mM MgCl2, 0.5mM CaCl2, 1.5mM 
EGTA, 10mM HEPES, and 4mM ATP-Na2 (pH 7.2). In f-RD retinas the 
photoreceptor recordings were only performed from cones, since rods died 
before our recordings. In s-RD retinas we used two criteria to identify cones 
before the recordings. First, since cone cell bodies occupy only the most distal 
row of the outer nuclear layer we recorded from cell bodies in this row. Second, 
since cone cell bodies are larger than rod cell bodies we only targeted the 
largest cell bodies. In a few cases we verified that we recorded from cones by 
filling the recorded cell with Lucifer yellow, which showed the characteristic 
axon terminals of cones. We cannot rule out completely the possibility that 
some of the recorded cells in s-RD retinas were rods.  
For ganglion cell recordings, the retina was mounted ganglion-cell-side up on a 
piece of filter paper (MF-membrane, Millipore) with a 2 mm2 opening in the 
middle. Ganglion cell spike recordings were performed with a loose cell-
attached patch, using the same electrodes pulled to 6-8 MΩ, and filled with 
Ringer’s medium. Excitatory currents were isolated by voltage clamping 
ganglion cells at the reversal potential of Cl- (-60 mV) (110). For these 
recordings, electrodes were filled with 112.5mM CsMeSO4, 1mM Mg SO4, 
7.8×10-3 mM CaCl2, 0.5mM BAPTA, 10mM HEPES, 4mM ATP-Na2, 0.5mM 
GTP-Na3, 5mM lidocaine N-ethyl bromide (QX314-Br), and 7.5mM neurobiotin 
chloride (pH 7.2). To record spikes and currents, or to record spikes and obtain 
the morphology of ganglion cells, we first performed cell-attached recordings. 
Next, we broke into the recorded cell using another electrode filled with 
intracellular solution containing neurobiotin in whole-cell mode and either 
recorded currents of simply filled cells with neurobiotin for subsequent 
anatomical analysis. For human photoreceptor patch clamp recordings, we 
used human retinal explants, which were incubated with the lentiviral vectors for 
1-2 days. The human retinas were cut into slices (200 μm) with a razor blade 
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tissue chopper using the method as described above. Brightly labeled 
photoreceptors from the parafoveal region were targeted with a patch electrode 
(8-10 MΩ) filled with 115mM K gluconate, 10mM KCl, 1mM MgCl2, 0.5mM 
CaCl2, 1.5mM EGTA, 10mM HEPES, and 4mM ATP-Na2 (pH 7.2). Patch-clamp 
recordings were also made from non-transduced human photoreceptors 
immediately after the isolation of the retina. The human tissue was superfused 
in Ringer’s medium at 36°C for the duration of the patch-clamp experiment. All 
chemicals were obtained from Sigma, with the exception of ATP (Labforce) and 
neurobiotin (Vector Laboratories). Data were analyzed offline using Matlab 
(Mathworks). For statistics, we averaged over ON and OFF responses. The 
direction-selectivity index  shown in Fig. 2E is computed as described (41).  
Multi­electrode array recordings.  
To record the spike trains of retinal ganglion cells, the isolated mouse retina 
was placed on a flat MEA60 200 Pt GND array with 30 µm diameter 
microelectrodes spaced 200 µm apart (Ayanda Biosystems or Multi Channel 
Systems). The retina was continuously superfused in oxygenated Ringer’s 
solution (110mM NaCl, 2.5mM KCl, 1.0mM CaCl2, 1.6mM MgCl2, 22mM 
NaHCO3, and 10mM D-glucose (pH 7.4 with 95% O2/5% CO2)) at 36ºC during 
experiments. Recordings ranged from 1 to 5 h in duration. The signals were 
recorded (MEA1060-2-BC, Multi-Channel Systems) and filtered between 500 
Hz (low cut-off) and 3,500 Hz (high cut-off). The spikes were extracted with a 
threshold of at least 4 times the standard deviation of the recorded trace 
(Matlab, Mathworks). 
Visual­evoked potentials.  
Mice (ages s-RD: P70-P99, f-RD: P67-118, wild-type: P42-60) were 
anesthetized by subcutaneous injection of 8% chloral hydrate. Atropine drops 
(1%) and Oculotect (Novartis) were applied to the right eyes to dilate and 
protect the pupils. After exposing the primary visual cortex (V1), platinum-
iridium recording electrodes (size 0.0035, California Fine Wire Company) were 
inserted. Responses were first measured at different cortical depths, and the 
depth with the maximum response was chosen for further recordings. 500 ms 
light stimulus was delivered to the contralateral eye every 3 seconds, 30 times, 
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using an optical cable attached to a band pass filtered (D595/40, Chroma 
Technology) light source (EXFO XI120PC-XL, 120W, Photonic Solutions). The 
distance of the tip of the optical cable from the eye was 1 cm. The intensity of 
light was 1016 photons cm-2 s-1 at the eye surface. Each neural response was 
band-pass filtered at 0.1-500 Hz.  
Dark­light box.  
Mice (ages s-RD: P44-P143, f-RD: P50-120, wild-type: P52-64, female) were 
kept under a 12-hour light-dark cycle and tested between 9 a.m. and 12 p.m. 
Movement of mice in the dark-light box was recorded with a wireless infrared 
camera (SA-6255, Stilus SA) equipped with a longpass-filter (FGL665, 
Thorlabs) and digitized at 25 frames s-1 (AV400MKII, TerraTec Electronic 
GmbH). The interior dimensions of the dark-light box were 
32(width)×40(length)×22(height) cm. We inserted a non-transparent wall with a 
7×3cm hole (the hole was at the bottom of the wall in the middle) in the middle 
of the box, creating two equal-sized compartments 
(32(width)×20(length)×22(height) cm). One compartment was illuminated from 
the top with two red LED arrays (OD-610-99-070, Opto Diode), while the other 
remained dark (<2 lux). Illumination in this “light compartment” could be 
adjusted between 2 and 2,000 lux. Mice were placed individually in the corner of 
the light compartment and allowed to freely explore the box. The movement of 
the animal was recorded for 5 minutes. The mouse’s head was used to define 
the compartment it occupied. The time spent in each compartment was 
recorded. f-RD animals (eNpHR- or EGFP-expressing) spent a variable amount 
of time in the light compartment before the first crossing. This increased the 
variance of the total time spent in the light or dark compartment. We eliminated 
this time in our analysis by calculating the time in light compartment as (total 
time in light compartment - time until the first crossing) / (total recording time - 
time until the first crossing). This modification introduced a slight preference for 
the dark compartment. Results were, however, still statistically significant 
without this correction.  
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Optomotor response.  
The experiment was carried out as described previously (16, 51) with small 
modifications. Briefly, each mouse (ages s-RD: P113-P153, f-RD: P69-120, 
wild-type: P52-64, female, kept in a 12-hour light-dark cycle, tested between 9 
a.m. and 3 p.m.) was placed on an elevated (20cm high) platform (9cm 
diameter) which was positioned in the middle of an optokinetic drum (30cm 
diameter, 40 cm height). The drum was made of transparent plastic and 
decorated with black vertical stripes of different widths corresponding to 
different cycles per degree (cpd) spatial frequencies (0.03, 0.07, 0.13, 0.26, 
0.52 cpd) and rotated with a predetermined number (1, 2, 3, 4, 7) of revolutions 
per minute (rpm). The platform did not rotate. The drum was illuminated from 
outside with 6 red LED arrays (OD-610-99-070, Opto Diode) that generated 
2,000 lux at the position of the animal’s head. The contrast was 1:23 using the 
0.26 cpd drum. During the test, the drum turned clockwise and then anti-
clockwise for 2 min in each direction. This procedure was repeated at every 
spatial frequency at 2 rpm and every rotational speed at 0.13 cpd. Mice were 
recorded using the same video recorder and capture board as described above 
in the context of the dark-light box. We analyzed all head movements which 
lasted more than 400 ms. If the speed of the head (estimated as different 
angular positions within 400 ms) was within ±15% of the angular speed of the 
drum for more than 320 ms then the mouse was given a score of +1, if not it 
received -1. These points were added together to form a total score for the 2+2 
min recording period. All RD analysis was done in an automated fashion by a 
program written in Matlab (Mathworks). Wild-type optomotor scores from female 
animals was obtained as previous described (51). 
Statistical analysis.  
If the Lilliefors test did not reject the hypothesis that the sample had a normal 
distribution at the 5% significance level and n>7, then the statistical significance 
was determined using a one-tailed heteroscedastic Student’s t-test. Otherwise 
the Wilcoxon rank-sum test was used. We used the Kruskal-Wallis non-
parametric 1-way ANOVA test to compare groups. The different levels of 
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significance are indicated by * for p < 0.05, ** for p < 0.01, and *** for p < 0.001. 
The error bars and ± values represent s.e.m. 
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Chapter 2: Experimental procedures 
Light/dark adaptation of mice and retina isolation 
C57BL/6 mice were obtained from RCC (Fullinsdorf, Switzerland). Unless 
indicated otherwise, 6- to 8-week-old animals were used for the experiments. 
LA animals were kept in a room at 450 lux. For dark adaptation, animals were 
kept in a dark chamber with a maximum of 0.4 lux. Retinas from DA mice were 
isolated under dim red light.   
 
Laser capture microdissection (LCM)  
For extraction of RNA from LCM dissected layers, isolated retinas were 
cryoprotected in 20% sucrose for 15 min and embedded in Shandon M-1 
(Thermo Fisher) embedding matrix to 20% sucrose ratio 1:2. Frozen tissues 
were cut into 18-μm-thick sections and mounted on RNase-free MMI (Molecular 
Machines & Industries AG) membrane slides. For RNA isolation, retinal sections 
from 5 mice were stained with Mayer’s haematoxylin for 5 sec, fixed, and 
dehydrated for 50 sec in 100% ethanol. After the sections were briefly air-dried, 
~50,000 cells were captured from each retinal cell layer using MMI CellCut 
Plus® System microscopy. Total RNA was extracted from captured cell layers 
using Trizol reagent. For protein analysis by Western blotting, retinas were 
cryoprotected in 20% sucrose containing 10 μg/ml DAPI and embedded as 
described above. Sections were fixed and dehydrated in ice-cold methanol for 
50 sec. Once the sections were briefly air-dried, ~100,000 cells were captured 
from each retinal layer, lysed in 1x lysis buffer containing 50 mM Tris, pH 7.5, 
10 mM EDTA, 1% SDS, and 1x protease inhibitor cocktail (Roche). For retinas 
infected with AAV2-Rho-EGFP/triple sponge or AAV2-Rho-EGFP/control 
viruses, ~50,000 cells from the EGFP-fluorescence-positive ONL+OS/IS layers 
were captured and lysed.   
In vivo retina electroporation and two­photon ratiometric imaging 
Subretinal injection and in vivo electroporation of plasmids into newborn (P0 or 
P1) mouse pups was as described (18). A two-photon microscope (custom in-
house design by J.D. and B.R.) equipped with a 60x water immersion lens 
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(0.90W, LUMPlanFI/IR, Olympus, Japan) was used for ratiometric EGFP/RFP 
imaging. 
Cell and organotypic tissue cultures  
Organotypic hippocampal slices were prepared from Wistar rats at postnatal 
day 5 (84). 25-day-old cultures were used for all experiments. Primary 
hippocampal neurons were prepared from E18.5 Sprague-Dawley rats and 
cultured on plates coated with laminin (85). They were maintained in culture for 
12 days in Neurobasal Medium (Invitrogen) supplemented with B27 (Invitrogen), 
0.5 mM L-glutamine, and antibiotics. Mouse neocortical primary neurons were 
isolated from E16.5 C57Bl/6 mouse embryos and cultured for 28 days in serum-
free medium, and supplements on dishes coated with poly-DL-ornithine. 
ES cells, derived from blastocysts (3.5 PC) of mixed 129-C57BL/6 
background mice, were cultured on feeder and subsequently without feeder of 
MEF cells, using 3i medium. Differentiation was performed essentially as 
described previously (87) and cells were collected either 15 or 25 days after 
embryoid bodies dissociation. 
Treatment with inhibitors 
For testing the effect of inhibitors on RNA metabolism in retina, animals 
maintained under 12-h light/dark photoperiods were anesthetized and one of 
the eyes was injected both subretinally and intravitreously with 2 μl of 200 μM α-
Am or ActD (106) in 1x PBS containing 1% DMSO. The inhibitors were injected 
10 min before initiating light/dark adaptation experiments (see Figures 4A, B 
and S5A, B). 
Organotypic hippocampal slices and cell cultures were treated with α-Am or 
ActD (both at 10 μg/ml; Sigma) for indicated time. To block voltage-dependent 
Na+-channels, TTX (LATOXAN, France) was added to the medium at final 
concentration of 1 μM either 1.5 h (organotypic slices) or 0.5 h (cell cultures) 
prior to blocking of transcription.  To block ionotropic glutamate receptors, 
NBQX (10 μM, Sigma) plus CPP (10 μM, Sigma) were used. Glutamate was 
added to the medium at final concentration of 10 μM (87), 15 min prior to 
blocking of transcription. 
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Chapter 2: Supplemental experimental procedures  
 
Light/dark adaptation of mice and retina isolation 
C57BL/6 mice were obtained from RCC (Fullinsdorf, Switzerland). Unless 
indicated otherwise, 6 to 8 week old animals were used for the experiments. 
Mice were bred in a pathogen-free environment with ad libitum access to food 
and drinking water. LA animals were kept in a room with the light phase (450 
lux) from 6:00 am (ZT0) to 6:00 pm (ZT12). For dark adaptation, animals were 
kept in a dark chamber with maximum of 0.4 lux. Two light-dark adaptation 
regimes were used. In one regime, some animals were transferred to light at 
ZT0, while other group was maintained in dark till ZT3. Both groups were then 
sacrificed. In a second regime, all animals were moved to light at ZT0 and one 
half of the group was then moved to dark at ZT3 for 3 hours. All animals were 
sacrificed at ZT6. Since changes in the light-regulated miRNA levels did not 
significantly differ between the two regimes of light-dark adaptation, the data 
from both regimes were combined together. For kinetic experiments, details of 
the retinas collection are indicated in individual figures. Unless indicated 
otherwise, in different experiments, retinas originating from three to ten animals 
per group were pooled together and used for RNA extraction. Animals were 
sacrificed by cervical dislocation and retinas were immediately dissected from 
enucleated eyes in RNase free conditions. Retinas from DA mice were isolated 
under dim red light. Procedures described above and also other procedures 
with mice and rats, described further below, were conducted in accordance with 
the animal care and use guidelines of the Veterinary Department Basel-Stadt. 
FACS isolation of retinal cells 
To obtain retinal Müller glia cells tagged with Red Fluorescence Protein (RFP), 
hemizygous PDGFRa-CRE mice (113) were crossed with floxed-RosaRFP mice 
(114) to generate mice hemizygous for PDGFRa/RosaRFP allele. Retinal rod 
bipolar cells tagged with Enhanced Green Fluorescence Protein (EGFP) were 
isolated from FVB-Tg (Pcp2-EGFP)2Yuza/J mice (The Jackson Laboratory, Bar 
Harbor, USA) expressing EGFP under the direction of the mouse Purkinje cell 
protein 2 promoter (115). Retinal amacrine cells were FACS-sorted using 
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retinas from Tg(Ier5-EGFP)267Gsat mice (MMRRC, Mutant Mouse Regional 
Resource Center, USA), expressing EGFP under the immediate early response 
5 promoter in subpopulation of amacrine cells (116). Adult LA animals were 
anesthetized and their eyes were injected intraocularly with a solution 
containing 200 μM α-Am and 1% DMSO in 1x PBS (right eye; see below) or 
with a control buffer containing no α-Am  (left eye). After 3 h, retinas from 5 
mice were isolated and dissociated to single cells by digestion with papain as 
described (112). RFP- or EGFP-positive cells were enriched using FACS and 
used for RNA extraction with Trizol reagent.  
In situ hybridization  
Retinas from LA mice were dissected in PBS containing diethyl pyrocarbonate   
(DEPC), fixed in 4% paraformaldehyde (PFA) in PBS for 20 min, infiltrated with 
30% sucrose, and embedded in Shandon M-1 embedding matrix. 20-μm-thick 
sections were cut and picked up on Superfrost™ slides. After brief wash in 
PBS, retinal sections were treated with 10 μg/ml Proteinase K (Roche) for 6 
min, post-fixed in 4% PFA and acetylated with 0.25% acetic anhydride in 0.1 M 
triethanoloamine. RNA in situ hybridization was performed as described (112, 
117) with some modifications. Briefly, slides were prehybridized for 1 h at 50°C 
in a buffer containing 10 mM Tris pH 7.5, 600 mM NaCl, 1 mM EDTA, 50% 
formamide, 0.25% SDS, 10% dextran sulfate, 1x Denhardt’s solution, 200 μg/ml 
yeast tRNA, and 2 mM vanadium ribonucleotide complex. Slides were 
hybridized in the same buffer for 16 h at 55°C with 100 ng per slide of 
digoxigenin (DIG)-labeled miRCURY LNA probe (Exiqon) in a chamber 
humidified with 50% formamide and 5x SSC. We used predesigned miRCURY 
LNA probes for mmu-miR-182 (Exiqon 39474-00), mmu-miR-96 (39208-00), 
mmu-miR-183 (39071-00), mmu-miR-211 (39105-00), mmu-let-7b (39001-00). 
Mutant LNA probes, containing six bases with mismatches (underlined) to 
mature miRNA, were as follows: mut-miR-182 
(GTGTCAACTACCTAAGCCATA), mut-miR-183 
(CAGTGTTAACTACCTCAGCCTAA), mut-miR-96 (AGCAATTTAGTGCT 
TCAGCCAA), mut-miR-204 (CAGGCAATCGATGACTTTCGGAA), mut-let7b 
(AACCGGACAACCTAAAGCCTCA). Slides were washed ones in 50% 
formamide/1x SSC, with 2x SSC, and with 0.2x SSC, each time for 30 min at 
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50°C. Sections were then shortly reequilibrated in 0.1 M maleic acid buffer 
(MABT; pH 7.5) containing 0.1% Tween 20, blocked for 1 h in 10% donkey 
serum (Chemicon, Millipore) in MABT, and incubated overnight at 4°C with anti-
DIG alkaline phosphatase (AP)-conjugated Fab fragment (1:2000). Sections 
were rinsed in MABT and AP buffer (100 mM Tris, pH 9.5, 50 mM MgCl2, 100 
mM NaCl, 0.1% Tween 20) and signals were developed with nitroblue 
tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate, supplemented with 2 
mM levamisol hydrochloride (Fluka), in the dark for 2 h. Finally, retinal sections 
were dehydrated and mounted using UltraKit (Medite Medizintechnik AG), 
examined, and photographed using an Axiophot microscope (Carl Zeiss 
MicroImaging) connected to a DFC480 camera (Leica).  
Cell and organotypic tissue cultures  
Organotypic hippocampal slices were prepared from Wistar rats at post-natal 
day 5 as described (84). Twenty-five days old cultures of hippocampal slices 
were used for all experiments. Primary hippocampal neurons were prepared 
from E18.5 Sprague-Dawley rats and cultured on plates coated with laminin as 
described (85). They were maintained in culture for 12 days in Neurobasal 
medium (Invitrogen) supplemented with B27 (Invitrogen), 0.5 mM L-glutamine, 
and antibiotics. Mouse neocortical primary neurons were isolated from E16.5 
C57Bl/6 mouse embryos and cultured in serum-free medium and supplements 
on dishes coated with poly-DL-ornithine (0.5 mg/mL) as described (118-120). 
Twenty-eight days old cultures of neocortical neurons were used for all 
experiments. 
ES cells, derived from blastocysts (3.5 PC) of mixed 129-C57BL/6 
background mice, were cultured on feeder and subsequently without feeder of 
MEF cells, using 3i medium (121). Differentiation was performed essentially as 
described previously (122) and unless indicated otherwise, cells were collected 
either 15 or 25 days after embryoid bodies dissociation. 
Mouse NIH3T3 cells were grown in Dulbecco’s modified Minimum 
Essential Medium (DMEM; Invitrogen, Basel, Switzerland) supplemented with 2 
mM L-glutamine and 10% heat-inactivated fetal calf serum (FCS) at 37°C in a 
humidified atmosphere containing 5% CO2. The h-TERT-immortalized human 
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retinal pigmented epithelium (RPE-1) cell line (Clontech Laboratories, Inc., Palo 
Alto, CA) was maintained in DMEM:F-12 nutrient mixture (Gibco) supplemented 
with 2 mM L-glutamine, 10% FCS and 0.348% sodium bicarbonate at 37°C in a 
humidified atmosphere containing 5% CO2. 
454 sequencing  
Total RNA from retinas of ten LA or DA seven-week-old mice was extracted 
with Trizol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer’s 
instructions. cDNA libraries for 454 sequencing were prepared by Vertis 
Biotechnologie AG (Freising, Germany). Briefly, 50 μg of RNA was combined 
with 25 fmol of 5´-end-32P-labeled 15-nt and 30-nt RNA size markers, 
electrophoresed on a 15% polyacrylamide denaturing gel, and gel fragments 
containing 15 to 30-nt-long RNA were excised. RNA was eluted in 300 μL 0.3 M 
NaCl, the eluate passed through a 0.2 μm Nanosep 100 microcolumn and was 
ethanol-precipitated with 20 μg of glycogen as a carrier. RNA was 3’-
polyadenylated, reverse-transcribed using oligo(dT) as a primer, and 454 
adapter oligonucleotides were ligated to the cDNA 5’-end. Sequencing was 
performed by 454 Life Sciences Inc., Branford, CT. Sequences of RNA inserts 
were extracted from 454 reads (average length 91.2 nt) by removing exact 
matches to the 5’ adapter 24-mer sequences 
(CTNNNNGACCTTGGCTGTCACTCA, containing a 4 nt barcode) from the 
beginning of the read, and any matches to a sequence of four or more adenines 
that were at least 17 nt downstream of the removed 5’ adapter. This procedure 
identified inserts in 99.5% of the reads, yielding sequences of an average length 
of 22.3 nt. These were then aligned to reference sequences for assignment to 
biological classes, in the following order: pre-miRNA (miRBase 10.1), rRNA 
(from GenBank R164), tRNA (from http://lowelab.ucsc.edu/GtRNAdb), snRNA 
and snoRNA (GenBank R164), piRNA (from (123)), repBase (release 13.02), 
mRNA (GenBank R164). Alignments were performed using oligomap (124), 
only considering perfect matches to reference sequences. Manual inspection of 
imperfect alignments indicated a high frequency of adenines in read sequences 
(close to their 3-termini) that were aligned to single nucleotide gaps in reference 
sequences. These “insertions” were likely caused by the strong adenine signal 
originating from the sequencing of the polyA tail in neighboring wells on the 
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sequencing plate. We therefore allowed for up to two non-templated adenines in 
read sequences to be removed if no perfect match of a read to any reference 
sequence was found. This increased the percentage of mapped reads from 
47% to 95%. Of 36,056 and 39,331 sequences that were obtained from DA and 
LA libraries, 15,729 (44%) and 17,003 (43%) mapped to known miRNA 
sequences, respectively. miRNAs were quantified by counting reads aligned to 
pre-miRNA hairpins, assigning them to mature or mature-star forms depending 
on the alignment coordinates within the hairpin and mature miRNA sequence 
annotation from miRBase.  
microRNA array profiling 
MicroRNA array profiling was performed by Exiqon, using miRCURY LNA array 
versions 10.0 (experiment I) or 11.0 (experiment II) (Exiqon, Vedbaek, 
Denmark). Total RNA from retinas of LA or DA seven-week-old mice was 
extracted with Trizol reagent. The quality of the total RNA was verified by an 
Agilent 2100 Bioanalyzer profile. 1 μg (experiment I) or 400 ng (experiment II) of 
total test RNA and reference RNA was labeled with Hy3 and Hy5 fluorescent 
compound, respectively, using the miRCURY LNA Array power labeling kit 
(Exiqon), as described by the manufacturer. The reference RNA sample 
corresponded to either a pool of RNA from 10 different mouse organs 
(experiment I) or a pool of all test retinal RNA samples used in the experiment 
(experiment II). The Hy3-labeled test RNA and the Hy5-labeled reference RNA 
were mixed pairwise and hybridized to the miRCURY LNA arrays. The 
hybridization was done according to the miRCURY LNA array manual using a 
Tecan HS4800 hybridization station (Tecan, Austria). After hybridization, the 
microarray slides were scanned and stored in an ozone-free environment 
(ozone level below 2.0 ppb) to prevent potential bleaching of the fluorescent 
dyes. The miRCURY LNA array microarray slides were scanned using the 
Agilent G2565BA Microarray Scanner System (Agilent Technologies, Inc., 
USA), and the image analysis was carried out using the ImaGene 7.0 
(experiment I) or 8.0 (experiment II) software (BioDiscovery, Inc., USA). The 
quantified signals were background corrected using the “Normexp with offset 
value 10” (125) followed by normalization using the global Lowess (locally 
weighted scatterplot smoothing) regression algorithm. In experiment I, pools of 
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retinas originating from LA or DA animals were analyzed on single arrays. In 
experiment II, two pools of retinas, for each LA and DA groups of animals 
(collected on different days) were analyzed; the data represent averages from 
these two biological replicates.   
Quantification of mature miRNAs by RT­qPCR 
Total RNA from mouse retina, dissected retina layers, or cell or tissue slice 
cultures was isolated with Trizol. For analysis of miRNA levels in mouse or rat 
material, we used the Applied Biosystem Taqman® microRNA Assay System 
(Applied Biosystems, Foster City, CA). RT reactions, in a final volume of 7.5 μl, 
contained: 1x RT buffer, 5 ng RNA, 50 nM miRNA-specific RT primer, 0.25 mM 
each dNTP, 0.25 U/μl RNase inhibitor, and 3.33 U/μl MultiScribe RT, and were 
incubated for 30 min at 16°C, 30 min at 42°C, 5 min at 85°C and then held at 
4°C. For each RNA preparation, RT-qPCR reactions (including RT steps and no 
template control), were performed in triplicate. RT-qPCR was performed using 
an Applied Biosystems Prism 7000 Sequence Detection System. The 10 μl 
PCR reactions contained 0.67 μl RT product, 1x Taqman Universal PCR master 
mix, and 1 μl of primers and a probe mix of the Taqman® MicroRNA Assay. The 
reactions were incubated in a 96-well optical plate at 95°C for 5 min, followed by 
40 cycles of 95°C for 15 s and 60°C for 60 s. The threshold cycle (Ct) values 
were determined using default threshold settings. The Ct is defined as the 
fractional cycle number at which the fluorescence passes the fixed threshold.  
The Ct values determined for each sample were normalized to the 
average Ct obtained for U6 RNA, calculated from triplicate reactions. Estimation 
of miRNA copy numbers was performed as described previously (126). Briefly, 
standard curves were generated using HPLC- and polyacrylamide-gel-
electrophoresis (PAGE)-purified oligoribonucleotides (Microsynth, Switzerland) 
corresponding to miR-182, miR-183, miR-96, miR-204, miR-211, let-7b, miR-
29c, and miR-124a miRNAs. The Ct values obtained from different reactions 
were converted to absolute copy number of specific miRNAs per 10 pg of total 
RNA from retina tissue using appropriate standardization curves.  
RT­qPCR quantification of miRNA precursors and mRNAs 
Total RNA, treated with RNase-free DNase I, was reverse transcribed to using 
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random hexamers and Superscript III thermostabile RT (Invitrogen). A 1 μg 
aliquot of RNA mixed with random primers was denatured at 65°C for 5 min and 
cooled to room temperature for 10 min to allow the hexamers to anneal. The 
remaining reagents (5 x Buffer, dNTPs, DTT, RNase inhibitor, Superscript III 
RT) were added as specified in Superscript III RT protocol and reactions were 
incubated for 60 min at 42°C. RT was inactivated by 5 min incubation at 85°C. 
Control reactions lacked Superscript III RT. All pri-miRNA- and pre-miRNA-
specific primers were designed using criteria described previously (127). RT-
qPCR was performed using standard protocol of Applied Biosystems Prism 
7000 Sequence Detection System.  Briefly, 1 μl of a 1/10 dilution of cDNA was 
added to 10 μl of the 2x SYBR green PCR master mix (Applied Biosystems) 
containing 0.5 μM primers. The reactions were amplified for 15 s at 95°C and 1 
min at 60°C for 40 cycles. Each reaction was performed in triplicate and the 
data normalized to either U6 snRNA or 18S rRNA. Sequences of primers are 
provided in Table S3.  
RNase Protection Assays 
RNase Protection Assays (RPA) were performed using the mirVana miRNA 
probe construction and detection kits (Ambion), according to the manufacturer’s 
instructions. Templates used for preparation of RPA probes complementary to 
miRNAs were: miR-182, TTTGGCAATGGTAGAACTCACCCTGTCTC; miR-
183, TATGGCACTGGTAGAATTCACCCTGTCTC; miR-96, 
TTTGGCACTAGCACATTTTTGCCTGTCTC; miR-204, 
TTCCCTTTGTCATCCTATGCCTCCTGTCTC; let-7b, 
TGAGGTAGTAGGTTGTGTGGTTCCTGTCTC. Briefly, RPA reactions 
contained 5 fmol (100,000 cpm) of internally-labeled (with [α-32P]UTP) and 
PAGE-purified RPA probe and 3 μg of total retina RNA. Hybridization was 
carried out overnight at 42°C and RNase A/T1 digestion was at 37°C for 30 min. 
The protected fragments were analyzed by 12% PAGE under denaturing 
conditions and quantified with PhosphorImager (Typhoon, Molecular 
Dynamics). 
Affymetrix microarray analysis 
Gene expression in retina cell layers originating from either LA or DA animals 
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was assessed using Affymetrix GeneChip® Mouse Gene 1.0 ST Arrays 
representing over 28,800 genes, with 27 probes spread along each gene. 
Analysis was performed at Functional Genomics Facility of the Friedrich 
Miescher Institute for Biomedical Research. RNA (100 ng) from the LCM-
dissected ~20,000 cells was processed according to Total RNA Labeling 
Protocol as per manufacturer’s instructions. Array analysis (two arrays per 
experiment) was performed with RNA originating from two independent 
experiments. Fragmented cRNA was hybridized to GeneChip 1.0 ST arrays 
according to the manufacturer’s instructions. Quality control and background 
normalization was performed using Refiner 4.1 from Genedata AG (Basel, 
Switzerland). Expression value estimates were obtained using the GC-RMA 
implementation in Refiner 4.1. Quantile-normalization and median scaling of the 
genes called present (detection p value <0.05) was performed in Genedata’s 
Analyst 4.1 package. Data analysis was performed using Expressionist Analyst 
4.1 from Genedata AG. Genes were required to pass a t-test (1-way ANOVA) 
with a p < 0.05. For photoreceptor cell layer, genes having a fold change of 1.5 
or greater (relative to median) (Figure S2A and Table S4) between two 
conditions (DA versus LA retinas) were identified. Microarray data were 
deposited in the GEO database (GSE20396). 
Reporter assays 
Luciferase reporters. Renila luciferase vector (pRL) was as described (128). To 
generate firefly luciferase vector (pFL) containing a CMV promoter, the CMV 
promoter region was excised from pRL as a NheI-BamHI fragment and inserted 
into corresponding sites in the pGL4.10[luc2] (Promega). RL and FL cDNAs 
contain codons optimized for better expression in mammalian cells. A full-length 
3’UTR of mouse Slc1a1 mRNA (positions 1649-3708, NM_009199) was 
generated by RT-PCR using retinal cDNA as a template. The amplified 
fragment was cloned into XbaI site present downstream of the FL ORF in pFL. 
A mutant containing 3 bases non-complementary to the miRNA seed region in 
each miRNA binding site was created using a Quick-Change II XL Site-Directed 
Mutagenesis Kit (Stratagene), according to the manufacturer’s protocol. miRNA 
mimics of miR-96, miR-182, miR-183 and a non-targeting control mimic were 
obtained from Dharmacon.  
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Mouse NIH3T3 cells were seeded onto 6-well plates one day before 
transfections. Cells (~60% confluent) were transfected with pFL-Slc1a1_wt or 
_mut (100 ng per well), pRL vector (100 ng per well), and miRNA mimics (5 
nM). All transfections were carried out in triplicate with Nanofectin siRNA Kit, 
according to the manufacturer’s instructions (PAA, Austria). Cell lysates were 
prepared with Passive Lysis Buffer (Promega) 48 h after transfection and 
luciferase activities were measured using the Dual Luciferase Reporter Assay 
(Promega).  
EGFP reporters. The wt or mutant 3’UTR regions of Slc1a1 mRNA were cloned 
in XbaI site downstream of the EGFP ORF in pd1EGFP-N1 reporter (Promega). 
The RFP coding region was excised from pDsRed2-N1 (Promega) as EcoRI-
NotI fragment and inserted into corresponding sites in the pd1EGFP-N1 to 
replace EGFP and yielding control pDsRed plasmid. NIH3T3 cells were 
transfected with pEGFP-Slc1a1_wt or _mut reporters, pDsRed and miRNA 
mimics as described above. Cells were analyzed on a FACSCalibur Flow 
Cytometer (Becton Dickinson Immunocytometry Systems), using Cell Quest Pro 
acquisition software. Green and red fluorescence was measured using a 530 
BP 30 nm and 630 BP 22 nm band pass filters, respectively. Gates were set to 
exclude necrotic cells and cellular debris, and the fluorescence intensity of 
events within the gated regions was quantified. Data were collected from 20,000 
events for each sample. 
Construction of sponge plasmids and viruses 
Sponge sequences specific for mouse miR-182, miR-183 and miR-96 were 
designed to have eight miRNA binding sites for each individual miRNA, 
interrupted by 15-nt spacers. The triple sponge for all three miR-183/96/182 
cluster miRNAs contained four binding sites for each miRNA. Binding sites for 
miRNAs were perfectly complementary to seed region, with a bulge at positions 
9-12 to prevent cleavage of the sponge RNA (Figure S3C-F). Sequences of 
spacers and bulged nucleotides were optimized to have random nucleotide 
composition and to keep sponge regions unstructured (M.S. and V.B., 
unpublished data). Sponge regions, originally assembled in pJ241 plasmids 
(DNA 2.0, CA, USA), were cloned into XbaI site downstream of the EGFP ORF 
109
 
 
in pd1EGFP-N1. Correctness of all reporter and sponge plasmids was verified 
by sequencing. NIH3T3 cells were cotransfected with sponge plasmids, pFL-
Slc1a1_wt or _mut reporters, control pRL reporter, and miRNA mimics, as 
described above. A ratio of sponge plasmid to target reporter was 8:1. 
Luciferase assays were performed 48 h post-transfection.  
To generate AAV constructs, the triple sponge sequence was excised 
from pJ241 vector using flanking HindIII sites and cloned into the EGFP 3’UTR 
region of AAV2-Rho-EGFP (36). AAV2-Rho-EGFP containing no sponge region 
served as a control (AAV2-Rho-EGFP/control). Recombinant AAVs (serotype 7) 
were produced by Penn Vector Core (Gene Therapy Program, PA). Penn 
Vector Core analyzed the genome copy (GC) number by real time PCR 
(TaqMan reagents, Applied Biosystems) as: 1.49E+13 GC/mL (AAV2-Rho-
EGFP/triple) and 3.81E+12 GC/ml (AAV2-Rho-EGFP/control). 
AAV administration and immunohistochemistry 
For AAV administration, the eyes of anesthetized animals were punctured in the 
sclera close to the lens by a sharp 30 gauge needle. 2 μL of AAV particle 
suspension were injected subretinally by a Hamilton syringe. After 3 weeks, 
some of the isolated retinas were fixed for 30 min in 4% PFA in PBS, followed 
by a washing step in PBS at 4°C. A Leica VT1000S vibratome was used to cut 
cross sections (150 μm) of retinas embedded in 3% agarose in PBS. The 
sections were treated with 10% normal donkey serum (NDS), 1% BSA, 0.5% 
Triton X-100 in PBS for 1h at room temperature. Treatment with polyclonal 
rabbit anti-GFP Ab (Molecular Probes Inc.; 1:200) in 3% NDS, 1% BSA, 0.5% 
Triton X-100 in PBS was for days at room temperature. Treatment with 
secondary donkey anti-rabbit Alexa Fluor-488 Ab (Molecular Probes Inc.; 1:200) 
and DAPI, was for 2 h. Sections were washed, mounted with ProLong Gold 
antifade reagent (Molecular Probes Inc.) on glass slides, and photographed 
using a Zeiss LSM 510 Meta Axioplan 2 laser scanning confocal microscope 
(Carl Zeiss Inc.). Remaining retinas were used for the LCM dissection of 
photoreceptor layers (see above).  
In vivo retinal electroporation and two­photon ratiometric imaging 
Subretinal injection and in vivo electroporation of plasmids into newborn (P0 or 
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P1) mice was performed as described previously (18). Briefly, the pups were 
anesthetized and a small incision was made in the eyelid and sclera near the 
lens with a 30-gauge needle. DNA solutions (~5 μg/μl of each plasmid) in PBS 
containing 0.1% fast green dye were injected into the subretinal space through 
the incision by using a Hamilton syringe with a 32-gauge blunt-ended needle. 
For electroporation, tweezer-type electrodes (model 520, 7 mm diameter; BTX, 
San Diego, CA) were used and five square pulses of 50-ms duration with 950-
ms intervals were applied by using a pulse generator. Plasmids pEGFP-
Slc1a1_wt or _mut were coelectroporated with pDsRed into right eyes only.  
A two-photon microscope (custom in-house design by J.D. and B.R.) 
equipped with a 60x water immersion lens (0.90W, LUMPlanFI/IR, Olympus, 
Japan) was used for ratiometric EGFP/RFP imaging. The excitation source was 
a mode-locked Ti:Sapphire laser (Mai Thai HP, Spectra Physics, CA) tuned to 
930 nm. Two-channel recording allowed simultaneous measurement of 
EGFP/RFP-signals (EGFP filter: 515 BP 30; RFP filter: 605 BP 75). Images 
from fluorescent photoreceptor somata were acquired in whole mount retina. 
The data were analyzed with MATLAB (MathWorks, Inc.). 
Western blotting 
Retinas were lysed on ice in a buffer containing 50 mM Tris pH 7.5, 10 mM 
DTT, 10 mM EDTA, 1% SDS, and 1x complete protease inhibitor cocktail 
(Roche).  Protein lysates (20 μg/lane) of were separated by SDS-PAGE 
followed by electrotransfer to PVDF membrane (Millipore). Membranes were 
incubated for 2 h at room temperature with primary antibodies: anti-SLC1A1(a) 
(Invitrogen; 1:200), anti-SLC1A1(b) (Chemicon; 1:300), anti-SLC1A1(c) (Alpha 
Diagnostic Int.; 1:1,000), anti-Dicer (129) (1:500), anti-Drosha (Abcam, 1:200), 
anti-PAIP2 (recognizing both isoforms A and B; (130), 1:500), anti-ATP1B3 
((131), 1:500) or anti-β-tubulin mAb (Sigma; 1:10,000), and then with 
peroxidase-conjugated secondary antibodies. For ATP1B3 detection protein 
lysates were treated with N-glycosidase F (Roche) as described (131). 
Immunoreactive bands were visualized using Amersham ECL Western blotting 
detection reagents (GE Healthcare). For quantitative Westerns, IRDye® 680 or 
IRDye® 800CW secondary antibodies were used and membranes were 
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analyzed with the Odyssey Infrared Imaging System (LI-COR Biosciences). For 
Western analysis of proteins isolated from LCM microdissected cell layers, ~5 
μg/lane of the protein lysate was separated by SDS-PAGE and Super Signal 
WestFemto Trial kit (ThermoScientific) was used for detection. Protein ladder 
PageRulerTM Plus (Fermentas) was used as a protein size marker. Anti-PAIP2 
and anti-ATP1B3 antibodies were kindly supplied by N. Sonenberg (McGill 
University) and K. Sweadner (Harvard Medical School, Boston), respectively.  
Immunofluorescence 
ES cell-derived terminal neurons or hippocampal neurons were fixed in 4% 
paraformaldehyde/4% sucrose for 15 min and permeabilized with buffer 
containing 20 mM sodium phosphate pH 7.4, 450 mM NaCl, 0.3% Triton and 
0.1% Gelatine. For Western analysis, anti-NeuN (Chemicon, 1:1000) and anti-
GFAP (DAKO, 1:1000) primary mAbs were used together with secondary 
Alexa488/594 anti-mouse/rabbit antibodies. 
Multi­electrode array (MEA) recordings 
ES cell-derived terminal neurons were differentiated as described above and 
plated on 0.1% polyathyleneimine (PEI)/laminin coated MEAs (Multi Channel 
Systems MCS GmbH, Reutlingen, Germany). PEI coating was prepared 
according the manufacturer instructions (Multi Channel Systems). Spontaneous 
network activity was recorded using MEA dishes with a square array of 59 
substrate-embedded titanium nitride microelectrodes (30 μm diameter, 200 μm 
inter-electrode distance), and an internal embedded reference electrode 
(200/30iR-Ti-gr). The MEA dishes were sealed with a semi-permeable 
membrane (ALA MEA-MEM, ALA Scientific Instruments Inc.,Westbury, NY) to 
prevent contamination. The signals were repeatedly recorded using MEA 
amplifier (MEA-1060-2-BC, Multi Channel Systems) and filtered between 500 
Hz (low cut-off) and 3500 Hz (high cut-off). At given time points, spikes were 
recorded for four minutes. Spikes were extracted with a threshold of at least 4 
times the standard deviation of the recorded trace (Matlab, Mathworks).   
Cell viability assays 
For cell viability assays, a LIVE/DEAD Viability/Cytotoxicity Kit for mammalian 
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cells was used as per manufacturer’s instructions (Molecular Probes, 
Invitrogen). For hippocampal slice cultures, calcein AM (CalAM; 0.5 μM) and 
ethidium homodimer-1 (EthD-1; 1 μM) were added to the medium following 
treatment with α-Am, TTX + α-Am, or buffer alone and incubation continued at 
37°C for 20 min. CalAM stains living cells and emits green light at 515 nm, 
whereas EthD-1 stains dead cells and emits red light at 635 nm. Slices were 
imaged using a custom-built two-photon microscope controlled by ScanImag 
(132). Integrated green and red fluorescence signals were collected from three 
independent regions of each slice. Photomultiplier dark noise was measured 
before shutter opening and subtracted from the dataset. For ES-cell-derived 
neurons, cell viability test was performed using the same LIVE/DEAD Kit 
described above. Cells stained with CalAM and EthD-1 were imaged using 
Axiovert 200 fluorescence microscope. Numbers of live and dead cells were 
counted in 10 pictures taken from two independent cultures.   
For assessment of apoptotic cell death in hippocampal primary neurons, 
chromatin state in nuclei was analyzed by staining cells with Hoechst 33342 dye 
(Invitrogen), following treatment with α-Am, TTX + α-Am, or buffer alone. Cells 
containing uniformly stained nuclei were scored as healthy viable cells, while 
cells containing condensed or fragmented nuclei were scored as apoptotic cells.  
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Chapter 3.1 ­ Methods 
Transgenic mice  
TN-L15, a gift of O. Griesbeck, was excised from TN-L15/pcDNA3 1 with BamHI 
(5’) and EcoRI (3’). The 1860-bp fragment was subcloned into pBluescriptII 
KS(+) (Stratagene) using BamHI (5’) and EcoRI (3’) restriction sites and further 
subcloned into pULmEB (pcDNA3.1(+) backbone from Invitrogen) using KpnI 
(5’) and NotI (3’) sites. An EcoRI fragment was isolated and was blunt-ended 
using T4 polymerase and inserted into the XhoI cut and blunt-ended pThy1-
mEGFP vector2 yielding pTTN. This plasmid was linearized with NotI and PvuI. 
The linear fragment was used for pronuclear injections to generate transgenic 
mice. 
 
Chapter 3.2 – Methods 
RNA Studies 
Whole hippocampi were dissected and snap-frozen on dry ice. Tissue was 
homogenized by sonication. Total RNA was isolated using Trizol (Invitrogen) 
according to supplier’s recommendations. For real-time PCR analysis RNA was 
treated twice with DNase (DNAFreeTurbo, Ambion). 0.5 mg of RNA was used 
for the reverse transcription performed with random primers (Invitrogen) and 
SuperscriptII (Invitrogen) according to supplier’s recommendations. SYBR 
green quantitative real-time PCR was performed with Power SYBR Green PCR 
Master Mix (Applied Biosystems) using standard procedures. Data was 
quantified using the ΔΔCt-method and were normalized to Gapdh and b-actin 
expression. All data shown is normalized to Gapdh. Actin-normalized data were 
very similar to Gapdh data. Primers were designed using PrimerExpress 
software (Applied Biosystems). The efficiency of all primer pairs were confirmed 
by performing reactions with serially diluted samples. The specificity of all 
primer pairs were confirmed by analyzing the dissociation curve. Primer 
sequences are found in Table S5. For analysis of the real-time PCR data one-
way ANOVA followed by Tukey’s post hoc test was used. The criterion for 
114
 
 
significance for all analyses was p < 0.05. All data are expressed as mean ± 
SEM. 
Chapter 3.3 –Methods 
Plasmid DNA Construction and In vivo Electroporation. 
DNA constructs were generated using standard molecular biology protocols. A 
200-base pair DNA sequence corresponding to nucleotide positions –8583 to –
8384 relative to the ATG start codon of the mouse metabotropic glutamate 
receptor subtype 6 (GRM6) gene1 (nucleotide positions 16160939 to 16161138 
of Mus musculus chromosome 11 genomic contig with Genbank accession no. 
NT_096135) was defined as a GRM6 enhancer element (D.S.K. and C.L.C., 
manuscript in preparation). This element was amplified from the genomic 
sequence upstream of the GRM6 coding region using the primers 5’–
gactagtGATCTCCAGATGGCTAAAC–3’ and 5’ 
ccgctcgagCAACCAGTCTTGTTTGAGCC–3’ to give the 200-base pair enhancer 
sequence, 5’-
GATGATCTCCAGATGATGGCTAAACTTTTATTAAATAATCATCATGAATGAA
GTAGATATTATTATTACTACCAAATTATTGCTTTTCAGCATCCATTATTTAGT
AGATAATAATAATCATCATGATGTTTTTTGCCTTTAATAATCTGTTATTAATG
ATGTAGTAGTGAATTATTAAGAAATAATAATACATCATTTCCTACTAAATAAT
CATCATTACTACATCATCCCCCAAATCATCGTTAATAATCTGCTACTAAAGT
ACTACATCATCTCTGGCTCAAACAAGACTGGTTG–3’, flanked by SpeI and 
XhoI restriction enzyme recognition sequences. The isolated GRM6 enhancer 
element was fused to a SV40 eukaryotic promoter sequence from the pGL3-
Promoter vector (Promega Corp.). The GRM6 enhancer-SV40 promoter fusion 
product was inserted into a modified2 pCAGGS vector (133) lacking the CAG 
promoter. The cDNA encoding a ChR2-EYFP fusion protein was excised from 
the pLECYT lentiviral vector (kind gift from K. Deisseroth) (134) and cloned 
downstream of the GRM6 enhancer-SV40 minimal promoter elements to 
produce the pGRM6-CY expression plasmid. Subretinal injection and in vivo 
electroporation of the pGRM6-CY plasmid into newborn (P0 or P1) mouse pups 
was performed as previously described (18). Plasmid DNA was transfected into 
right eyes only. 
115
 
 
References 
1. R. H. Masland, Nat Neurosci 4, 877 (Sep, 2001). 
2. B. Roska, A. Molnar, F. S. Werblin, J Neurophysiol,  (Mar 1, 2006). 
3. B. Roska, F. Werblin, Nature 410, 583 (Mar 29, 2001). 
4. D. Larhammar, K. Nordstrom, T. A. Larsson, Philos Trans R Soc Lond B 
Biol Sci 364, 2867 (Oct 12, 2009). 
5. F. A. Dunn, M. J. Lankheet, F. Rieke, Nature 449, 603 (Oct 4, 2007). 
6. F. A. Dunn, F. Rieke, Neuron 57, 894 (Mar 27, 2008). 
7. J. B. Demb, J Physiol 586, 4377 (Sep 15, 2008). 
8. H. Grosshans, W. Filipowicz, Nature 451, 414 (Jan 24, 2008). 
9. J. K. Phelan, D. Bok, Mol Vis 6, 116 (Jul 8, 2000). 
10. K. Shintani, D. L. Shechtman, A. S. Gurwood, Optometry 80, 384 (Jul, 
2009). 
11. B. Lin, R. H. Masland, E. Strettoi, Exp Eye Res 88, 589 (Mar, 2009). 
12. E. Bamberg, J. Tittor, D. Oesterhelt, Proc Natl Acad Sci U S A 90, 639 
(Jan 15, 1993). 
13. G. Nagel et al., Biochem Soc Trans 33, 863 (Aug, 2005). 
14. F. Zhang et al., Nature 446, 633 (Apr 5, 2007). 
15. A. Bi et al., Neuron 50, 23 (Apr 6, 2006). 
16. P. S. Lagali et al., Nat Neurosci 11, 667 (Jun, 2008). 
17. Y. Zhang, E. Ivanova, A. Bi, Z. H. Pan, J Neurosci 29, 9186 (Jul 22, 
2009). 
18. T. Matsuda, C. L. Cepko, Proc Natl Acad Sci U S A 101, 16 (Jan 6, 
2004). 
19. T. Matsuda, C. L. Cepko, Proc Natl Acad Sci U S A 104, 1027 (Jan 16, 
2007). 
20. S. Daya, K. I. Berns, Clin Microbiol Rev 21, 583 (Oct, 2008). 
21. T. R. Flotte, B. J. Carter, Gene Ther 2, 357 (Aug, 1995). 
22. Z. Boldogkoi et al., Nat Methods 6, 127 (Feb, 2009). 
23. J. Jakobsson et al., Neuron 60, 818 (Dec 10, 2008). 
24. T. Cronin, T. Leveillard, J. A. Sahel, Curr Gene Ther 7, 121 (Apr, 2007). 
25. R. E. Marc, B. W. Jones, C. B. Watt, E. Strettoi, Prog Retin Eye Res 22, 
607 (Sep, 2003). 
26. Z. Y. Li, I. J. Kljavin, A. H. Milam, J Neurosci 15, 5429 (Aug, 1995). 
27. A. H. Milam, Z. Y. Li, R. N. Fariss, Prog Retin Eye Res 17, 175 (Apr, 
1998). 
28. E. Banin et al., Neuron 23, 549 (Jul, 1999). 
29. B. Schobert, J. K. Lanyi, J Biol Chem 257, 10306 (Sep 10, 1982). 
30. A. Seki et al., Biophys J 92, 2559 (Apr 1, 2007). 
31. V. Gradinaru, K. R. Thompson, K. Deisseroth, Brain Cell Biol 36, 129 
(Aug, 2008). 
32. G. P. Gao et al., Proc Natl Acad Sci U S A 99, 11854 (Sep 3, 2002). 
33. C. Lebherz, A. Maguire, W. Tang, J. Bennett, J. M. Wilson, J Gene Med 
10, 375 (Apr, 2008). 
34. E. Claes et al., Invest Ophthalmol Vis Sci 45, 2039 (Jun, 2004). 
35. D. B. Farber, J. G. Flannery, C. Bowes-Rickman, Prog Retin Eye Res 13, 
31 (1994). 
36. M. Allocca et al., J Virol 81, 11372 (Oct, 2007). 
37. Y. Wang et al., Neuron 9, 429 (Sep, 1992). 
116
 
 
38. X. Zhu et al., FEBS Lett 524, 116 (Jul 31, 2002). 
39. C. Punzo, K. Kornacker, C. L. Cepko, Nat Neurosci 12, 44 (Jan, 2009). 
40. S. S. Nikonov, R. Kholodenko, J. Lem, E. N. Pugh, Jr., J Gen Physiol 
127, 359 (Apr, 2006). 
41. W. R. Taylor, D. I. Vaney, J Neurosci 22, 7712 (Sep 1, 2002). 
42. P. Degenaar et al., J Neural Eng 6, 035007 (Jun, 2009). 
43. S. W. Kuffler, J Neurophysiol 16, 37 (Jan, 1953). 
44. T. Gollisch, M. Meister, Neuron 65, 150 (Jan 28). 
45. E. V. Famiglietti, Jr., H. Kolb, Science 194, 193 (Oct 8, 1976). 
46. H. B. Barlow, J Physiol 119, 69 (Jan, 1953). 
47. J. B. Demb, Neuron 55, 179 (Jul 19, 2007). 
48. K. Yoshida et al., Neuron 30, 771 (Jun, 2001). 
49. H. B. Barlow, R. M. Hill, Science 139, 412 (Feb 1, 1963). 
50. M. Bourin, M. Hascoet, Eur J Pharmacol 463, 55 (Feb 28, 2003). 
51. J. Abdeljalil et al., Vision Res 45, 1439 (May, 2005). 
52. R. Zufferey, D. Nagy, R. J. Mandel, L. Naldini, D. Trono, Nat Biotechnol 
15, 871 (Sep, 1997). 
53. B. Chen, C. L. Cepko, Science 323, 256 (Jan 9, 2009). 
54. T. Leveillard, J. A. Sahel, Sci Transl Med 2, 26ps16 (Apr 7). 
55. Y. Yang et al., Mol Ther 17, 787 (May, 2009). 
56. B. Povazay et al., Opt Express 17, 4134 (Mar 2, 2009). 
57. S. G. Jacobson et al., Invest Ophthalmol Vis Sci 51, 1079 (Feb). 
58. N. Grossman et al., J Neural Eng 7, 16004 (Feb). 
59. B. Y. Chow et al., Nature 463, 98 (Jan 7). 
60. U. B. Kaupp, R. Seifert, Physiol Rev 82, 769 (Jul, 2002). 
61. J. C. Corbo, C. A. Myers, K. A. Lawrence, A. P. Jadhav, C. L. Cepko, 
Proc Natl Acad Sci U S A 104, 12069 (Jul 17, 2007). 
62. H. Wassle, Nat Rev Neurosci 5, 747 (Oct, 2004). 
63. Y. Fu, K. W. Yau, Pflugers Arch 454, 805 (Aug, 2007). 
64. E. N. Pugh, Jr., S. Nikonov, T. D. Lamb, Curr Opin Neurobiol 9, 410 
(Aug, 1999). 
65. W. Filipowicz, S. N. Bhattacharyya, N. Sonenberg, Nat Rev Genet 9, 102 
(Feb, 2008). 
66. D. P. Bartel, Cell 136, 215 (Jan 23, 2009). 
67. N. Bushati, S. M. Cohen, Annu Rev Cell Dev Biol 23, 175 (2007). 
68. A. Arora, G. J. McKay, D. A. Simpson, Invest Ophthalmol Vis Sci 48, 
3962 (Sep, 2007). 
69. M. Karali, I. Peluso, V. Marigo, S. Banfi, Invest Ophthalmol Vis Sci 48, 
509 (Feb, 2007). 
70. C. J. Loscher et al., Genome Biol 8, R248 (2007). 
71. S. Xu, P. D. Witmer, S. Lumayag, B. Kovacs, D. Valle, J Biol Chem 282, 
25053 (Aug 24, 2007). 
72. K. S. Kosik, Nat Rev Neurosci 7, 911 (Dec, 2006). 
73. G. Schratt, Nat Rev Neurosci 10, 842 (Dec, 2009). 
74. X. C. Ding, J. Weiler, H. Grosshans, Trends Biotechnol 27, 27 (Jan, 
2009). 
75. S. N. Bhattacharyya, R. Habermacher, U. Martine, E. I. Closs, W. 
Filipowicz, Cell 125, 1111 (Jun 16, 2006). 
76. D. Gatfield et al., Genes Dev 23, 1313 (Jun 1, 2009). 
117
 
 
77. H. W. Hwang, E. A. Wentzel, J. T. Mendell, Science 315, 97 (Jan 5, 
2007). 
78. D. G. Ryan, M. Oliveira-Fernandes, R. M. Lavker, Mol Vis 12, 1175 
(2006). 
79. C. W. Morgans et al., Proc Natl Acad Sci U S A 106, 19174 (Nov 10, 
2009). 
80. Y. Shen et al., J Neurosci 29, 6088 (May 13, 2009). 
81. A. Nieoullon et al., J Neurochem 98, 1007 (Aug, 2006). 
82. A. V. Tzingounis, J. I. Wadiche, Nat Rev Neurosci 8, 935 (Dec, 2007). 
83. M. S. Ebert, J. R. Neilson, P. A. Sharp, Nat Methods 4, 721 (Sep, 2007). 
84. L. Stoppini, P. A. Buchs, D. Muller, J Neurosci Methods 37, 173 (Apr, 
1991). 
85. G. M. Schratt, E. A. Nigh, W. G. Chen, L. Hu, M. E. Greenberg, J 
Neurosci 24, 7366 (Aug 18, 2004). 
86. P. Landgraf et al., Cell 129, 1401 (Jun 29, 2007). 
87. M. Bibel et al., Nat Neurosci 7, 1003 (Sep, 2004). 
88. D. R. Copenhagen, C. E. Jahr, Nature 341, 536 (Oct 12, 1989). 
89. L. Gaal et al., J Neurophysiol 79, 190 (Jan, 1998). 
90. J. Hasegawa, T. Obara, K. Tanaka, M. Tachibana, Neuron 50, 63 (Apr 6, 
2006). 
91. P. Kugler, A. Beyer, Histochem Cell Biol 120, 199 (Sep, 2003). 
92. H. Y. Cheng et al., Neuron 54, 813 (Jun 7, 2007). 
93. G. A. Wayman et al., Proc Natl Acad Sci U S A 105, 9093 (Jul 1, 2008). 
94. S. Impey et al., Mol Cell Neurosci 43, 146 (Jan). 
95. P. Rajasethupathy et al., Neuron 63, 803 (Sep 24, 2009). 
96. P. Sethi, W. J. Lukiw, Neurosci Lett 459, 100 (Aug 7, 2009). 
97. S. W. Flavell, M. E. Greenberg, Annu Rev Neurosci 31, 563 (2008). 
98. S. Chatterjee, H. Grosshans, Nature 461, 546 (Sep 24, 2009). 
99. V. Ramachandran, X. Chen, Science 321, 1490 (Sep 12, 2008). 
100. T. Katoh et al., Genes Dev 23, 433 (Feb 15, 2009). 
101. C. J. Barnstable, U. C. Drager, Neuroscience 11, 847 (Apr, 1984). 
102. D. S. Kim et al., J Comp Neurol 507, 1795 (Apr 10, 2008). 
103. S. Rowan, C. L. Cepko, Dev Biol 271, 388 (Jul 15, 2004). 
104. C. L. Schlamp, E. C. Johnson, Y. Li, J. C. Morrison, R. W. Nickells, Mol 
Vis 7, 192 (Aug 15, 2001). 
105. J. I. Korenbrot, R. D. Fernald, Nature 337, 454 (Feb 2, 1989). 
106. R. Weiler, K. Schultz, M. Pottek, S. Tieding, U. Janssen-Bienhold, Proc 
Natl Acad Sci U S A 95, 7139 (Jun 9, 1998). 
107. S. Shetty, Mol Cell Biochem 271, 13 (Mar, 2005). 
108. S. Blackshaw et al., PLoS Biol 2, E247 (Sep, 2004). 
109. H. L. Schulz, T. Goetz, J. Kaschkoetoe, B. H. Weber, BMC Genomics 5, 
50 (Jul 29, 2004). 
110. T. A. Munch et al., Nat Neurosci,  (Sep 6, 2009). 
111. C. J. Jeon, E. Strettoi, R. H. Masland, J Neurosci 18, 8936 (Nov 1, 1998). 
112. J. M. Trimarchi et al., J Comp Neurol 502, 1047 (Jun 20, 2007). 
113. K. Roesch et al., J Comp Neurol 509, 225 (Jul 10, 2008). 
114. H. Luche, O. Weber, T. Nageswara Rao, C. Blum, H. J. Fehling, Eur J 
Immunol 37, 43 (Jan, 2007). 
115. M. Tomomura, D. S. Rice, J. I. Morgan, M. Yuzaki, Eur J Neurosci 14, 57 
(Jul, 2001). 
118
 
 
116. S. Siegert et al., Nat Neurosci 12, 1197 (Sep, 2009). 
117. D. Damiani et al., J Neurosci 28, 4878 (May 7, 2008). 
118. D. Lindholm, P. Carroll, G. Tzimagiogis, H. Thoenen, Eur J Neurosci 8, 
1452 (Jul, 1996). 
119. A. Weiss et al., J Neurochem 104, 846 (Feb, 2008). 
120. F. Zafra, B. Hengerer, J. Leibrock, H. Thoenen, D. Lindholm, EMBO J 9, 
3545 (Nov, 1990). 
121. Q. L. Ying et al., Nature 453, 519 (May 22, 2008). 
122. M. Bibel, J. Richter, E. Lacroix, Y. A. Barde, Nat Protoc 2, 1034 (2007). 
123. A. Aravin et al., Nature 442, 203 (Jul 13, 2006). 
124. P. Berninger, D. Gaidatzis, E. van Nimwegen, M. Zavolan, Methods 44, 
13 (Jan, 2008). 
125. M. E. Ritchie et al., Bioinformatics 23, 2700 (Oct 15, 2007). 
126. M. Sarasin-Filipowicz, J. Krol, I. Markiewicz, M. H. Heim, W. Filipowicz, 
Nat Med 15, 31 (Jan, 2009). 
127. T. D. Schmittgen, J. Jiang, Q. Liu, L. Yang, Nucleic Acids Res 32, e43 
(2004). 
128. R. S. Pillai et al., Science 309, 1573 (Sep 2, 2005). 
129. E. Billy, V. Brondani, H. Zhang, U. Muller, W. Filipowicz, Proc Natl Acad 
Sci U S A 98, 14428 (Dec 4, 2001). 
130. J. J. Berlanga, A. Baass, N. Sonenberg, RNA 12, 1556 (Aug, 2006). 
131. E. Arystarkhova, K. J. Sweadner, J Biol Chem 272, 22405 (Sep 5, 1997). 
132. N. Holbro, A. Grunditz, T. G. Oertner, Proc Natl Acad Sci U S A 106, 
15055 (Sep 1, 2009). 
133. H. Niwa, K. Yamamura, J. Miyazaki, Gene 108, 193 (Dec 15, 1991). 
134. E. S. Boyden, F. Zhang, E. Bamberg, G. Nagel, K. Deisseroth, Nat 
Neurosci 8, 1263 (Sep, 2005). 
 
  
119
 
 
Curriculum Vitae of Volker Busskamp 
 
Personal Details 
 
Name:   Volker Busskamp 
Date of Birth:  25th December 1980 
Nationality:  German 
Address:  Chesterplatz 6 
D-79539 Lörrach 
Tel:   +49-176-21171450 
Email:   volker.busskamp@fmi.ch 
  
 
Education 
 
Since 10/2007 Friedrich Miescher Institute for Biomedical Research (FMI) in 
Basel and “Frontiers in Genetics” Geneva, Switzerland 
 PhD thesis in Botond Roska’s group 
 
08/2007  University of Geneva, Switzerland 
Post graduate diploma in biology (DEA), average grade: 5.7 
(max. grade 6.0) 
 
Since 10/2006 “Frontiers in Genetics” Graduate School, National Center of 
Competence in Research (NCCR), Geneva, Switzerland 
 
09/2006  Technical University of Braunschweig, Germany 
   Diploma in biotechnologies, average grade: “Sehr gut” (1.1) 
 
120
 
 
10/2005 – 09/2006 Friedrich Miescher Institute for Biomedical Research (FMI) in 
Basel, Switzerland 
External diploma thesis in Neurobiology, Botond Roska’s group 
entitled: “Lighting up neurons in the mammalian retina to 
understand their morphology, connectivity and function”  
Grade: 1.0 
 
 
10/2003 – 10/2005 Technical University of Braunschweig, Germany 
Advanced study period in biotechnologies, Viva voce diploma 
examination in Genetics, Technical Chemistry, Process 
Engineering, Technical Biochemistry and Microbiology, average 
grade: 1.2 
 
10/2001 – 09/2003 Technical University of Braunschweig, Germany 
Intermediate diploma in biotechnologies, average grade: 1.6 
 
08/1991 – 06/2000 Euregio-Gymnasium in Bocholt, Germany 
   Degree: German Abitur, average grade: 1.5 
 
Work experience 
 
05/2007 – 09/2007 Friedrich Miescher Institute for Biomedical Research (FMI) in 
Basel, Switzerland 
 Rotation within the scope of the NCCR graduate school in 
Botond Roska’s lab, project title: “Restoring photoreceptor 
function in blind mice” 
 
01/2007 – 04/2007 Friedrich Miescher Institute for Biomedical Research (FMI) in 
Basel, Switzerland 
Rotation within the scope of the NCCR graduate school in Prof. 
Susan Gasser’s lab, project title: “Telomere position effect in 
yeast” 
121
 
 
 
10/2006 – 12/2006 Ecole Polytechnique Fédérale de Lausanne (EPFL), School 
of Life Sciences, Laboratory of Virology and Genetics (LVG), 
Lausanne, Switzerland 
 Rotation within the scope of the NCCR graduate school in Prof. 
Didier Trono’s lab, project title: “KAP1 knock out effects” 
 
02/2005 – 04/2005 Institute of Developmental Genetics in Braunschweig, 
Germany 
 Student research project in Prof. Ralf Schnabel’s lab, thesis: 
“Establishment of an ADH depending selection system for C. 
elegans” 
   
07/2003 – 06/2004 Institute of Developmental Genetics in Braunschweig, 
Germany  
 Student assistant, tasks: DNA extraction, PCR, DNA sequencing, 
4D microscopy 
 
Publications 
 
Busskamp V, Duebel J, Balya D, Fradot M, Viney TJ, Siegert S, 
Groner AC, Cabuy E, Forster V, Seeliger M, Biel M, Humphries 
P, Paques M, Mohand-Said S, Trono D, Deisseroth K, Sahel JA, 
Picaud S, Roska B. ”Genetic Reactivation of Cone 
Photoreceptors Restores Visual Responses in Retinitis 
pigmentosa”, Science 23 July 2010: Vol. 329. no. 5990, pp. 413 - 
417 
 
Krol J, Busskamp V, Markiewicz I, Stadler MB, Ribi S, Richter J, 
Duebel J, Bicker S, Fehling HJ, Schübeler D, Oertner TG, Schratt 
G, Bibel M, Roska B, Filipowicz W. “Characterizing light-
regulated retinal microRNAs reveals rapid turnover as a common 
property of neuronal microRNAs”, Cell. 2010 May 14;141(4):618-
31. 
 
Boldogkoi Z, Balint K, Awatramani GB, Balya D, Busskamp V, 
Viney TJ, Lagali PS, Duebel J, Pásti E, Tombácz D, Tóth JS, 
Takács IF, Scherf BG, Roska B. “Genetically timed, activity-
sensor and rainbow transsynaptic viral tools”, Nat Methods. 2009 
Feb;6(2):127-30. 
122
 
 
    
Jakobsson J, Coredero MI, Bisaz R, Groner AC, Busskamp V, 
Bensadoun JC, Cammas F, Losson R, Mansuy IM, Sandi C, 
Trono D, “KAP1-mediated Epigenetic Repression in the 
Forebrain Modulates Behavioral Vulnerability to Stress”, Neuron 
2008 Dec 10;60(5):818-31 
 
Lagali PS, Balya D, Awatramani GB, Münch TA, Kim DS, 
Busskamp V, Cepko CL, Roska B. “Light-activated channels 
targeted to ON bipolar cells restore visual function in retinal 
degeneration”, Nat Neurosci. 2008 Jun;11(6):667-75. 
 
 
Fellowships 
 
06/2006 Accepted for the “Frontiers in Genetics” graduate school 
 
01/2006 Accepted for the Friedrich Miescher Institute for Biomedical 
Research (FMI) international PhD program  
 
Skills Profile 
 
IT Competent in Microsoft Windows, Linux and Unix system 
software 
 Extensive knowledge in Microsoft Office 
Image processing (Adobe Photoshop, Adobe Illustrator, Bitplane 
Imaris™) 
  
Languages  English: fluent in writing and speaking 
   German: native speaker 
   French: basic level 
   Latin:  “grosses Latinum” 
123
 
 
Interests & Activities  
  Enjoy travelling and meeting people from different cultures 
  Sports: running, swimming, cycling and football 
  Fond of reading literature books 
  Music and cinema 
 
Additional Information 
 Military obligations fulfilled (07/00 – 04/01) 
 
References    
Available on request 
 
 
124
